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ABSTRACT 
Since the year 2000, researchers have made extensive efforts to develop novel materials with 
self-healing ability by embedment of microencapsulated self-healing agents. The motivation 
behind these studies is to heal the crack once it occurs and to slow down crack growth in the 
materials. These materials were designed with the capability of repairing damage/fracture 
autonomously whenever it happens, and the materials subsequently recover their original 
properties. Many of the early-developed healing systems focused on the healing of polymers 
and their fibre-reinforced composites with a room temperature-curing system. Because of the 
difficulty in applying resins with microcapsules normally around 100 μm in size to reinforcing 
fibres during the fabrication process of composites and due to the limited space between the 
plies, most studies have adopted a low fibre volume fraction for ease of processing and 
fabrication. The realisation to structural composites containing a high fibre volume fraction 
was less studied. In general, a high fibre volume fraction is a critical factor for achieving high 
specific strength and high specific modulus of the resultant composites.  
Firstly, this study aims to develop a diglycidyl ether of bisphenol A (DGEBA) epoxy as the 
self-healing agent and characterise its capability in healing the elevated temperature-cured 
epoxy, epoxy-based adhesive joints, and carbon-fibre reinforced epoxy composites. A dual-
capsule self-healing system containing DGEBA epoxy and mercaptan as its hardener, 
microencapsulated in similar sizes, was developed to be embedded into the base epoxy resin. 
This healing system was chosen to match that of the matrix of composite laminates fabricated 
in this study for its superior thermal stability. Although the DGEBA epoxy/mercaptan self-
healing system has been reported to provide the epoxy with room temperature healing, the high 
viscosity imposed by the healing agent has made room temperature healing conditions less 
reliable for healing of composite laminates of a high fibre volume fraction, where the amount 
of the embedded microcapsules is constrained by fibres. Therefore, the effect of healing 
temperature on viscosity and healing efficiency in the base epoxy is studied to obtain the 
improved healing conditions. It was found that the better healing performance for this healing 
system is achieved at 70°C since the viscosity of DGEBA epoxy is much lower at this 
temperature. With a better flow behaviour, the healing agent has a better capacity to flow and 
spread onto crack surfaces. Apart from that it was also found that the formed healant film 
covering thin cavity between two crack surfaces is critical for the healing performance, and at 
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the elevated temperature of 70°C, the full recovery in fracture toughness (KIC) is achieved for 
Mode I fracture in the epoxy. 
The dual-capsule self-healing system was then extended to heal delamination in carbon fibre 
(CF)/epoxy (EP) composite laminates after Mode I interlaminar fracture. One of the main 
focuses of this study is centred on CF/EP composite laminates embedded with the dual-capsule 
and with a high fibre volume fraction fabricated using the vacuum assisted resin infusion 
technique, with the aims to effectively heal delamination as well as matrix microcracking once 
they occur. Here, it was demonstrated that by properly modulating the amount of microcapsules 
dispersed on reinforcing CF fabrics, CF/EP composite laminates with a fibre volume fraction 
as high as 65% can be achieved.  
The self-healing performance after Mode I delamination in CF/EP composite laminates with 
the dual-capsule self-healing system of two different sizes (average 123 µm and 65 µm, 
respectively) of microcapsules was investigated. Effects of incorporating microcapsules on 
baseline properties of the composite laminates were investigated, and it was found that such 
incorporation first leads to some reduction in the baseline properties of the laminates. The 
CF/EP laminate with large size (123 µm) microcapsules shows 4.6% reduction in the original 
Mode I interlaminar fracture toughness (GIC) as compared to that of the base laminate; while 
the CF/EP laminate with small size (65 µm) microcapsules shows a reduction of 36.9%. 
Healing efficiency is characterised by the recovery in the Mode I critical stress intensity factor 
(KIC) measured using width-tapered double cantilever beam (WTDCB) specimens. Although 
the full recovery was achieved for the base laminate injected with the same healing agent, the 
healing efficiency with only 54% recovery was achieved for the laminate with the small size 
microcapsules, with the maximum being 57% in some cases. In the case of large size 
microcapsules, the healing efficiency increased to 69% recovery with the maximum being 80% 
in some cases. It was also observed that the recovery in Mode I interlaminar fracture toughness 
was directly correlated with the amount of healant film covering the fracture surfaces, with the 
highest healing efficiency obtained for the laminate with the largest film. 
In the following study, the self-healing performance after Mode II delamination in CF/EP 
laminates containing the dual-capsule self-healing system was investigated. The effect of 
incorporation of the microcapsules on Mode II interlaminar fracture toughness (GIIC) of CF/EP 
laminates was characterised using end-notched flexure (ENF) specimens. In contrast to the 
Mode I delamination tests, the results indicated that the Mode II interlaminar fracture toughness 
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(GIIC) of the base CF/EP laminate was improved (up to 48%) with the incorporation of the dual-
capsule self-healing system. When healed at 70°C, the dual-capsule self-healing system also 
provided the laminate with healing capability on Mode II delamination with 63% recovery in 
GIIC. Observation on the fracture surfaces also revealed that the healing efficiency varies 
directly with the concentration of healant and the healing of interlaminar region after Mode II 
fracture. 
Finally, the self-healing epoxy adhesive was developed using this dual-capsule self-healing 
system.  The healing system was incorporated into a commercial two-part room temperature-
cured epoxy adhesive. The addition of 3 wt. % microcapsules in concentration into adhesive 
of 172 (± 50) μm in thickness was shown to increase the baseline lap-shear strength by 28%.  
The results also revealed an increment to the baseline fracture toughness (GIC) of the epoxy 
adhesive, with improvement as high as 80% for adhesive with thickness of 273 (±66) μm, 
measured using tapered-double cantilever beam (TDCB) specimens. The increase in fracture 
toughness was mainly attributed to enhanced plastic deformation of the host adhesive as well 
as the crack path deflection caused by the poor adhesion between the microcapsules and the 
epoxy adhesive. The healing efficiency based on the recovery in the original crack initiation 
and crack propagation fracture toughness is 52% and 74% respectively.
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EPA Ethyl Phenylcetate 
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General Introduction 
 Motivation 
The term “composites” denotes that two (or more) materials consisting of matrix and 
reinforcement are combined on a macroscopic level to form a useful third material that 
possesses the best qualities of their components [1]. The function of the matrix phase is to hold 
the reinforcements in the desired position and transferring the external load to the 
reinforcements, while the reinforcements phase usually consists of materials with high strength 
and modulus, and serves as the principal loading-carrying phase [2, 3]. 
Over the past years, fibre reinforced polymers (FRPs) composites such as carbon fibre 
reinforced polymer (CFRP) and glass fibre reinforced polymer (GFRP) have replaced 
conventional materials, such as metals, in various applications. These composite materials now 
dominate the aerospace, automotive, construction and sporting industries [4-8]. Their high 
specific strength (strength/density) and specific stiffness (modulus/density), were seen as their 
main advantages in comparison to conventional single macroscopic phase materials, allowing 
them to be used in many high performance applications [9]. However, these FRPs have some 
disadvantages related to the matrix dominated properties. Epoxy resins are among the most 
commonly used thermosets materials being employed as matrix phase for the FRPs and as 
structural adhesives, due to their strong adhesive properties. However, they are also identified 
as rigid and brittle polymeric materials, which often limits their extensive applications. Brittle 
matrix phase-dominated damages such as delamination and matrix microcracking are often 
difficult to detect and, if left untreated, will propagate and might cause catastrophic failure. 
1. General Introduction 
2 
The current strategy to counter these problems is by modifying epoxy resins with additives, 
such as rubbers, thermoplastics, and inorganic particles, to improve the fracture toughness of 
matrix phase [10-14]. Despite this effort, once damage happens, its propagation is uncertain 
and thus reduces the overall reliability of the material.  
Various non-destructive testings (NDTs), such as visual inspection, tap-testing, x-ray 
inspection and ultrasonic inspection, have been used for the assessment and restoration of 
damages and defects in advanced FRPs composites. However, most NDTs cannot be performed 
while the structures are in service and require service downtime, which can raise financial 
issues. Apart from that, often very small damages such as matrix microcracks cannot be 
detected via these testings. Therefore, these issues have raised the need to develop new types 
of composite materials with autonomous damage detection and repair capability. 
The concept of materials that self-heal with encapsulated healing agents composed of a healing 
resin and its curing catalyst was proposed more than two decades ago [15-17]. However, it did 
not evolve into a viable method because of the very limited “no-curing” lifetime, until recently 
when researchers developed techniques to encapsulate the healing resin and/or encapsulate or 
graft the curing catalyst independently. In the early 2000s, researchers from the University of 
Illinois at Urbana-Champaign developed a capsule-based self-healing material system 
consisting of a microencapsulated dicyclopentadiene (DCPD) as healing agent, and a catalytic 
chemical trigger within an epoxy matrix to automatically heal cracks; that system can been 
seen as an engineering approach to address material failures. The self-healing ability helps 
materials to recover their load-bearing capability after damage, with some approaching 90% 
recovery of their original material properties [18-22]. 
For high performance structural composites, where the fabrication process was usually 
performed in an elevated temperature (temperatures of 120°C and above), epoxy with elevated 
temperature curing system is commonly used as a matrix. Matrix phases with high glass 
transition temperature (Tg) are not achievable by room temperature curing, hence limiting the 
service temperature of the composites. Nearly all of the reported studies on capsule-based self-
healing have only focused on epoxies with room temperature curing systems, with the 
exception of studies by Jin et al. [18, 23] , Yuan et al. [24] and Mangun et al. [25]. These studies 
have proposed viable thermally stable self-healing systems which consist of several healing 
chemistries to be employed with elevated temperature-cured neat epoxy; (i) encapsulated 
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diluted epoxy and its encapsulated curing agents POPTA [18] and (ii) aliphatic polyamine [23], 
(iii) encapsulated pure DGEBA epoxy and its curing agent; mercaptan [24] and (iv) 
encapsulated poly(dimethylsiloxane) and organotin catalyst [25]. However, their integration 
with elevated temperature curing FRPs was never attempted, let alone in laminated composites 
consisting high fibre volume fraction (Vf  > 50%).  
In theory, any of these capsule-based self-healing systems have the potential to be integrated 
into advanced FRPs, for production of composites with healing ability. However, it was 
speculated that this goal has not been realised due to challenges associated with the fabrication 
process of these microcapsules and its integration into composite laminates. The dual-capsule 
based self-healing system consists of pure DGEBA and mercaptan as its hardener reported by 
Yuan et al. [24], and it shows a lot of promise to be integrated into composite laminates due to 
a more simple fabrication process (fabrication of both microcapsules employed the same 
procedures), in comparison to the other systems. On the other hand, achieving a strong and 
uniform crack-healed zone might be problematic because of the viscous nature of DGEBA. 
Healing cycle optimisation for this healing system needs to be further investigated to find the 
most suitable healing conditions for composite laminates with high fibre volume fraction (Vf). 
A high fibre volume fraction is essential in producing good structural FRPs component [26]. 
Because of the difficulty in applying resins with microcapsules normally 100 m in size to 
reinforcing fibres during the fabrication process of composites, most studies have adopted a 
low fibre volume fraction for the ease of processing. However, that approach undermines the 
key advantages of high specific strength and stiffness of fibre-reinforced composites. 
Among the studies involving laminated composites, Kessler et al. [27, 28], Yin et al. [29, 30] 
and Yuan et al. [31] have discussed the embedment of capsule-based healing agents in FRPs 
fabricated with the common wet hand lay-up process, where a limit of 27 - 40% Vf can be 
achieved. Healing efficiency up to 80% was reported. In a very recent study by Manfredi et al. 
[32] where vacuum assisted resin infusion (VARI) fabrication technique was used, Vf at about 
50% was successfully achieved. However, due to the choice of healing chemistry, where the 
healing needs to be triggered by hidden functionality of the matrix (matrix swelling and the 
presence of latent residual functionalities), no healing phenomenon can be observed. Therefore, 
the question of whether capsule-based healing mechanism can be integrated in advanced 
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composites, without jeopardising its original properties and at the same time introducing the 
healing ability to it, still remains unexplored. 
In composites with low fibre volume fraction, the crack-healed zone is mostly observed inside 
the thick resin-rich area of the laminate, which is similar to the phenomenon of healing in bulk 
epoxy; whereas in composite laminates with high fibre volume fraction, when delamination 
happens, the fibre/matrix interface is often affected. Therefore, the effectiveness of the healing 
system after a fracture incident, and the effect of such integration to the original properties of 
the composite laminates, needs to be assessed to further understand the self-healing capacity 
of laminated composites with industrial significance. 
 Objectives of this thesis 
Capsule-based self-healing systems had attracted extensive research efforts over the past two 
decades. Therefore, a complete understanding of the healing mechanism and the effect of the 
modification on properties of epoxy and its composites are very important for the successful 
application of these materials in engineering structures. 
Epoxy-loaded microcapsules containing pure DGEBA epoxy have been used as polymerisable 
self-healing components in the past, with the ability to heal at room temperature when reacting 
with mercaptan. This self-healing chemistry was proven to be compatible with elevated 
temperature-cured epoxy systems due to its thermal stability. However, an argument exists for 
whether room temperature healing cycles for such high viscosity substances (10 Pa s – 15 Pa 
s) can be fully utilised in laminated composites; considering the thickness of resin-rich region 
between the laminated plies that can be seen as geometric constraints on the amount of 
microcapsules that can be used. With a limited number of capsules, a substance with a low 
viscosity is needed to ensure uniform healing and its miscibility with its hardener. Therefore, 
one of the research focuses in this thesis will be on the optimisation of the healing cycle of 
elevated temperature-cured neat epoxy, containing dual-capsule loaded with pure DGEBA 
epoxy and mercaptan as its hardener. 
One of the main research objective of this thesis is focusing on the fabrication of CF/EP 
composite laminates consist of a high fibre volume fraction (Vf > 60%) using VARI process, a 
material that is commonly used for advanced structural application. The influence of the 
addition of microcapsules with different mean sizes on the interlaminar fracture toughness of 
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laminated polymer composites also needs to be recognised. Previous studies on the effect of 
microcapsules’ weight fraction and microcapsules/carriers’ diameter (size) on neat epoxy have 
reported that healing efficiency varies positively with microcapsule diameter (healing 
efficiency increase when diameter of microcapsules increases and vice versa) for a given 
weight fraction of capsules. This means that healing efficiency can be maximised when larger 
size microcapsules with higher weight fraction are embedded into bulk polymer. However, in 
composite laminates with high fibre volume fraction, the weight fraction of microcapsules that 
can be embedded are also constrained by the interlaminar thickness. Thus, for better 
understanding, this issue needs to be addressed. 
Epoxy/mercaptan self-healing system has been reported to be able to provide neat epoxy and 
low fibre volume fraction GFRP with self-healing capability. When talking about the healing 
ability of composite laminates with lower fibre volume fraction, the healing basically occurred 
in the matrix region of the composites, instead of healing fibre/matrix delamination. Studies on 
the influence of the incorporation capsule-based healant on composite laminates with high fibre 
volume fraction (Vf ≥ 60%) are still overlooked. Since these types of composite laminates are 
industrially significant materials, the self-healing of this laminate should be elaborated. 
To this date, self-healing fracture toughnesses have been broadly characterised under Mode I 
loading conditions. In many cases, for isotropic materials, crack initiation and propagation is 
caused by normal stresses. Therefore, more caution has been given to Mode I fracture. 
However, in FRPs composite laminates, shear stresses may also cause delamination damage. 
The lack of reliable data related on Mode II fractures of self-healing materials might prevent 
them from being readily used in a real-life application. Therefore, one of the research focuses 
in this thesis is to establish a self-healing assessment of composite laminates on Mode II 
damage. 
Capsule-based self-healing materials have shown a lot of potential to be used as structural 
polymeric materials, but very little studies have addressed its application in thin layer adhesive. 
The final objective of this thesis is to develop a self-healing adhesive consisting of a dual-
capsule system based on using a readily available two-part epoxy adhesive as host materials. 
A metal joint with TDCB geometry was established to easily measure the fracture toughness 
and the self-healing ability of the thin adhesive layer. The data obtained from this preliminary 
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study was intended to be used as technical support for future research and the further 
application of self-healing in polymeric adhesive. 
The aforementioned aspects form the basic objectives of this thesis. It is believed that these 
research activities will certainly make several contributions to the field of self-healing 
materials. 
 Scope of the study 
A huge number of studies on the ability of polymer to self-heal have been conducted. Many of 
these studies have suggested the potential of introducing this self-healing characteristic on 
advanced structural composites such as CFRP and GFRP, where a typical volume fraction of 
fibre is about 60-70%. Integrating microencapsulated healants into such high fibre content 
composites imposed certain difficulties; hence, less studies were undertaken to tackle this topic. 
Thermosetting resin, such as elevated temperature-cured epoxy, is generally adopted as a 
matrix component in advanced carbon fibre/epoxy (CF/EP) laminates. In general, the higher 
temperature curing of epoxy the higher the service temperature, whereas many room 
temperature-cured epoxies become less effective at elevated temperatures. Therefore, firstly, 
the performed work through this thesis engaged with the experimental work on elevated 
temperature piperidine-cured neat epoxy containing microencapsulated diglycidyl ether of 
bisphenol A (DGEBA) epoxy resin and mercaptan as a healing agent. The data obtained was 
essential in determining the most suitable healing cycle for the composite laminates.  
With the main research objective to integrate healing ability to advanced FRPs, the VARI 
process was used to fabricate composite laminates with targeted Vf  > 60%. Image analysis on 
the resulting laminates was performed to investigate the distribution of the microcapsules on 
the interlaminar region. Experimental testings were performed on the resulting laminate to 
study the effect of this integration on the original Mode I and Mode II fracture toughness of 
the composites. A new way to assess healing efficiency using Mode II testing was also 
developed.  
Finally, the effectiveness of combining this dual-capsule self-healing system into two-part 
commercial epoxy adhesives was also evaluated in this research. Preliminary investigations on 
strength and toughness involving this self-healing adhesive on metal joints were explored at 
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room temperature. A new way to easily measure the fracture toughness and the self-healing 
ability of the thin adhesive layer was established. The data obtained was hoped to be used as 
technical support for future research and the application of self-healing in polymeric adhesive.  
 Chapter overviews 
Chapter 2 
In this chapter, the past research efforts in self-healing materials are reviewed, with particular 
attention on capsule-based self-healing mechanisms as well as the self-healing of neat epoxy, 
epoxy adhesive and epoxy-based composites. This chapter also presents critical investigation 
on the best capsule-based healing chemistry to be employed with high Vf composites.  
Chapter 3 
This chapter addresses the fabrication and characterisation process of microcapsules containing 
DGEBA epoxy resin and its hardener mercaptan, adapting the method from established 
protocol.  
Chapter 4 
In this chapter, experimental investigation of elevated temperature-cured epoxy resin 
containing microencapsulated DGEBA/mercaptan self-healing agents are presented in order to 
understand the effect of the microcapsules embedment on the inherent fracture toughness of 
the epoxy. Tapered double cantilever beam (TDCB) Mode I test was used in this experimental 
study. The influence of temperature on viscosity of the healants and healing of epoxy have 
been investigated, and the optimum healing cycle for CF/EP laminates is selected based on the 
findings in this study. 
Chapter 5 
This chapter is devoted to the fabrication of the CF/EP composite laminates containing 
microencapsulated self-healing agents. Step by step VARI fabrication process is explained. 
Width tapered double cantilever beam (WTDCB) specimens have been used to investigate the 
Mode I fracture toughness and the healing efficiency of the composites.  
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Chapter 6 
In this chapter, the assessment of self-healing efficiency using Mode II end-notch-fracture 
(ENF) test is established. The toughening effect and the healing efficiency on Mode II fracture 
by incorporating the microcapsules are also elaborated. 
Chapter 7 
This chapter focuses on the study of the performance of two-part epoxy adhesive, a typical 
commercial structural adhesive, incorporated with DGEBA/mercaptan microcapsules. Single-
lap adhesive joints (SLJs) test according to ASTM D 1002 and TDCB Mode I test with 
aluminium adherents have been performed to assess the influence of the incorporated 
microcapsules on the lap shear strength and original Mode I fracture toughness of the adhesive. 
The healing mechanism of the epoxy adhesive consisting of this dual-capsule self-healing 
system is also explored.  
Chapter 8 
This final chapter conveys the conclusions from this systematic study and suggestions for 
further studies in line with this work are presented. 
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Self-Healing Materials: A Review 
 Failure of structural polymer composites 
Advanced polymer composites such as CFRP and GFRP composites are well known for their 
superior properties, such as high specific strength and specific stiffness, allowing them to be 
used in many high performance applications [9, 33, 34]. Despite the many benefits, there are 
some well-known disadvantages in polymer composites that will cause them to lose their 
functionality. Figure 2-1 describes a range of possible failures in polymer composites. 
 
Figure 2-1: Possible failures in laminated polymer composites structures. 
The three most common damage initiation modes of failure in laminated FRPs are: matrix 
microcracking; delamination; and fibre fracture. The first two of these failure modes hugely 
depend on the property of the matrix [35-37]. Matrix microcracking and delamination can 
modify macromechanical properties, such as strength, stiffness and dimensional stability of the 
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laminated structure.  Epoxy resins have been widely used as structural adhesives and as matrix 
materials for polymer composites, due to their superior mechanical properties and strong 
adhesive properties.  
Epoxy resins belong to thermosets polymer group, and – once cured – they cannot recover any 
of their original properties, owing to their three-dimensional network of bonds. In respect to 
this, epoxy resins are fairly brittle, which makes them susceptible to crack initiation and 
propagation. As a result, many studies have been conducted to modify epoxy resin by the 
addition of toughening agents such as micro- or nano fillers to create a microstructure 
inherently resistant to the brittle failure [36, 38-40]. But despite these efforts, once microcracks 
occur within the materials, there is no way in stopping it from propagating further, which will 
lead to delamination and complete failure of the material. 
Extensive efforts have been paid to develop materials with self-healing abilities as a solution 
to slow down and halt mechanical failure in structural materials, such as structural adhesive 
and laminated polymer composites structure [19]. This material was designed with the idea of 
repairing damage autonomously whenever it happens, and the material subsequently recovers 
its load bearing ability [19, 22, 41]. Self-healing materials show a lot of potential in increasing 
dependability and feasibility of structural materials. 
 Self-healing materials – State of the art 
In biological systems, for example: human bone, self-healing is an ability of the bone to recover 
its original conditions after a fracture. This healing process happens in three stages as shown 
in Figure 2-2: 1) the early inflammatory stage; 2) the repair stage; and 3) the late remodelling 
stage [42]. 
 
 
 
 
2. Self-Healing Materials – A Review 
11 
Stage 1 
 
Stage 2 
 
Stage 3 
 
Figure 2-2: Self-healing mechanism of human bone (stage 1) the early inflammatory stage 
(stage 2) repair stage (stage 3) bone remodelling [43]. 
Unlike biological systems, conventional engineering materials such as metals, polymers, 
ceramics and their composites generally do not possess such abilities. But just like human bone, 
damages to and defects of these materials are unavoidable. Therefore, man-made materials with 
self-healing ability can be seen as potential solution to these problems. Taking motivation from 
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biological systems, synthetic routes of self-healing ability for these materials have been widely 
studied in recent years to improve their resistance against damages [16, 19, 27, 44, 45].  
The concept of a viable self-healing material consisting of microencapsulated healing agents 
was first introduced by White et al. [19], in the early 2000s. In this study, DCPD was 
encapsulated inside a urea formaldehyde (UF) shell and used as healing agent. These 
microcapsules were embedded in a host polymer material pre-dispersed with a catalyst 
(Grubb’s catalyst) that was capable of polymerising the healing agent. When the embedded 
microcapsules ruptured by damage such as polymer matrix microcracks, the self-healing 
mechanism is activated by the release and polymerisation of the healing agents onto the damage 
area and subsequently preventing the crack from propagating further (Figure 2-3) [19]. Ever 
since this breakthrough, self-healing approaches have been emerging one after another. The 
three main approaches that have been widely reported during the past few years are; i) capsule-
based self-healing [19, 20, 30] ii) vascular self-healing [46-48] and iii) remendable polymer 
matrix self-healing [49-51].  
 
Figure 2-3: Microcapsules based self-healing approach (a) cracks form in the polymer 
matrix (b) release of polymerisable healing agent onto the crack plane through capillary 
action upon microcapsules rupture (c) polymerisation of healing agent when in contact with 
dispersed catalyst (Adapted by permission from Nature Publishing Group [19]). 
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In the vascular self-healing approach, healing agent(s) is/are held in a series of microvascular 
networks such as hollow glass fibre (HGF) [52]. Similar to capsule-based self-healing 
approach, healing of the material is triggered when damage occurs to the microvascular 
networks and the agent is released and polymerised onto the damage area. Conversely, in a 
remendable polymer matrix self-healing approach, the host material itself possesses a dormant 
self-healing functionality that can be triggered by external stimulus such as thermal activation 
[41].  
In-depth review of the classification of self-healing materials and their applications in polymer 
materials and their composites will be the focus from here onwards.  
 Self-healing approaches  
2.3.1 Capsule-based self-healing  
In the capsule-based self-healing approach, the healing agents are stored inside a protective 
film in the form of micro-size capsules. The contents of the capsules are protected from the 
external atmosphere until damage triggers the rupture of the protective film and release of the 
healant [19, 41]. Figure 2-4 shows the design sequence of microcapsules based self-healing 
approach as adopted from Blaiszik et al. [41]. The sequence starts with the fabrication of the 
capsules, followed by its integration to the host materials. The resulting composites were then 
characterised via mechanical testing. The testing subsequently will trigger damages that break 
the capsules and release the healing agent onto the damage area. Healing of the material 
happens when the healing agent polymerises and repairs the damage area. 
Since the introduction of capsules based self-healing approach by White et al. this self-healing 
system has received a lot of attention, with three of the most common systems shown in Figure 
2-5: i) capsule-catalyst [19, 53-56] ii) dual-capsule [20, 24, 57-59] iii) single-capsule [30, 60]. 
The capsule-catalyst healing system involves the curing reaction between the monomer that 
has been encapsulated with the pre-dispersed catalyst phase, such as Grubbs’ catalyst, inside 
the host material. Another model of capsule-catalyst system has been presented by Kamphaus 
et al. [53]; a cost-effective way to achieve self-healing was demonstrated using tungsten (VI) 
chloride (WCl6) catalyst for DCPD polymerisation, where a damaged materials property 
recovery of around 20% can be achieved. 
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Figure 2-4: Microcapsules based self-healing approach design sequence: (1) fabrication of 
microcapsules containing healant (2) incorporation of microcapsules into host material (3) 
mechanical characterization (4) crack triggers rupture and subsequently release of healant 
(5) healed fracture. Adapted from reference [41].   
   
(a) (b)   (c)  
Figure 2-5: Different types of microcapsules based self-healing system: (a) capsule-catalyst 
(b) dual-capsule (c) single-capsule. 
In the dual-capsule system, both polymerisable monomer and its curing agent are encapsulated 
inside a fragile protective shell, which is in contrast to capsule-catalyst. Healing is triggered 
when damages such as microcracks rupture the microcapsules. The content of these 
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microcapsules will be released onto the crack surface. The polymerisable monomer will start 
reacting once in contact with the released curing agent and polymerised to repair the crack 
surface together. Yuan et al. [20, 24, 57, 58], have investigated a dual-capsule system 
containing various types of epoxy resins and mercaptan as its curing agent, where 100 % 
recovery of the host material original properties can be observed. Ye and co-workers [59] 
introduced an ultra-fast dual-capsule healing chemistry consisting encapsulated epoxy and 
pentafluoride–ethanol complex (SbF5) in their study, encapsulated inside a hollow silica wall 
microcapsules. They have reported 60% repair of impact damage within a few seconds with 
this healing chemistry. A study by Jin et al. [18] established a thermally stable dual-capsule 
self-healing system consisting of epoxy and amine reactants (Polyoxypropylenetriamine) as 
healing agents. Zhang and Yang [61], reported the fabrication of micro-containers through 
etching hollow glass bubbles (HGBs) with diluted hydrofluoric acid solution in a specially 
designed mixer for self-healing applications. Self-healing epoxy by two-part epoxy–amine 
chemistry was formulated based on multi-carrier (multicapsule), which in this case etched 
HGBs containing epoxy and amine [62, 63].  
In single-capsule system, the polymerisation of the encapsulated monomer depends on the 
latent functionality of the host materials. Caruso et al. [60, 64, 65] developed a single-capsule 
healing system that consisted of encapsulated solvents such as chlorobenzene, phenylacetate 
(PA) and ethyl phenylacetate (EPA) as healing agents. When damage that will rupture the 
capsules happens, the solvent release will swell the crack surface of the host material. The 
repair is triggered by the swelling and the post-curing of the residual epoxy and its curing agent 
inside the host epoxy. Yin et al. [30] have investigated a single-capsules system consisting of 
UF microcapsules that contain epoxy and CuBr2(2-MeIm)4 (the complex of CuBr2 and 2-
methylimidazole) as its latent hardener that was pre-mixed with the host epoxy polymer (Figure 
2-6). In this study, they found that incorporation of this healing system did not noticeably 
change the fracture toughness of the neat epoxy, and up to 111% recovery of original fracture 
toughness can be obtained from the healed specimen. They have extended the study using this 
self-healing system as a matrix in glass fibre reinforced polymer (GFRP) [66], where healing 
efficiency as high as 79% can be observed.  
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Figure 2-6: Single-capsules self-healing consists of a latent curing agent dissolved in the host 
matrix (Adapted from reference [30] with permission of Elsevier). 
2.3.2 Vascular based self-healing 
Figure 2-7 shows the design sequence of a microvascular based self-healing system. This self-
healing system involves embedding microvascular network(s) inside a polymer matrix or its 
composites to hold the healing agents. The idea of this self-healing system is based on arteries 
in human biological system [47, 67]. The activation of self-healing happens when cracks occur 
in the host materials, which subsequently breaks the microvascular network and releases the 
healing agents on the crack zone. The healing agents will then polymerise to close the crack.  
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Figure 2-7: Design sequence of microvascular self-healing system: (1) incorporation of 
microvascular networks (2) mechanical testing (3) microvascular network damage triggered 
by the rupture and release of healant (4) healing of the crack by polymerisation of the 
healant. Adapted from reference [41]. 
A study by Bleay et al. [46] describes a technique for potential self-repair of delaminations in 
FRPs composites by using HGF as a microvascular network to stored self-healing agent. In this 
study, they found that HGF is an ideal microvascular network candidate for storing a functional 
component, as it simultaneously offers mechanical reinforcement to the composite materials. 
The use of HGFs as microvascular networks have been progressing since then [8, 52, 68-70]. 
Figure 2-8a shows the incorporation of HGF as a microvascular network inside CFRP as 
reported by Williams et al.[69]. In this study, the concept of self-healing CFRP has been 
developed and demonstrated, with resin filled HGF being shown to provide recovery in flexural 
strength. 
Toohey et al. [47, 71] have employed direct ink-writing to produce a three-dimension (3D) 
vascular channel. In these studies, Grubb’s catalysts were pre-dispersed in brittle epoxy 
coating, and then the coating was deposited on flexible epoxy substrate containing the 3D 
vascular channel filled with DCPD. Healing of the coating was activated upon surface cracking, 
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which then releases the healant from 3D microchannel and subsequently polymerises upon 
contact with the catalyst. This self-healing system was reported of being capable of 
autonomously repairing repeated damage events. Hansen et al. [72], have advanced the method 
and reported that the system was able to heal at least 30 cycles of mechanical damage in the 
coating. 
Studies done by Norris et al. [73-76], demonstrated the inclusion of an open vasculature 
network in FRPs composite (Figure 2-8b). Fabrication of the open vasculature was done with 
the aid of steel wire with a diameter up to 0.5 mm. This vasculature provides the means to 
deliver the healing agents from an exterior reservoir to regions of interior damage. Using a pre-
mixed epoxy-amine healing agents, healing efficiencies of up to 100% were observed.  
(a) 
 
 
(b) 
 
 
Figure 2-8: Examples of microvascular based self-healing systems: (a) incorporation of HGF 
into CFRP host material (Adapted from reference [69] with permission from Elsevier). (b) 
open vasculature (Adapted from reference [74] with permission from Elsevier). 
2.3.3 Remendable polymer matrix system 
Unlike the capsule- and vascular-based self-healing approach, where self-healing ability is 
achieved by pre-embedded healing agents [19, 52], in remendable polymer approach, healing 
is achieved merely by macromolecular interaction [77]. Figure 2-9 shows the design cycle for 
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the remendable polymer matrix approach. In this approach, the host polymer itself possesses a 
hidden healing functionality that can be activated with eternal stimulus, such as thermal 
activation [41, 78], or supramolecular reactions. The three most reported systems are i) healing 
by thermal activation, ii) light induce healing, and iii) healing based on supramolecular 
reaction. 
 
Figure 2-9: Design cycle of remendable polymer self-healing approach: (1) preparation of 
reversible bonding polymer (2) mechanical characterization (3) crack triggering healing (4) 
healing with intervention of external stimulus. Adapted from reference [41]. 
Thermal activation 
Chen and co-workers [78, 79] have developed a remendable cross-linked polymeric material 
based on thermally reversible Diels−Alder (DA) cycloaddition. It was found that the DA cross-
links of these materials were thermally reversible, and can be used to heal fractures. Qualitative 
studies show that the cracks in this material can be recovered effectively with a thermal 
activated healing procedure, and this healing process is repeatable. Figure 2-10 shows the 
scanning electron microscopy (SEM) image of the thermally treated polymer sample, where a 
repairing effect can obviously be seen. Studies done by Liu and Hsieh [80], Liu and Cho [81], 
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Park et al.[82, 83], Murphy et al. [84] and Zhang et al. [85], similarly discuss a self-healing 
approach, utilising reversible thermal crosslinking by DA reaction.  
  
As healed surface Scraped surface  
Figure 2-10: An example of thermally remendable healing system – thermal healing of DA 
cross-links (Reprinted in part of reference [78] with permission from The American 
Association for the Advancement of Science). 
Luo et at. [50] synthesised a thermally remendable epoxy-polycaprolactone (PCL) polymer 
matrix. Upon heating, healing of cracks was activated when phase separated PCL in the epoxy 
matrix dissolved and filled the damage area. This is possible due to the thermoplastic behaviour 
of PCL, which enables it to change form upon heating. Figure 2-11 shows the conception of 
the fracture-healing process of this thermoplastic/thermoset polymer by thermal activation. In 
studies by Hayes et al. [49, 86], epoxy resin was employed blended with thermoplastic 
materials, poly(bisphenol-A-co-epichlorohydrin), to synthesise their thermoplastic/thermoset 
blend healing matrix. After being subjected to impact testing, and upon heating to 130°C, this 
material blend shows recovery of up to 50% of its virgin properties. Repeatable healing cycles 
were also reported in these studies, mainly contributed by the ability of the thermoplastic phase 
to change its form with temperature increase or decrease. Rodriguez et al. [87] reported that a 
system called shape memory assisted self-healing by synthesising linear/network poly(ε-
caprolactone) blends that are capable of simultaneously self-closing and rebonding cracks with 
the aid of thermal activation (Figure 2-12). 
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Figure 2-11: Thermoplastic/thermoset blend healing process upon heating (Reprinted with 
permission  from reference [50].  Copyright (2009) American Chemical Society). 
 
Figure 2-12: Sequence of healing process in shape memory assisted self-healing (Reprinted 
with permission from [87]. Copyright (2011) American Chemical Society). 
Meure et al. [88] proposed a thermoplastic healing agent by directly adding poly(ethylene-co-
methacrylic acid) (EMAA) particles into epoxy resin. At a temperature of 150°C for 30 min, 
healing of up to 85% recovery of critical stress intensity and over 100% recovery in sustainable 
peak load were achieved. Microscopic analysis revealed that strength recovery in the damaged 
resin was achieved via EMAA particle healing, as well as the formation of an adhesive EMAA 
layer between adjacent epoxy fracture surfaces. Figure 2-13 shows the healing agent delivery 
mechanism that produced remendable polymer matrix in this study. The chemical reactions 
between EMAA and epoxy resins have been investigated using Attenuated Total Reflectance 
Fourier Transformed Infrared (ATR-FTIR) spectroscopy [89]. Alterations in the surface 
chemistry of EMAA, following epoxy resins adsorption, revealed the possible formation of 
hydrogen bonds and ionic bonds respectively during the curing process. The use of higher 
temperatures during post-curing and healing also promoted the formation of covalent bonds 
that can be expected to contribute significantly to the interfacial strength. They have furthered 
their study by using two-dimensional (2D) mesh EMAA fibres as an interleaf on woven carbon 
fibre plies to fabricate remendable CFRP. By using the same healing condition, 100% 
restoration of interlaminar fracture toughness, failure energy, and peak loads over repeated 
damage-healing cycles was reported [90].  
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Figure 2-13: (a) Healing mechanism in remendable epoxy resin consisting EMAA particles 
(b) reflectance optical microscopy image showing epoxy consisting EMAA particle and the 
healing process by thermal activation. (Reprinted from reference [88] with permission of 
Elsevier). 
Pingkarawat and co-workers [91, 92] have extended the use of EMAA particles in carbon-fibre 
epoxy laminate to study the healing behaviour of the material after Mode I delamination and 
fatigue-induced delamination fractures. With a thermally induced healing cycle, the 
incorporation of EMAA thermoplastic into the composite laminates was capable of providing 
the host material with full recovery of its properties after static and dynamic loadings. Figure 
2-14 shows the formation of EMAA ligaments bridging the delamination crack of composite 
laminates. 
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Figure 2-14: Crack bridging of carbon-fibre epoxy delamination with EMAA ligaments 
(Reprinted from reference [92] with permission of Elsevier). 
Light induced healing 
Amamoto and co-workers [93] demonstrated the self-healing of covalently cross-linked 
polymers under light irradiation. In their research, they have reported self-healing of cross-
linked polymer material based on reshuffling thiuram disulphide units by exposing the 
materials to ultra-violet (UV) irradiation in nitrogen atmosphere (Figure 2-15). Since 
disulphide (S-S) bonds in the thiuram disulphide units dissociate in visible light, the radical 
reshuffling reactions allow the restructuring of the linking units in the covalently cross-linked 
polymer materials, successfully healing significantly damaged polymers [93, 94]. The study 
was further refined, and self-healing was able to be achieved in air instead of a nitrogen 
atmosphere, by light irradiating from a conventional tabletop lamp [95]. 
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Figure 2-15: Repetitive self-healing reactions under UV irradiation stimulus (Reprinted from 
reference [93] with permission of John Wiley and Sons). 
Self-healing based on supramolecular reactions 
Self-healing based on supramolecular reactions is a mechanism of material healing without the 
aid of a healing agent and/or external stimulus. In contrast to molecular chemistry (which is 
mostly based upon covalent bonding of atoms), supramolecular chemistry is the chemistry of 
the intermolecular bond/interactions, covering structures and functions of the units formed by 
the association of two or more chemical species [96, 97]. The concept of supramolecular self-
healing materials depends on the use of noncovalent, temporary bonds to generate networks, 
which are able to heal the damage inside of the materials [98]. Figure 2-16 shows the steps of 
self-healing in supramolecular polymers. 
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Figure 2-16: Self-healing mechanism of supramolecular polymer: a) when the material is 
damaged (i.e. crack) the weak supramolecular bonds are broken b) the supramolecular 
bonding appear disconnected on the fractured surface, but can reposition itself c) after being 
brought into contact again the supramolecular bonds are reformed, consequently healing the 
crack (Reprinted from reference [98] with permission of John Wiley and Sons). 
Cordier and co-workers demonstrated supramolecular assembly to produce a supramolecular 
rubber that has the properties of rubber and can also self-heal upon damage [99]. They have 
demonstrated the design and synthesise of molecules that associate together to form both chains 
and cross-links via hydrogen bonds. One of the outstanding differences of these systems to 
conventional cross-linked, or thermoreversible rubbers made of macromolecules, is that when 
broken or cut, it can be simply repaired by bringing together fractured surfaces to heal at room 
temperature. Breaking and healing cycles as shown in Figure 2-17 can be repeated many times 
[99, 100]. 
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Figure 2-17: Breaking and healing sequence of supramolecular rubber (Adapted from 
reference [100] with permission of Nature Publishing Group). 
 Capsule-based self-healing in epoxy and epoxy composites 
Polymeric materials have long been utilized in high performance applications, most widely in 
applications demanding lightweight structures. Epoxies are among the most commonly used 
polymeric materials for this purpose, owing to their versatility [101].  Epoxy resins belong to 
a group of polymeric materials called thermosetting resins. The generic term epoxy is now 
understood to mean the base (uncured) resins, as well as the resultant highly cross-linked cured 
plastic [10, 102].  
The diglycidyl ether of bisphenol A (DGEBA) remains the most common type of epoxy resin 
utilised as a matrix in structural composites and structural adhesive, accounting for almost 90% 
of all epoxies [103]. DGEBA is a product of the reaction between epichlorohydrin with alkaline 
solution of bisphenol-A in the presence of sodium hydroxide (Figure 2-18). These epoxy resins 
have been widely been employed as engineering adhesives and the matrix for fibre reinforced 
plastics (FRP) due to their highly valuable properties, such as high adhesion strength, stiffness, 
thermal stability and good processing ability [104]. 
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Figure 2-18: Synthesis of DGEBA from bisphenol A and epichlorohydrin [105]. 
Despite their excellent mechanical properties, epoxies are vulnerable to damage in the form of 
microcracks due to their brittleness [38, 106]. Because of these reasons, many studies in self-
healing have been focusing on the ability of epoxy polymer to self-heal, in order to improve its 
reliability in structural materials applications. This section presents an elaborated review on 
past literatures on capsule-based self-healing of epoxy and its composite.  
2.4.1 Capsule-based self-healing of neat epoxy 
Among the earliest efforts in the study of epoxy healing were experiments by Outwater and 
Gerry [107], where an epoxy sample was subjected to heating above the epoxy glass transition 
temperature (heating temperature up to 121°C). The rehealed portion was reported to have 
refractured at the same fracture energy as the original. Wool and co-workers [108, 109] studied 
the theory involved in the crack healing of polymer materials, where the theory is presented in 
terms of five distinct stages; (i) surface rearrangement, (ii) surface approach, (iii) wetting, (iv) 
diffusion, and (v) randomization (Figure 2-19). 
Bisphenol-A Epichlorohydrin 
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Figure 2-19: Five stages of crack healing presented by Wool and co-workers [108, 109] 
(Reprinted (adapted) from reference [110] with permission of Elsevier). 
The addition of microcapsules containing healing agents for self-repair in epoxy resin was first 
reported by White et al. [19]. This self-healing technology uses the ring-opening metathesis 
polymerisation of DCPD and solid phase Grubbs’ catalyst (Figure 2-20) that were embedded 
in an epoxy resin to repair the damage. This system was reportedly able to produce neat epoxy 
with the ability to automatically heal cracks by recovering as much as 75% of its fracture 
toughness during the fracture experiment. The development of self-healing epoxy with this 
healing chemistry has been studied extensively ever since [54, 55, 111-120].  
 
Healing Stages Interface Model Molecular Model 
1 and 2 
Rearrangement and 
surface approach 
3 
Wetting of the 
surface 
4 
Low level 
diffusion between 
surfaces 
5 
 Diffusion, 
equilibration, 
randomisation 
2. Self-Healing Materials – A Review 
29 
(a) 
 
 
(b) 
 
 
Figure 2-20: (a) Polymerisation of DCPD with Grubbs’ catalyst [121] (b) the polyDCPD 
film (highlighted in blue) covers most of the epoxy fracture surface. A Grubbs' catalyst wax 
microsphere is present in the top right corner of the image (highlighted in purple) (Reprinted 
from reference [119] with permission of Elsevier). 
Caruso et al. [60, 65] demonstrated autonomous crack healing and the prevention of crack 
propagation in neat epoxy containing organic solvents (encapsulated chlorobenzene), a single-
capsule self-healing agent. Recovery of 82% of the epoxy original fracture toughness was 
reported in this study. Figure 2-21 shows the healed fracture surface of epoxy matrix, 
containing encapsulated organic solvent as the healing agent reported in this study.  
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Figure 2-21: ESEM image of healed fracture surface of epoxy matrix containing organic 
solvent microcapsules (Reprinted (adapted) with permission from reference [65]. Copyright 
(2007) American Chemical Society). 
The study on solvent-based self-healing chemistry was then further expanded to two additional 
‘‘greener’’ solvents, PA and EPA by the same team [64], where healing efficiencies of up to 
100% for neat epoxy were achieved. Neuser and Michaud [122] followed by studying the effect 
of the same EPA solvent loaded capsules on neat epoxy during fatigue testing, where a 
complete crack arrest was observed for very high loading conditions. 
Preparations of epoxy based self-healing materials containing epoxy-loaded microcapsules 
have been reported in several literatures [20, 23, 30, 123, 124]. Epoxy resins are reactive 
monomers and react with a wide range of hardeners, such as amines of different functionalities 
and anhydrides at different temperatures [125]. Yin et al. [30], as mentioned earlier, used 
single-capsule healing systems, consisting of UF microcapsules containing epoxy pair with 
CuBr2(2-MeIm)4 (the complex of CuBr2 and 2-methylimidazole), as its latent hardener 
dispersed in epoxy based polymer. The resulting epoxy exhibited a 111% recovery of its 
original fracture toughness. Yuan et al. [20], employed mercaptan-loaded microcapsules as the 
hardener for a low viscosity epoxy (diglycidyl tetrahydro-o-phthalate (DTHP))-loaded 
microcapsules in their dual-capsule self-healing system in epoxy base polymer, where they 
achieved a very high healing efficiency (104%) using only 5 wt.% microcapsules and 
successful retardation or arrest of fatigue crack is observed. 
Alternatively, Blaiszik et al. [123] reported on neat epoxy containing a single-capsules system 
loaded with solvents (PA and EPA) together with reactive epoxy monomer. This system is 
based on the presence of unreacted hardener in the epoxy polymer and the swelling of the epoxy 
in the presence of the solvents. Coope et al. [124] extended this self-healing chemistry, using 
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Scandium(III) Triflate (Sc(OTf)3) particles as catalytic curing agent in epoxy matrix. Results 
show that the epoxy samples recovered greater than 80% of their original fracture strength. 
For high performance epoxy-based composites, the fabrication process was usually performed 
in elevated temperature (temperature 120°C and above); therefore, epoxy with elevated 
temperature curing system is commonly used as a matrix. In general, elevated temperature-
cured epoxies possess a higher glass transition temperature (Tg) value in comparison to room 
temperature-cured epoxy, which is desirable for high-temperature application. Nearly all of the 
studies on capsule-based self-healing discussed previously only focused on epoxies with room 
temperature curing system, with the exception of studies by Jin et al. [18, 23] , Yuan et al. [24] 
and Mangun et al. [25]. These studies have proposed a viable thermally stable self-healing 
chemistries consisting of: encapsulated diluted epoxy and its curing agent POPTA [18] and 
encapsulated aliphatic polyamine [23]; encapsulated pure DGEBA epoxy and mercaptan [24]; 
and encapsulated poly(dimethylsiloxane) and organotin catalyst [25] for neat epoxy with 
elevated temperature curing system. However, their employment into FRPs was never 
attempted, to the best of the author’s knowledge. 
2.4.2 Capsule-based self-healing of epoxy adhesive 
Thin epoxy adhesives are commonly used in aerospace and automotive industries for bonding 
metallic and composite substrates due to their superior properties, such as high modulus and 
strength. Despite the advantages, as previously discussed, epoxies are fairly brittle once 
crosslinked, which make them susceptible to crack initiation and propagation. 
Although studies of microcapsule-based self-healing in bulk epoxy have been growing rapidly 
in recent decades, very few have addressed the application and performance as thin film 
adhesives.  
Translating the results from bulk epoxy to thin film adhesives presents a number of unique 
technical challenges, as presented by Jin et al. [126]. As adhesives are typically applied as thin 
films over large areas, there are necessary geometric constraints on the maximum size and 
weight fraction of microcapsules that can be used. The existence of a microencapsulated self-
healing agent must not inhibit the bond between the substrate surface and the host epoxy 
adhesive. Finally, the healing chemistry must provide not only good adhesion to the host epoxy 
adhesive, but also to the substrate materials to heal both cohesive and adhesive failure. The 
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self-healing of thin film epoxy (360 µm) in this study was demonstrated by employing 
encapsulated DCPD monomer and Grubbs’ catalyst particles. Both quasi-static fracture and 
fatigue performance were evaluated, showing recovery of 56% of the original fracture 
toughness under quasi-static fracture; and complete crack arrest is demonstrated for fatigue test 
conditions. The same group then extended the study using the same healing chemistry 
commercialized rubber-toughened epoxy adhesive (Figure 2-22) [127].  
 
Figure 2-22: SEM micrographs of fracture plane of rubber-toughened epoxy adhesive DCPD 
microcapsules and Grubbs’ catalyst (Reprinted from reference [127] with permission of 
Elsevier). 
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2.4.3 Capsule-based self-healing of fibre-epoxy composites 
The fabrication of fibre-epoxy composites is fundamentally more difficult than the neat epoxy. 
Despite extensive research and further refinement on capsule-based self-healing chemistry and 
mechanism, not much work has been done involving this mechanism in FRPs.  
A highly cited piece of research done by Kessler et al. [27, 28], studies a self-healing FRPs 
with epoxy as matrix material. The initial work involving the healing of delamination damage 
in woven E-glass/epoxy composites is performed using DCPD/Grubbs’ catalyst healing 
chemistry as healing agents [28]. This study was conducted to assess the feasibility of 
developing a self-healing epoxy based FRPs, consisting of microencapsulated healant. It was 
shown that healing of delaminations damage could be self-activated by incorporating Grubbs’ 
catalyst within the matrix of fibre reinforced composites. They have extended the study by 
developing FRPs composites (Vf  ≈ 30%) with healing capability to repair delamination, 
recovering up to 80% of its fracture toughness using the same healing chemistry [27]. Self-
sealing capability in epoxy based GFRP by the addition of aforementioned capsule-catalyst 
self-healing chemistry was demonstrated by Moll et al. [128]; self-sealing behaviour was 
observed in composite laminates with no nitrogen gas flow through the laminates in the 
thickness direction, after damage by repeated indentation at prescribed loads.  
 
Figure 2-23: Delamination separation of GFRP laminates consisting of DCPD 
microcapsules with wax protected Grubbs’ catalyst (Reprinted from reference [129] with 
permission of Elsevier). 
Patel et al. [129], in extension of using DCPD microcapsules, demonstrates fully autonomic 
self-healing of low-velocity impact damage in FRPs and explores impact behaviour up to 45 J. 
In this study, self-healing functionality was integrated in epoxy-based GFRP, based on the 
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system described by White et al. [19], and paraffin wax microspheres containing 10 wt% 
Grubbs’ catalyst modified by Rule et al. [54]. The fibre content was estimated, based on panel 
thickness, to be approximately 33% by volume, corresponding to 4 mm laminate thickness 
consisting of four layers of woven glass fibre. Figure 2-23 shows the delamination separation 
of the impacted GFRP consisting of this capsule-catalyst system.  
Blaiszik et al. [130] established a protocol for healing interfacial damage in fibre reinforced 
composite materials by functionalising both catalyst and microcapsules directly on the surface 
of a glass fibre, as shown in Figure 2-24a. They have suggested in this study that healing of 
fibre/matrix interfacial bond has the potential to halt or delay the large-scale damage from 
developing inside the composites. A similar study of carbon fibre interfacial functionalization 
was undertaken by Jones et al. [131] using capsules containing reactive epoxy resin and EPA 
solvent (Figure 2-24b). A maximum of 91% recovery of interfacial shear strength was 
successfully attained. 
(a) 
 
 
(b) 
 
 
Figure 2-24: SEM microscopy images interfacial functionalization of (a) e-glass fibre with 
DCPD microcapsules and Grubbs’ catalyst (Reprinted from reference [130] with permission 
of  John Wiley and Sons) (b) carbon fibre with capsules containing reactive epoxy resin and 
EPA (Reprinted (adapted) with permission from reference [131]. Copyright (2014) American 
Chemical Society). 
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Yin et al. [29, 30, 66, 132] employed the used of a single-capsule healing system consisting of 
urea–formaldehyde microcapsules containing epoxy into epoxy based GFRP (Vf ≈ 30%) 
(Figure 2-25). The microcapsules were dispersed into the epoxy matrix that was pre-dissolved 
with CuBr2 (2-MeIm)4 latent hardener. It was observed that when the structure heated to 140°C 
after fracture this healing chemistry can provide GFRP healing ability by recovering its fracture 
toughness as well as its compressive strength.  
  
Figure 2-25: Fracture surface of GFRP laminate containing epoxy microcapsules and latent 
hardener [132]. 
Yuan et al. [31], as a continuation of their previous study in diluted-epoxy/mercaptan self-
healing chemistry [20, 58], fabricated epoxy-based GFRP containing this dual-capsule self-
healing agent with fibre volume fraction of the resulting composite laminates at about 41%. In 
this study, they found the incorporation of epoxy/ mercaptan microcapsules into epoxy based 
GFRP can provide the composites with crack healing capability, as revealed by the reduction 
in impact damage areas with time and the recovery of compressive strength after impact.  
A more recent development on FRPs by Manfredi and Michaud [133] and Manfredi et al. [32] 
on GFRP containing EPA filled capsules revealed that healing did not take place for high fibre 
volume fraction (50%) composite samples. This healing system is based on the presence of an 
unreacted fraction of hardener in the host matrix material and on the swelling of the matrix 
crack faces in the presence of the organic solvent released from the ruptured capsules, which 
also contain a small amount of epoxy. Therefore, healing in composites with a lower volume 
fraction of matrix shows no healing effect since the epoxy monomer inside the capsules needs 
to react with the hardener carried by the host epoxy matrix. 
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 Quantification of healing efficiency 
In general, healing efficiency can be defined as: the ratio of healed property to original property 
of any measured material property (fracture toughness, peak fracture load, tear strength etc.). 
To quantify healing efficiency, researchers have suggested many definitions; and definitions 
have been made for convenience, where Blaiszik et al. [41] proposed the general definition of 
healing efficiency (η) as ratio of changes in material properties of interest, 
 η (%) =
f
healed
-f
damaged
f
original
-f
damages
×100 2-1 
where f is the property of interest. 
In neat epoxy and epoxy-based composites, several healing efficiency evaluation methods have 
been employed depending on damage mode. 
2.5.1 Mode I damage 
2.5.1.1 Neat epoxy Mode I damage assessment 
Healing efficiency quantification of neat epoxy specimen utilising TDCB specimen geometry 
was first outlined by White el al. [19]. The TDCB geometry developed by Mostovoy et al. 
[134] provides a geometry that will ensure controlled crack growth along the centreline of the 
specimen. Apart from that, it was also designed for constant compliance with crack length, so 
that the fracture toughness, KIC, calculation is independent of crack length [135]. Since this was 
first established, many research studies on self-healing of neat polymer materials have used the 
same protocol [18, 22, 25, 31, 53, 58, 59, 65, 113, 114, 119, 122, 136-140].  
Figure 2-26a shows the geometry of TDCB specimen outlined for self-healing polymers. For 
the case of brittle polymer, the Mode I stress intensity factor, KIC can be defined as [19, 22], 
 KIC=2PC
√mt
β
 2-2 
which requires knowledge of only the critical load, Pc, and geometric constants m and β. The 
value of β is dependent on the specimen widths b and bn (referring to Figure 2-26a) and the 
value of mt is defined by the theoretical relation as follows: 
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 mt = 
3a2
h(a)3
+
1
h(a)
 2-3 
As for TDCB geometry shown in Figure 2-26a, the equation (2-2) can now be written as: 
 KIC=α∙Pc 2-4 
where α = 11.2 × 103 m-3/2  as experimentally determined in [22]. 
  
(a) (b) 
Figure 2-26: Geometry of (a) TDCB specimen (b) CT specimen (Reprinted from reference 
[141] and [49] with permission of Elsevier). 
Therefore for TDCB specimen, as outlined by White et al. [19] where healing efficiency was 
defined as the ratio of stress intensity factor of healed specimen to original specimen, the 
measure of η (%) is as follows; 
 η(%)= 
KIC(healed)
KIC(original)
×100=
PC(healed)
PC(original)
×100 2-5 
As for Mode I fatigue crack growth, the performance of a self-healing system was evaluated 
using the fatigue life extension ratio (λ) [31, 114, 116, 141]: 
 λ = 
Nhealed-Ncontrol
Ncontrol
  2-6 
where Ncontrol is the total number of cycles to failure for a non-self-healing sample and Nhealed is 
the total number of cycles to failure for a self-healing sample. 
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Compact tension (CT) sample (geometry as shown in Figure 2-26b) has also been used for 
Mode I crack growth healing assessment [49, 142]. Using CT sample, KIC was calculated as 
follows: 
 KIC=
PY (
a
W)
BW1/2
 2-7 
where a is the crack length, P is the fracture load, B is the sample thickness and W is the sample 
width. Y(a/W) is a geometry factor which compensates for the fact that in the compact tension 
fracture test, the compliance of the sample depends on the crack length (a) to sample width (W) 
ratio. Healing efficiency (η) was calculated using equation (2-5). 
2.5.1.2 Epoxy adhesive Mode I damage assessment 
Jin et al. [126, 127] employed the WTDCB specimens as shown in Figure 2-27 to measure the 
fracture toughness of adhesively bonded steel substrates, to evaluate the healing efficiency of 
epoxy adhesive containing self-healing microcapsules. Similar with TDCB geometry, WTDCB 
sample geometry offers a crack length independent measurement of Mode I fracture toughness 
[143, 144]. 
Using WTDCB geometry, Mode I stress intensity factor was calculated as follows: 
 KIC=2𝑃𝑘√
3Ea
(1-ν2)Eshs
3
 2-8 
where P is the applied load, k is the taper ratio (for WTDCB specimen in Figure 2-27, k = 3 is 
used), νs (0.33) is the substrate Poisson’s ratio, hs is the substrate thickness, and Ea and Es are 
the modulus of elasticity of the adhesive and the substrate, respectively. 
Equation (2-8), can then be reduced as follows: 
 KIC=ά∙Pc 2-9 
where ά is the constant related to material properties and geometry. The healing efficiency is 
then calculated using equation (2-5). 
2. Self-Healing Materials – A Review 
39 
No traces are found in the literatures related to self-healing assessment using TDCB sample 
geometry for epoxy adhesives.  
 
Figure 2-27: Geometry of WTDCB specimen consisting of steel adherents bonded with self-
healing epoxy adhesive. (Reprinted from reference [126] with permission of Elsevier). 
2.5.1.3 Fibre-epoxy composites Mode I damage assessment 
WTDCB and double cantilever beam samples are the two most employed specimen geometry 
for the assessment of self-healing for laminated FRPs structures (Figure 2-28).  
For WTDCB specimens (Figure 2-28a), the quantification of self-healing efficiency was 
calculated using equation (2-5), with the Mode I stress intensity factor KIC calculated as 
follows, 
 KIC=2𝑃𝑘√
3
(1-ν2)h
3
 2-10 
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where P is the applied load, k is the taper ratio (a/b), h is the specimen half-thickness, and ν is 
the Poisson's ratio. The only unknown variable in this equation is P and the fracture toughness 
can therefore be directly related to the critical load measured during crack growth [27]. 
(a) 
 
 
(b) 
 
 
Figure 2-28: Geometry of specimen (a) WTDCB (all dimensions are in mm) and (b) DCB 
(Reprinted from reference [27] and [28] with permission of Elsevier). 
For DCB specimen in Figure 2-28b, the Mode I energy release rate, GIC in terms of sample 
compliance, can be expressed as: 
 GIC =
1
 2B
P2
dC
da
 2-11 
The critical stress intensity factor, KIC, under the plane stress condition for Mode I loading, can 
be defined as: 
 KIC= √EGIC 2-12 
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In line with the quantification of healing efficiencies in equation (2-5), DCB sample healing 
efficiencies can be quantified as follows [66, 132]: 
 η (%) = 
KIC(healed)
KIC(original)
×100 = √
GIC(healed)
GIC(original)
×100 2-13 
where GIC(original) is the energy release rate for original fracture and GIC(healed) is the energy 
release rate for healed fracture.  
2.5.2 Mode II damage 
For laminated polymer composites, Norris et al. [73] investigated the interactions of Mode I 
and Mode II crack propagation with self-healing vascular networks integrated in GFRP. End 
loaded split specimen and corrected beam theory was used to calculate the Mode II strain 
release energy, while Quanqian [145] has proposed a type of ENF specimen to evaluate Mode 
II fracture toughness for self-healing materials. However, the self-healing assessment was not 
investigated or quantified in either of these studies. 
Manfredi et al. [32] focused on the assessment of healing a woven E-glass reinforced epoxy 
using microencapsulated epoxy/solvent self-healing chemistry tested through ENF test for 
Mode II damage, but concluded that the obtained Mode II testing results were inadequate for 
assessing the healing capability of the material.  
2.5.3 Impact 
One of the major factors limiting the application of laminated polymer-based composites, such 
as CFRP and GFRP, is the susceptibility of the material to impact damage in the form of 
multiple through thickness delamination [146]. Research studies on self-healing focused on 
impact damage in fibre reinforced polymers have been conducted in the hopes of extending 
their service life [29, 31, 70, 76, 129]. 
Using compression after impact (CAI), the quantification of healing efficiency is assessed by 
the recovery of the compressive strength of the sample as follows [29, 31]:  
 ηCAI(%)= 
σhealed-σimpact
σoriginal-σimpact
×100 2-14 
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where σhealed denotes the compressive strength of the impacted specimen after healing, σimpact is 
the compressive strength of the impacted specimen, and σoriginal is the compressive strength of 
the virgin specimen. Figure 2-29 shows the impact damage area before and after healing of 
epoxy based GFRP containing epoxy-loaded microcapsules and latent hardener dissolved in 
epoxy matrix [29]. 
 
Figure 2-29: T-scan ultrasonic images of the impacted self-healing laminated polymer 
composites before and after being healed (Reprinted from reference [29] with permission of 
Elsevier). 
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 Fabrication techniques of self-healing fibre-epoxy 
composites 
Generally, fabricating self-healing capsule-based composite laminates employed a more 
complex process when compared to self-healing neat polymer specimens. Due to the difficulty 
in applying resins with microcapsules normally 100 m in size to reinforcing fibres during the 
fabrication process of composites, most studies have adopted a low fibre volume fraction for 
the ease of processing using a hand lay-up technique. This technique involved brushing epoxy 
resin (containing pre-dispersed microcapsules) onto the dry reinforcement ply by hand [27, 66, 
132, 147]. Typically with a common hand lay-up fabrication process, a limit for fibre volume 
fraction is approximately 20-40%,; this is obviously a lower quality than those fabricated using 
advanced techniques such as VARI process, where fibre volume fraction as high as 70% can 
be achieved.  
A recent study by Manfredi et al. [32, 133] demonstrated the fabrication of capsule-based self-
healing composites via VARI process, where 50% fibre volume fraction capsule-based 
laminate was achieved. But due to the choice of healing agent (solvent based self-healing), no 
healing effect was reported. As explained earlier on, with single-capsules of EPA solvent self-
healing agent, the need for thicker resin rich area that carries the unreacted hardener is required, 
which is not the standard in structural composite with high fibre volume fraction.  
 An outlook on healing approach for advanced fibre-epoxy 
composites 
In general, high fibre volume fraction (Vf  > 50%) is essential in producing good structural FRPs 
components [26]. In principle, any form of self-healing approach has the potential to be 
integrated into FRPs to produce composites with healing ability. However, there are several 
factors that have to be considered in choosing the right self-healing system to be integrated 
with FRPs consisting a high fibre volume fraction. 
Each one of the three approaches discussed previously has advantages and limitations that 
come into play when considering its applications. Microencapsulation techniques have been 
rapidly developed over the past few decades; various techniques, ranging from physical 
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methods [148, 149] to chemical methods [150, 151], are available for encapsulation of core 
materials. This is one of the key advantages of using a capsule-based self-healing mechanism, 
as the mass production of microcapsules can easily be commercialised [152]; this is in contrast 
to the other two approaches where the fabrication of materials containing the vascular network 
self-healing and the synthesising of remendable matrix remain highly complex procedures.  
As for the ease of composite laminates fabrication, capsule-based self-healing approaches have 
an advantage when compared to vascular self-healing mechanism. The size of the 
microcapsules makes it easy for them to be dispersed inside the host materials, such as an epoxy 
matrix [67, 153]. With regard to remendable polymer matrix, often the properties of the 
polymer matrix are not sufficient to be employed as matrices in advanced FRPs, where some 
of the application involves extreme temperature and high mechanical performance. 
In respect to healing performance, capsule-based self-healing composites can only cope with 
small sized cracks due to the limited amount of healing agents contained inside the capsules. 
Such limitation can be seen as an advantage in dealing with delamination and other kinds of 
damage on the micro level, which is a common issue in brittle polymeric materials, or when 
using laminated composites [38, 154]. 
Having said that, not all capsule-based systems can be potentially integrated with composite 
laminates consisting high fibre volume fraction. In such composite laminates, the thickness of 
the resin-rich regions between plies is not as thick as the lower Vf composites. Therefore, to 
employ a capsule-based system that requires a hidden functionality of the matrix, such as 
single-capsule system, might not be sufficient in providing the self-healing capability to the 
FRPs. As for catalyst-capsule systems, the activity of catalyst particles such as the Grubbs’ 
catalyst can be influenced and deactivated by the curing agent contained in the surrounding 
epoxy matrix, consequently limiting the healing ability of the FRPs. Dual-capsule systems 
however, provide a healing chemistry that is independent of the functionality of the matrix and 
the reinforcement, thus concluded here as the best system to be integrated with composite 
laminates with high fibre volume fraction. 
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Microencapsulation of Dual-Capsule Self-
Healing System 
 Introduction 
Microcapsules are micro-size spherical materials, consisting of encapsulating materials that act 
like a protecting film separating an active or non-active substance from the external 
environment and avoiding the effects of its inappropriate exposure [155-157]. This protective 
film is designed to release its content when it is broken by pressure, melted, or dissolved. In 
self-healing materials with capsule-based healing agent, the microcapsules store a healing 
agent that will release its content when triggered by damages that occur to the host materials 
[19, 150]. To qualify as self-healing agents, microcapsules should meet these requirements: 
1. The core materials should possess low viscosity so that they will easily flow to the crack 
surfaces and fill up the void [137, 152]. 
2. The resultant capsules with high core content are favourable; this is to ensure enough 
healing agent to fill and subsequently close the gap resulting from the crack [137]. 
3. Core content of microcapsules should have high stability and remain reactive for a long 
time [20]. 
4. For advanced FRPs, elevated temperature-cured epoxy resin are normally employed as 
matrix materials. Therefore, microcapsules must be able to tolerate high temperature during 
fabrication of composites materials [20, 158]. 
5. The microcapsules must remain intact during the fabrication processing of composites 
[158]. 
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6. The shell of the microcapsules must be readily able to rupture when microcracks happen, 
in order to release the healing agent [159, 160]. 
The self-healing system used in this study consists of a pure DGEBA epoxy resin as 
polymerisable monomer and mercaptan (Pentaerythritol tetrakis(3-mercaptopropionate) 
(PETMP)) as its hardener/curing agent, with 2,4,6-Tris (dimethylaminomethyl)phenol (DMP-
30) as the catalyst. The healing agent microcapsules were prepared by an in-situ polymerisation 
technique with poly(melamine formaldehyde) (PMF) as a shell material. The initiation of 
healing agent polymerisation is achieved by the interaction of epoxy with its hardener on the 
crack plane. This dual-capsule healant has been reported to meet those requirements as 
previously discussed above [24, 57, 58]. However, the viscosity of pure DGEBA at room 
temperature is quite high to be employed as a room temperature healing agent, but this 
substance shows a reduction in viscosity with increasing temperature. 
This chapter discusses the microencapsulation process of DGEBA epoxy and mercaptan via 
in-situ polymerisation, with PMF as the shell material as outlined by Yuan et al. [20, 24, 57, 
58] with slight modifications.  
 Experimental  
3.2.1 Materials 
A diglycidyl-ether of bisphenol-A (DGEBA) epoxy resin – Araldite-F supplied by Ciba-Geigy, 
Australia, was employed as the polymerisable component of the dual-capsule self-healing 
system. This epoxy resin has an epoxy content of 5.20 – 5.35 equiv/kg. This is the same epoxy 
resin that is normally used as a matrix in elevated temperature-cured polymer composites. 
Pentaerythritol tetrakis(3-mercaptopropionate) (PETMP), was used as a hardener for the epoxy 
in this dual-capsule system. 
As epoxy would not react with mercaptan in the absence of catalyst [152], the second step in 
producing viable mercaptan-loaded microcapsules was to infuse it with a proper catalyst. 2,4,6-
Tris (dimethylaminomethyl)phenol (DMP-30) was used for this purpose. The chemical 
structures for healing agents used in this study are presented in Table 3-1. Melamine with purity 
99% and formaldehyde (36.5 - 38 wt. % in H2O) were used as shell-forming monomers. 
Triethanolamine and citric acid were used for controlling the pH value of the emulsified 
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solution. 1-octanol was used to eliminate the bubble of the emulsified solution containing 
healing agents. For the preparation of emulsifier solution, styrene, maleic anhydride, benzoyl 
peroxide (BPO), toluene, sodium hydroxide (NaOH) were used. 
All substances other than the DGEBA were purchased from Sigma Aldrich, Australia. Figure 
3-1 shows the materials used for the fabrication of the microcapsules. 
Table 3-1: Chemical structures for self-healing agents. 
Substance Chemical Structure 
DGEBA 
 
PETMP 
 
DMP-30 
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(a) 
3  
 
(b) 
 
 
Figure 3-1: (a) Chemical used to fabricate the dual-mechanism self-healing microcapsules 
(b) chemical used to prepare emulsifier solution. 
3.2.2 Preparation of the emulsifier - poly(styrene–maleic sodium) 
(PSMS) solution 
The first step in preparing the emulsifier solution is to prepare the styrene-maleic anhydride 
(SMA) copolymer. Firstly, maleic anhydride (60 g), benzoyl peroxide (1.2 g) and styrene (24 
ml) dissolved in toluene (500 ml) were added to a three neck round bottom flask (1000 mL), 
set with reflux condenser and a nitrogen gas inlet system. The mixture was stirred at 75°C at 
100 rpm inside a silicone oil bath until its cloud point. After reaching its cloud point, a mixture 
of toluene (260 ml) and styrene (46.4 ml) was added. The reagent was added slowly (i.e.: drop-
NaOH 
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wise) using dropping funnel. The temperature then increased to 80°C and maintained at this 
temperature for 1 hour before cooled to room temperature. 
With a filtration process, the styrene-maleic anhydride (SMA) copolymer was recovered from 
the mixture reaction as white fine particles. The particles were washed repeatedly with toluene 
and oven dried at 60°C for 24 hours to a constant weight. The 10 wt. % hydrolysed solution 
was prepared by dissolving SMA copolymer particles in sodium hydroxide solution (10% 
NaOH in H2O), and stirred at 80°C for 10 hours (until solution become clear). Figure 3-2 shows 
the processing route to produce PSMS emulsifier solution. 
 
Figure 3-2: Preparation of PSMS emulsifier solution. 
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3.2.3 Preparation of melamine-formaldehyde prepolymer 
The prepolymer of melamine (22.4 g) and formaldehyde (48.4 g) was synthesized at 70°C for 
13 minutes. The mixture was stirred continuously with magnetic agitator and 2 drops of 
triethanolamine were added to the solution in order to adjust the pH value to about 9-10. The 
solution was then cooled down to 50°C. The product was used directly in the following 
synthesis. 
3.2.4 Preparation of DGEBA epoxy-loaded microcapsules 
Microcapsules production begins by adding 320 grams of water into 80 grams 10 wt. % of 
PSMS emulsifier solution in the three neck round flask. The mixture was stirred for about 2 
minutes and then two drops of 1-octanol were added to eliminate surface bubbles of the 
mixture. The pH value of the mixture was controlled by adding 3 wt. % citric acid into the 
mixture. Once the pH was in the appropriate range (pH 4.2), DGEBA epoxy (100 g) was then 
added into the mixture. Polytetrafluoroethylene stirring blades were lowered to approximately 
half way from the surface of the solution. The solution then stirred at 60°C for 2 hours with 
stirring speed of 450 rpm for larger size microcapsules and 1200 rpm for smaller size 
microcapsules. Stirring was done without any excessive vibration. 
Subsequently, the prepolymer of melamine-formaldehyde solution was added to epoxy 
emulsion with continuous agitation for 30 minutes before adding 35 ml of 3 wt. % citric acid 
to adjust and maintain the pH value at about 3. The speed of agitation was reduced to 350 rpm 
(larger microcapsules) and 1100 rpm (smaller microcapsules) with the addition of citric acid 
for about 2 hours. Next, the temperature of the system was increased to 70°C and the speed 
was again reduced to 260 rpm with continuous agitation for 2 hours.  
Eventually, the reaction mixture was cooled down to room temperature and the resultant slurry 
of microcapsules was sieved using mesh sieve with different aperture opening with running 
water. Microcapsules of the desired size were collected from appropriate sieve. The clumps of 
microcapsules were dried at room temperature for 24 hours and then placed inside the drying 
cabinet for another 24 hours. Figure 3-3 summarised the microencapsulation of epoxy utilising 
in situ polymerisation of melamine formaldehyde the form the capsule shell. 
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Figure 3-3: Microencapsulation of epoxy utilising in situ polymerisation of melamine-
formaldehyde to form capsule shell. 
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[152, 161]. Microcapsules with a smaller size range were stirred at a higher stirring speed (1200 
rpm), while microcapsules with a larger size range were stirred at a lower stirring speed (450 
rpm). 
3.2.5 Preparation of mercaptan-loaded microcapsules 
Microcapsules containing mercaptan were prepared in two steps. Firstly, mercaptan was 
encapsulated by adapting a similar process to make DGEBA epoxy-loaded microcapsules as 
explained in section 3.2.4. Secondly by adapting procedure established by Yuan et al. [58], the 
resulting microcapsules were then dispersed into the catalyst solution, DMP-30, at 40°C for 48 
hours and then filtrated and washed with ethyl ether. The microcapsules were then leave to dry 
at room temperature for a few minutes in a covered container to avoid evaporation of DMP-30 
and immediately used in the fabrication of composites afterward. 
 Results 
3.3.1 Microcapsules size distribution 
The first attempt to fabricate the dual-mechanism self-healing microcapsules in the Centre of 
Advanced Material (CAMT), at the University of Sydney was successful. The average larger 
size of the DGEBA epoxy-loaded microcapsules is 110.6 µm and for mercaptan-loaded 
microcapsules is 136.4 µm. For smaller sized capsules, the average size was about 65.2 µm for 
DGEBA epoxy-loaded microcapsules and 66.1 µm for mercaptan-loaded microcapsules. From 
herein the larger size range of microcapsules will be referred to as Type-A microcapsules, and 
the smaller size range microcapsules referred to as Type-B. The size distribution of the 
microcapsules was done by images obtained by optical microscope. Figure 3-4 shows an 
example of the image used in the determination of the microcapsules’ size distribution. Figure 
3-5 shows the size distribution of all the microcapsules fabricated in this study. 
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Figure 3-4: Determination of capsules size distribution with optical microscopy image. 
  
(a) 
  
(b) 
Figure 3-5: Size distribution of microcapsule (a) Type-A microcapsules (left) DGEBA epoxy-
loaded microcapsules (right) mercaptan-loaded microcapsules (b) Type-B microcapsules 
(left) DGEBA epoxy-loaded microcapsules (right) mercaptan-loaded microcapsules. 
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3.3.2 Microcapsules geometry and shell feature 
Figure 3-6 shows the geometry and feature of Type-A and Type-B microcapsules obtained by 
SEM (Hitachi S4600). From this figure, it can be seen that all microcapsules have similar 
spherical features except for Type-B mercaptan-loaded microcapsules, where collapsed shell 
phenomena can be seen. As explained by Yuan et al. [57], in the course of microencapsulation 
of mercaptan-loaded microcapsules, some PETMP was consumed to build up the shell wall, 
this is defined as a “loss of PETMP”. The agitation rate is one of the factors that influence the 
microcapsules core content and the loss of PETMP by changing the microcapsules’ diameter 
and specific surface area. Increasing the agitation rate will decrease the average diameter the 
microcapsules. This will result with microcapsules with larger specific surface area certainly 
convey a higher loss of PETMP, causing the microcapsules to shrink. 
  
(a) 
  
(b) 
Figure 3-6: The geometry and shell features of (a) Type-A microcapsules (left) DGEBA 
epoxy-loaded microcapsules (right) mercaptan-loaded microcapsules (b) Type-B 
microcapsules (left) DGEBA epoxy-loaded microcapsules (right) mercaptan-loaded 
microcapsules. 
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The shell surface of both Type-A and Type-B DGEBA epoxy-loaded microcapsules appear 
very smooth without nano PMF debris observed, in contrast with mercaptan-loaded 
microcapsules. This feature was not distinctive to the microcapsules fabricated in CAMT, as it 
was also present in the capsules fabricated in research done by Yuan et al. [57]. Figure 3-7, 
shows a higher magnification of SEM images of the shell surface morphology of the 
microcapsules. 
  
(a) (b) 
Figure 3-7: Higher magnification SEM image of shell wall feature of (a) DGEBA epoxy-
loaded microcapsules (b) nano particles PMF debris on mercaptan-loaded microcapsules. 
3.3.3 Shell wall thickness 
The extrinsic part of the microcapsules is the shell, which plays a very important role in 
ensuring the functionality of the microcapsules. As previously mentioned, the shell protects the 
core content from the external atmosphere. In microcapsules containing self-healing agents, 
the impermeable shell that protects the healing agent must be able to be ruptured by the external 
force when damage happens to the host materials. Therefore, controlling the thickness of the 
shell wall is vital for their proper release behaviour. The shell wall should be thick enough to 
prevent the leaking of the core content, but the thickness should not be too thick as to prevent 
it from rupture when damage happens [161]. The shell wall thickness will also influence the 
core content of the microcapsules, microcapsules with thicker shell carry less core content (i.e. 
healing agent). 
 
3. Microencapsulation of Dual-Capsule Self-Healing System 
56 
  
(a) 
  
(b)  
Figure 3-8: SEM image of shell wall thickness of microcapsules (a) DGEBA-loaded (b) 
mercaptan-loaded. 
The shell thickness of the microcapsules was observed by SEM. Prior to SEM observation, 
microcapsules were dispersed on double-sided carbon tape and crushed with a razor blade to 
release the core content. The capsules were then dried in a vacuum chamber for 16 hours. This 
is done to protect the SEM’s vacuum system from contamination. After that, the samples were 
coated with gold to improve the imaging of the samples. It was observed that the thickness of 
the DGEBA epoxy-loaded microcapsules was 1.48 (±0.20) µm, and for mercaptan-loaded 
microcapsules the thickness was 1.53 (±0.24) µm as shown in Figure 3-8.  
3.3.4 Microcapsules core content 
The Soxhlet extraction method was employed to determine the core content (weight ratio of 
core content to microcapsule, WM) of the microcapsules [20, 57]. Figure 3-9 shows the 
experimental set-up of the Soxhlet extraction method. Acetone was used as an extraction 
solvent. A small amount of microcapsules was thoroughly ground to ensure all the capsules 
40 µm 2 µm 
30 µm 3 µm 
1.48 (±0.20) µm 
1.53 (±0.24) µm 
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were broken. The microcapsule samples were then wrapped using the WhatmanTM qualitative 
filter paper (Grade 3, 6 µm, medium flow) and weighed. This is the weight of the core content, 
Wc, and the shell, Ws, of the microcapsules, WM. The microcapsule samples were extracted by 
Soxhlet apparatus for 240 hours to remove the core content. After extraction, the weight of the 
sample was measured once again. The final weight is the weight of the shell, Ws. The extraction 
was done 3 times for both Type A (epoxy-loaded and mercaptan-loaded microcapsules) and 
Type B (epoxy-loaded and mercaptan-loaded microcapsules) to get the average value. 
 
Figure 3-9: Experimental set-up for Soxhlet extraction method to determine the core content 
of the microcapsules. 
The estimation of the core content percentage is the calculated using equation (3-1): 
 
Wc (%)= (1-
Ws
WM
) × 100 3-1 
Furthermore, the core content of the microcapsules was estimated using the thickness of the 
microcapsules’ shell, RS (Rm-Rc) and density of the core, ρM, and shell materials, ρs. Since the 
microcapsules were in a spherical shape, the idealized shape can be schematically presented as 
Figure 3-10, where Rm is the radius of the microcapsules and Rc is the radius of the core content. 
The core content is then estimated using equation (3-2).  
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Figure 3-10: Idealized shape of microcapsules [162]. 
 Wc(%)= (1-
Ws
WM
) × 100 =  (1 − (
4 3π(Rm
3 -Rc
3)ρ
s
⁄
4 3⁄ π(Rm
3 )ρ
m
)) ×100 3-2 
The data for the core content of the microcapsules, based on two methods of estimation, is 
presented in Table 3-2. From these data points, both methods of core content estimation appear 
to be in agreement with each other. The slight differences might be caused by the irregularity 
of the spherical shape of the microcapsules. 
Table 3-2: Core content percentage of both Type-A and Type-B microcapsules 
Microcapsules 
Core Content (%) 
Soxhlet extraction method 
(wt. %) 
Idealized sphere method 
(wt. %) 
DGEBA Type-A 96.70 93.05 
Mercaptan Type-A 93.10 (0.6 wt.% DMP-30) 94.35  
DGEBA Type-B 90.29 88.50 
Mercaptan Type-B 89.63 (0.6 wt.% DMP 30) 88.65  
Density of DGEBA, mercaptan and PMF are 1.24 g/cm3, 1.28 g/cm3 and, 1.10 g/cm3 
respectively 
3.3.5 Reactivity of the microcapsules 
The reactivity of the dual-capsule self-healing agent was analysed with differential scanning 
calorimetry (DSC). In this study, 1 to 1 stoichiometry between DGEBA and mercaptan was 
decided. At 1:1 epoxy/mercaptan weight ratio, there is an excess of epoxy compared to 
R
m
 
R
c
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mercaptan groups. However, with DMP-30 as catalyst, this will cause the epoxy to self-cure. 
Evidently, variation greatly from 1:1 ratio will cause problems of incomplete cure [163]. 
 
Figure 3-11: DSC analysis showing reactivity of epoxy and mercaptan as self-healing agent 
(solid line – mixture of unencapsulated epoxy resin/mercaptan/DMP-30, dashed line – 
mixture of ground epoxy/mercaptan microcapsules). 
At first, a mixture of unencapsulated healant (DGEBA epoxy resin, mercaptan, DMP-30 with 
weight ratio of 100:100:2) was heated from 30°C to 200°C at a rate of 10°C/min in N2 
environment. An obvious exothermic reaction peak can be observed (Figure 3-11– solid line) 
due to the cure reaction of the mixture. The exothermic peak of this curing is located at 
approximately 98°C, signifying that the fastest cure for this mixture will happen at this 
temperature. The onset of the cure peak is about 70°C. Second analysis was done on grounded 
DGEBA epoxy- and mercaptan-loaded microcapsules (readily infused with DMP-30) with a 
weight ratio of 100:100. The exothermic peak shifted a little (Figure 3-11– dashed line), as 
there is no way to ensure 100% of the ground microcapsules were broken; therefore, the 
stoichiometric ratio of epoxy and mercaptan in the mixture might not be the same as the 
unencapsulated healing agents. 
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 Summary 
Based on these results, it can be concluded that viable self-healing microcapsules as outlined 
by research done by Yuan et al. [20, 24, 57, 58] was successfully fabricated. Microcapsules 
with two different size ranges were prepared by controlling the agitation rate (ranging from 
460 – 1200 rpm). Microcapsules with a larger size range (Type-A) were stirred at a lower 
stirring speed, while microcapsules with a smaller size range (Type-B) were stirred at a higher 
stirring speed. The average size of Type-A DGEBA epoxy-loaded microcapsules is 110.6 µm 
and 136.4 µm for mercaptan-loaded microcapsules. For Type-B the DGEBA epoxy-loaded 
microcapsules mean size is 65.20 µm and 66.10 µm for mercaptan-loaded microcapsules. All 
microcapsules featured a perfect spherical shape, except for Type-B mercaptan-loaded 
microcapsules, where a collapse phenomenon can be seen. The shell morphology of DGEBA 
epoxy-loaded microcapsules shows a smooth surface, whereas for mercaptan-loaded 
microcapsules, nano-size PMF debris can be observed. The shell thickness of DGEBA epoxy-
loaded microcapsules is 1.48 (±0.20) µm and 1.53 (±0.24) µm for mercaptan-loaded 
microcapsules. 
The core content for all microcapsules fabricated was approximately ≈ 90 wt. %. The results 
obtained by two methods to calculate the core content seem to be in agreement with each other. 
The core content percentage of the microcapsules is similar as previously reported in Yuan et 
al. [20] but slightly higher when compared to a smaller diameter capsules reported in [58] due 
to the loss of PETMP during the formation of shell wall. 
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Influence of Temperature on Viscosity 
and Healing Efficiency of Elevated 
Temperature-Cured Epoxy 
 Introduction 
As previously discussed in the literature review (Chapter 2), thermosetting polymers such as 
epoxy resins play an important role and have widely been used as a matrix in structural 
composite materials, adhesives and organic coatings due to their superior mechanical and 
adhesive properties [101, 164-166]. Despite their excellent mechanical properties, epoxies are 
vulnerable to damage in the form of microcracks due to their brittleness [38, 106, 167]. 
Therefore, many efforts have been made in the past to improve the fracture toughness of epoxy 
resin by modifying the monomers with additives, such as silica, rubbers and thermoplastics 
particles [10-14, 167, 168]. Despite these efforts, once microcracks or interlaminar cracks 
happen, there is no way in stopping the crack from propagating. Due to these reasons, many 
studies in self-healing have been focusing on the ability of epoxy polymer to self-heal in order 
to improve its reliability in structural materials applications [20, 22, 24, 53, 65, 113, 114, 169].  
Various approaches to self-healing have been developed over the years. The three approaches 
receiving most attention are the capsule-based healing system [18-22, 30, 53-55, 59, 61, 62, 
170], intrinsic healing system [49-51] and vascular self-healing system [16, 46, 47, 52]. Among 
these systems, capsule-based self-healing can be applied in composite laminates with the 
advantage of easy dispersion into matrix resins [153, 171] with little change to manufacturing 
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procedures or microstructure of the composites. Among the three, the capsule-based self-
healing system discussed in Chapter 2, Figure 2-5, known as dual-capsule system shows 
promising advantages to be employed in composite laminates with high fibre volume fraction. 
Both catalyst-capsules and single-capsule systems are dependent on the functionality of the 
polymer matrix, where polymerisation of the monomer (healant) needs to be triggered by the 
reaction with catalyst or hardener premixed with the matrix. In FRPs composites system with 
high fibre content, the lack of matrix ratio might not be sufficient to trigger of the healing in 
these capsule-based systems. However, in dual-capsule systems, the healing can be triggered 
independently since the healing system is not dependent on the host matrix of the system as 
well as the reinforcing fibres. 
Several dual-capsule self-healing systems have been previously reported [18, 20, 58, 62], 
achieving recovery of mechanical property of up to 100%. Dual-capsule self-healing systems 
involve a polymerisable monomer and hardener/curing agent, in which both parts have to be 
respectively protected and dispersed in the host materials [172]. When damage such as 
microcracks happen to the host material, healing will be triggered by the release of the healants 
on the damage area; at this point, the reaction between the two substances will create a film 
that will repair the crack surface together. Epoxy/amine and epoxy/mercaptan are among the 
reported dual encapsulated healing chemistries [18, 20, 23, 58, 62]. Generally, preparation of 
capsules containing a liquid amine is very difficult and complex [23, 173]; therefore, to employ 
this capsules for application in self-healing systems for neat epoxy and its composites will be 
tough. However, for mercaptan-loaded microcapsules as reported by Yuan et al. [20, 58] and 
discussed in the Chapter 3, the microencapsulation technique of mercaptan employed the same 
route as the epoxy-loaded microcapsules, which makes it a more suitable healing chemistry 
candidate. 
Thermosetting resin such as elevated temperature piperidine-cured DGEBA epoxy is generally 
adopted as a matrix component in advanced CF/EP laminates. In general, higher temperature-
cured epoxy usually has a higher service temperature and better mechanical properties, whereas 
many room temperature-cured epoxy become less effective at elevated temperatures. Due to 
the elevated temperature fabrication process, a healant with good thermal stability is needed; 
and for good adhesion and miscibility with the host material, DGEBA epoxy-loaded 
microcapsules were reported as suitable candidates [24, 174]. 
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DGEBA epoxy-loaded microcapsules paired with mercaptan-loaded microcapsules have been 
reported to provide room temperature healing of bulk epoxy [24]. However, DGEBA epoxy is 
known for its high viscosity at room temperature, which makes it difficult to flow. In high Vf  
composite laminates, the amount of capsules that can be embedded is restricted to the area and 
thickness of the interlaminar region; thus, the flow ability of the substance is crucial to ensure 
the trigger of healing phenomenon. In this chapter, experimental investigations were conducted 
on neat piperidine-cured epoxy as a host material, embedded with DGEBA epoxy-loaded and 
mercaptan-loaded microcapsules. This study is essential in order to have a clear understanding 
of the healing phenomenon of this system at different healing temperatures, and the influence 
of the healant viscosity on the repair of damages. The optimum healing cycle for laminated 
CF/EP in later studies was decided from this experimental study. 
 Materials and methodology 
4.2.1 Materials 
DGEBA epoxy resin (Araldite-F (Ciba-Geigy, Australia)), was used as polymerisable 
monomer of the host material and piperidine (Sigma–Aldrich Australia) as curing agent. The 
Type-A DGEBA epoxy-loaded and mercaptan-loaded microcapsules with average diameter of 
110.6 µm and 136.4 µm respectively as explained in Chapter 3, Section 3.3.1 were used for the 
study.  
4.2.2 Sample preparation for mechanical tests  
For the control experiment, unmodified neat epoxy specimens were prepared by mixing 100 
parts of epoxy resin with 5 parts of its curing agent, piperidine. For the self-healing epoxy 
sample, microcapsules with a weight ratio of 10 wt. % (1:1 ratio of DGEBA epoxy/mercaptan 
microcapsules) were added to the host DGEBA matrix and further dispersed in an ultrasonic 
bath. The mixture was degassed and poured into a silicon mould, and cured with piperidine at 
room temperature for 8 hours, followed by 16 hours at 120°C. Four specimens were prepared 
for unmodified neat epoxy, and twelve for self-healing epoxy. 
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4.2.3 Mode I fracture toughness and flexural tests 
For the Mode I fracture toughness test, TDCB specimen geometry as employed by Brown et 
al. [22, 113] was used (Figure 4-1). The Mode I fracture toughness test was done with an Instron 
universal testing machine, model 5567, equipped with 1 kN load cell, under displacement 
control at a rate of 5 µm/sec using pin loading. The specimen was pre-cracked with fresh razor 
blade before loading. Figure 4-2 shows the formation of pre-crack on the TDCB specimen. The 
specimen then tested to failure. The geometry of TDCB specimen controlled the crack to grow 
along the centreline of the specimen. Load and displacement were recorded throughout the test. 
Figure 4-3 shows the experimental setup of the Mode I fracture toughness test. 
 
 
Figure 4-1: TDCB specimen for Mode I fracture toughness test (all dimensions are in mm). 
Data points from load vs. displacement curves were used to generate KIC and GIC values. The 
KIC values were calculated according to equation (2-4). Since the geometries of the TDCB 
specimen is adapted from Brown et al. [22], experimentally determined constant α = 11.2 × 103 
m-3/2 was used for the calculation. For cracks that move in the straight line, the KIC is related 
to GIC by the following: 
 GIC=
KIC
2
E
 4-1 
where E is the modulus of elasticity of the sample. As the calculation of GIC required the 
knowledge of E, three point bending tests according to ASTM D790 [175] were performed to 
both unmodified neat epoxy and self-healing epoxy. At least four samples were tested for neat 
epoxy and self-healing epoxy. From this, it was possible to obtain the E values.  
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In the case of unstable (stick/slip) crack propagation, which was expected for brittle polymeric 
material, the load-displacement curve in TDCB test was schematised in Figure 4-4. This crack 
propagation behaviour produced multiple peaks of critical load, Pc, for the onset of crack 
propagation, leading to multiple values of the KIC and GIC.  For this reason, rather than 
characterising KIC and GIC with only a single maximum value, the average value of fracture 
toughness was considered. 
 
Figure 4-2: Introduction of pre-crack on TDCB specimen with fresh razor blade. 
 
Figure 4-3: Experimental setup to conduct Mode I fracture toughness test of epoxy-based 
self-healing polymer. 
Razor blade 
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Figure 4-4: Schematic of load vs. displacement curve for unstable crack propagation. 
4.2.4 Assessment of healing of neat epoxy through TDCB test 
Three different healing temperatures were chosen to highlight the role of temperature on 
viscosity of the healant and healing efficiency: i) 25°C (room temperature), ii) 50°C and iii) 
70°C. Four self-healing epoxy specimens containing 10 wt. % microcapsules were tested for 
each healing temperature. 
 
Figure 4-5: Steel jig used for clamping fractured specimen. 
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After the first original TDCB fracture test, the fractured surfaces of the specimen were brought 
back together with the aid of a steel jig as shown in Figure 4-5, to initiate the healing process. 
Healing at temperature 50°C and 70°C were done inside a vacuum oven. After healing, the 
specimens were cooled down to room temperature and retested with the same procedure as the 
original fracture. The quantification of healing efficiency was calculated according to equation 
(2-5). 
4.2.5 Differential Scanning Calorimetry 
DSC analysis was done on unmodified epoxy (0% microcapsules) to ensure that the matrix was 
fully cured, and therefore the possibility of the post-curing effect of the host epoxy contributing 
to healing at elevated temperatures can be eliminated. Calorimetric analysis was carried out by 
a DSC, TA Instruments (2920 Modulated DSC). The analyses were performed by scanning the 
temperature from room temperature to 200°C at a scan rate of 10°C/min. The mass of the 
sample was about 10 mg, in aluminium pans with a diameter of 5 mm.  
DSC analysis was also done to DGEBA epoxy film cured by mercaptan with the presence of 
DMP-30. DGEBA epoxy samples cured at difference healing cycles (i. 25°C (Room 
Temperature) -24 hours, ii. 50°C – 24 hours and iii. 70°C – 24 hours) were tested. This is to 
highlight the difference in glass transition temperature, Tg of the resulting DGEBA 
epoxy/mercaptan system when cured at different temperatures. 
4.2.6 SEM analysis  
SEM examination was carried out on the fracture surface. The surfaces were coated with a thin 
layer of gold to increase conductivity. SEM Hitachi S4600 and SEM Zeiss EVO/Qemscan at 
low voltage were used to observe the toughening mechanism (if any) and the healing 
mechanism of the neat epoxy. 
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 Effect of incorporation of dual-capsule on fracture 
toughness of elevated temperature piperidine-cured epoxy 
Figure 4-6 shows the load vs. displacement curve obtained from the three point bending test, 
performed to determine the modulus of elasticity of the unmodified neat epoxy and self-healing 
epoxy. Based on the test results, it was found that the modulus values of elasticity of the 
unmodified neat epoxy and self-healing epoxy are 3.12 (±0.09) GPa and 2.59 (±0.06) GPa 
respectively. These data points were used in the calculation of GIC according to equation (4-1). 
 
Figure 4-6: Load vs. displacement from three-point-bending test. 
Figure 4-7 shows load vs. displacement curves of unmodified neat epoxy and self-healing 
epoxy specimens after TDCB fracture tests. Both epoxies show the same stick/slip crack 
propagation behaviour, indicating unstable brittle fractures. The average KIC and GIC for 
unmodified neat epoxy are 0.62 (± 0.12) MPa.m1/2 and 133.22 (± 47.30) J/m2 respectively. The 
average KIC and GIC values for self-healing epoxy are 0.56 (± 0.03) MPa.m1/2 and 121.46 (± 
12.86) J/m2 respectively.  
From these results, it can be seen that the incorporation of microcapsules into elevated 
temperature-cured epoxy did indeed have an effect on epoxy original properties. A reduction 
in modulus can be observed with the addition of microcapsules into epoxy. A decrease in KIC 
value can be observed, but almost no difference in GIC value was observed. Observations on 
the fracture surface of self-healing epoxy can be seen in Figure 4-8. Although the toughening 
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effect is not noticeable in this study, the “tail” like markings near the microcapsules as observed 
by Brown et al. [113] can be seen from this figure, indicating the appearance of a crack pinning 
mechanism [176]. However, it is worth noting for room temperature-cured epoxy in general, 
and as in [113], the percentage of plastic deformation at the fracture is higher than the elevated 
temperature-cured epoxy; consequently it can tolerate more plastic shear deformation, and 
dissipate more strain energy. 
 
Figure 4-7: Load vs. displacement of Mode I fracture toughness test. 
  
Figure 4-8: Toughening of epoxy based polymer via microcapsules tailing. 
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 Healing of elevated temperature-cured epoxy 
4.4.1 DSC analysis on unmodified piperidine-cured epoxy  
Figure 4-9 shows the DSC curve of the piperidine-cured epoxy. Note the Tg of the cured epoxy 
at 96°C; no exothermal peaks present suggests the maximum cure was achieved. From this 
data, it can be concluded that the healing effect of the elevated temperature-cured epoxy 
containing DGEBA epoxy/mercaptan dual-capsule was not contributed by the post-curing of 
the host epoxy. 
 
Figure 4-9: DSC curve of cured unmodified DGEBA epoxy. 
4.4.2 Viscosity of the microcapsules’ core content/healant 
The viscosity of the healant plays an important role in achieving better crack healing ability. 
Healants with lower viscosity are required since they have a better capacity to move on the 
fracture surface [152, 177, 178]. The viscosity of both DGEBA epoxy and mercaptan used in 
this study were measured using a parallel-plate type rheometer (Anton Paar - MCR 300 
rheometer) at three different temperatures; i) 25°C, ii) 50°C and iii) 70°C. As can be seen in 
Figure 4-10, the viscosity of epoxy resin and mercaptan decreases with increasing temperature, 
indicating better flow ability. The viscosity of DGEBA epoxy decreases dramatically at higher 
temperature, comparable to the viscosity of DTHP epoxy resin which has been used as self-
healing agent before [20]. This indicates that DGEBA epoxy is more effective used as a healant 
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at elevated temperatures, as it can uniformly spread on the fracture surface due to the lower 
viscosity. 
 
Figure 4-10: Effect of temperature on viscosity of epoxy resin and mercaptan. 
4.4.3 Room temperature healing with DGEBA epoxy/mercaptan self-
healing system 
Figure 4-11 shows typical load vs. displacement curves of original and healed fractures of self-
healing epoxy containing 10 wt. % microcapsules when healed at room temperature. Unlike 
the ‘stick and slip’ fracture behaviour of the original fracture, for healed specimens, most of 
the samples failed after the maximum value was achieved; by this time sudden decrease of load 
can obviously be seen (rapid propagation). An average healing efficiency of 26% (±12.61) can 
be observed for room temperature healing of the TDCB specimens. 
However, this result contradicts the observation of Yuan et al. [24] where they have reported 
room temperature healing of 72-86% healing efficiency for epoxy-based polymer containing 
DGEBA epoxy- and mercaptan-loaded microcapsules. In their study, a larger amount of 
capsules was added into the host epoxy (10 wt. % epoxy-loaded microcapsules, 10 wt. % 
mercaptan-loaded microcapsules), resulting more healing agent being released onto a crack 
surface during healing. Apart from that, in comparison to their host epoxy with “medium-
temperature” curing system (curing temperature closely related to this thesis), 2-ethyl-
methylimidazole (2E4MIm) was used as a curing agent. With 2E4Im as curing agent only 6 
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hours thermal exposure above 120°C was required to fully cure the epoxy. Whereas, in this 
thesis, piperidine was used as curing agent, which require 16 hours thermal exposure at 120°C. 
It was believed that during this thermal exposure, the epoxy prepolymer inside the 
microcapsules has been slightly deteriorated. 
 
Figure 4-11: Load displacement curves for TDCB sample healed at room temperature. 
It is also worth noting that the viscosity of DGEBA at room temperature is about 10.6 Pa s 
(Figure 4-10). Since the flow ability and viscosity are inversely proportional to each other, 
healing with DGEBA epoxy-loaded microcapsules might not be beneficial at room temperature 
[174]. An investigation of the healed fracture surface of the specimen is shown in Figure 4-12 
and appears to be in agreement. As can be observed, the clean fracture surface with small lumps 
of polymerised healant (Figure 4-12a) indicates the lack of healant film formed on the original 
brittle fracture surface. It can also be observed from Figure 4-12b and Figure 4-12c that the 
healant remains intact inside the capsules, caused by the lower flow ability of the substance 
(DGEBA epoxy) at room temperature. 
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(a) (b) 
  
(c) 
Figure 4-12: SEM images of healed fracture surface of cured epoxy containing 10 wt. % 
DGEBA epoxy/mercaptan microcapsules (a) clean fracture surface indicating poor healing 
(b-c) healant was observed remain intact inside the capsules.  
To simulate the effect of uniform spreading on the healing effectiveness, a mixture of DGEBA 
epoxy and mercaptan (mixed with 0.6 wt. % DMP-30) with 1:1 weight ratio was prepared and 
immediately spread thoroughly onto the unmodified neat epoxy crack surface. The specimens 
were left at room temperature for 24 hours and retested with same procedures. Figure 4-13 
shows the load vs. displacement curves of the original fracture in unmodified cured epoxy and 
the healed fracture (healed with the prepared mixture). When the healant mixture was 
uniformly spread onto the crack surface, the healing efficiency increased to around 60% with 
a room temperature healing cycle.  
100 µm 
50 µm 
70 µm 
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Figure 4-13: Load vs. displacement of unmodified cured epoxy healed with a mixture of 
DGEBA/mercaptan/DMP-30. 
Apart from that, to reach the maximum adhesive properties of epoxy, a higher temperature cure 
schedule should be selected to achieve a higher crosslink density of the epoxy. When an epoxy 
is cured at lower temperature, the crosslinks will form slowly, resulting in a more expanded 
network structure. A higher cross-link density formation will enable the cured epoxy to display 
enhanced mechanical, physical and adhesive properties [179, 180]. DSC analysis on cured 
DGEBA epoxy/mercaptan healant film is shown in Figure 4-14, showing the Tg of the healant 
cured at different temperature. Since the relationship of cross-link density and Tg is 
substantially linear [181], it is obvious that the resultant healant film was unable to show the 
best performance with a room temperature healing cycle. With Tg only 18°C, even at room 
temperature service application, the resultant healant film will start to soften and likely to lose 
some of its strength. 
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Figure 4-14: DSC curves of showing Tg of DGEBA epoxy/mercaptan healant cured at room 
temperature, 50°C and 70°C. 
4.4.4 Thermally activated healing with DGEBA epoxy/mercaptan self-
healing system 
Figure 4-15a and Figure 4-15b show load vs. displacement curves of thermally activated 
healing for healing cycle at 50°C and 70°C respectively. The curve of thermally healed 
specimens shows the same ‘slip and stick’ characteristic as the original fracture after crack 
propagation initiation. The average healing efficiency of specimens healed at 50°C and 70°C 
are 70% (±28.98) and 111% (±10.08) respectively, indicating that thermally activated healing 
conditions are better suited for DGEBA epoxy/mercaptan healing chemistry. Figure 4-16 
summarised the fracture toughness and healing efficiency for self-healing epoxy healed at room 
and elevated temperature. 
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(a) 
 
 
(b) 
 
 
Figure 4-15: Load vs. displacement of thermally activated healing of cured epoxy containing 
10 wt. % microcapsules (a) healing at 50°C and (b) healing at 70°C. 
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Figure 4-16: (a) Average fracture toughness of original fracture and healed fracture at 
different healing temperature (b) healing efficiency of epoxy-based polymer containing 10 wt. 
% DGEBA/mercaptan microcapsules at different temperature. 
Figure 4-17 shows the healed fracture surfaces for healing at elevated temperatures. As can be 
seen most of the failure occur between the interface of healant film and the matrix (adhesive 
failure). What is also obvious from these images is that healant film formation can be observed 
spreading on the crack surfaces, resulting in higher healing efficiency. A reaction between 
DGEBA epoxy and mercaptan only happens when two substances were in contact; thus with a 
lower viscosity, the substances have a higher likelihood to come into contact with each other. 
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(a) (b) 
Figure 4-17: SEM images of healed fracture surfaces of healed at elevated temperature 
(healant film highlighted in purple) (a) 50°C (b) 70°C. 
Healing at 70°C shows a recovery of fracture toughness higher than the original fracture. This 
shows that the DGEBA epoxy/mercaptan healing chemistry at higher temperature not only 
heals the crack, but also provides the damage locations with higher fracture toughness. As 
explained by Gupta et al. [180], in their glassy state, large strain properties of epoxy such as 
their tensile strength and toughness, are affected by intermolecular packing, molecular 
architecture and molecular weight between crosslinks. As the curing temperature increases, 
cured epoxy shows a relatively large change in these parameters, consequently resulting in 
higher fracture toughness. Figure 4-14 observed that healant film healed at 70°C has Tg at about 
27°C, whereas when cured at temperature below that, the Tg is below the room temperature. 
This indicated that at even at room temperature service, healant cured below 70°C is in its 
rubbery state, hence showing undesirable performance. Furthermore, in specimen with the 
highest healing efficiency, since DGEBA epoxy is also the same polymerisable monomer used 
as a host material, a good adhesion between the healing film (cured to its best performance) 
and the host materials can be expected; consequently this can cause the crack to deviate from 
the original fracture plane (Figure 4-18) [152, 182], which subsequently contributed to a high 
healing efficiency. 
200 µm 200 µm 
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Figure 4-18: Good adhesion between the healant with the host material causing the healed 
crack plane to deviate from the original fracture plane (different colour indicate different 
crack plane). 
 Summary 
From the experimental result, it can be concluded that the inclusion of 10 wt. % DGEBA 
epoxy/mercaptan microcapsules into elevated temperature-cured epoxy has slightly affected its 
inherent fracture toughness as well as its modulus of elasticity. 
DSC analysis on unmodified neat epoxy shows that maximum cure was achieved with the 
aforementioned curing cycle (120°C for 24 hours); this indicates that the healing phenomenon 
of the cured epoxy containing DGEBA epoxy/mercaptan microcapsules was not contributed 
by the post-curing of the host epoxy. 
The specimen healed at 70°C shows the highest healed fracture toughness, followed by the 
specimen healed at 50°C. Healing at room temperature shows the lowest recovery 
corresponding to the original fracture toughness. Investigation of the fracture surfaces shows 
that the healing agents remained intact inside the microcapsules at room temperature, due to 
their higher viscosity and lower flow ability. Therefore, uniform spread of the healing agent 
cannot be achieved, resulting in low healing efficiency (26%). 
A 70°C healing temperature can be concluded as the best healing condition that can be observed 
for DGEBA epoxy/mercaptan self-healing system in comparison to room temperature and 
40 µm 
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50°C healing temperature. At a higher temperature, viscosity of DGEBA epoxy reduce to 0.1 
Pa s, and since flow ability is inversely proportional to viscosity, healing capacity can be 
maximised at this temperature. SEM images revealed good adhesion between the healing 
agents with the host material, causing the crack to deviate from its original fracture plane. 
Yuan et al. [24] and Xiao et al. [174] have reported that encapsulated DGEBA epoxies possess 
higher thermal stability when compare to lower viscosity epoxy resins, such as DTHP. 
Therefore, for the manufacturing of self-healing epoxy composites with elevated temperature 
curing system, DGEBA epoxy/mercaptan self-healing system is a suitable healing candidate.
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Mode I Interlaminar Fracture of CF/EP 
Composite Containing a Dual-Capsule 
Self-Healing System 
 Introduction 
 
Figure 5-1: Schematic of self-healing mechanism for crack/delamination closure in fibre 
composites. 
Figure 5-1 shows the basic concept of a dual-capsule self-healing system embedded in FRPs. 
In this system, the two components of the healant, – namely a polymerisable monomer and 
hardener – are independently encapsulated in fragile capsules and incorporated into the 
interlaminar region of the composite laminates [20]. The capsules rupture and release the 
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monomer and hardener upon the approach of a crack, whereupon the mix of monomer and 
hardener polymerise and subsequently heal the crack [153]. 
Because of the difficulty in applying resins with microcapsules normally 100 µm in size to 
reinforcing fibres during the fabrication process of composites, most studies have adopted a 
low fibre volume fraction (Vf < 50%) for ease of processing [27, 29, 31, 66, 128, 132]. 
However, that approach undermines the key advantages of high specific strength and stiffness 
of fibre-reinforced composites. Wet-hand-layup using a brush and a roller has been widely 
employed in fabricating composites, but these normally have clearly lower quality than those 
fabricated using advanced techniques, such as vacuum assisted resin infusion (VARI).  
The VARI process is a manufacturing approach that holds promise in producing laminated 
composites structure with high fibre volume fraction (Vf = 50%) [183-186]. The VARI process 
is a very clean and economical manufacturing method. VARI is typically a three steps process 
comprised of: (i) reinforcement fabric stacking, (ii) resin infusion and (iii) resin cure [187]. 
This process increases the component mechanical properties and fibre content by reducing void 
ratio compared to manufacturing process such as hand lay-up [183]. 
This chapter focuses on the fabrication process of self-healing CF/EP with VARI process. To 
be able to achieve composites with high fibre volume fraction, two microcapsule packing 
models were established to estimate the maximum number of capsules that can be distributed 
on the interlaminar region of the composites to form a single layer capsule distribution. The 
microstructure and quality of the resulting composites laminate are also described.  
Apart from that, in this chapter, the Mode I interlaminar fracture toughness of the CF/EP 
composite embedded with a dual-capsule self-healing system was evaluated to fully understand 
the effect on the inherent fracture toughness of CF/EP composite laminates as well as its ability 
to heal. Interlaminar fracture surfaces were examined using SEM to establish the relationship 
between the healant coverage on the fracture surface with the healing efficiency of the 
laminates.  
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 Fabrication of self-healing CF/EP Composite via vacuum 
assisted resin infusion processing route 
5.2.1 Microcapsules packings and mass measurement 
Previous studies on the effect of microcapsules weight fraction and microcapsules/carriers 
diameter (size) by Rule et at. [118] and He and Jinglei [188] on bulk epoxy have reported that 
the healing efficiency can be maximized when the amount of healing agent delivered to a crack 
is enough to seal the “crack” volume. As discussed by Rule et al. [118] for a bulk epoxy system, 
the amount of liquid that microcapsules deliver to a crack face varies linearly with 
microcapsule diameter for a given weight fraction of capsules. Huang and Yang [189], have 
investigated the self-healing anticorrosive property of the hexamethylene diisocyanate (HDI) 
microcapsule-based coatings with various coating thicknesses (200 - 400 µm). They observed 
that corrosion protection performance is directly related to the microcapsules’ diameter, 
microcapsules weight fraction, and coating thickness, and a simplified model was established 
to explain the influences of these parameters. 
However, in composite laminates with a high fibre volume fraction, the weight fractions of 
microcapsules that can be embedded are constrained by the interlaminar region as visualised 
in Figure 5-2. Ideally, a single layer distribution of microcapsules is needed in order to obtain 
composite laminates with high fibre volume fractions. By using simple assumed packing 
geometry, the maximum number of microcapsules (Nmax) that can be packed in the interlaminar 
region, and subsequently the mass of the capsules, can be defined. This is important in order to 
establish the upper bound for the mass of capsules to be distributed on top of the reinforcing 
fabrics. 
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Figure 5-2: Visualisation of interlaminar region of FRPs containing microcapsules. 
For the sake of simplicity, capsules were assumed to be spherical (diameter, DMC) and packed 
in a monolayer. Two packing models were considered for this estimation: (i) square cell, and 
(ii) hexagonal cell. The packing factor of the cell is defined as the ratio of the projected area of 
the capsules, AMC, over the total area of the reinforcing fabrics, ARF. 
For square packing as shown in Figure 5-3, the packing factor (φmax) can be defined is as 
follows: 
 
φ
max 
 = 
π (
DMC
2
)
2
Asqr
 = 
π (
L2
4
)
Asqr
 = 0.78 
5-1 
where Asqr =L2 is the square area of the reinforcing fabric bounding one microcapsule (Figure 
5-3). From here the maximum number of microcapsules, Nmax that can be dispersed on top of 
reinforcing fabric can be calculated as follows: 
 Nmax  =  
φ
max
(ARF)
AMC
=  
0.78(ARF)
AMC
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Using the density of the microcapsules, ρ
MC,
 and volume of the capsules, (VMC=
4
3
π (
DMC
2
)
3
), 
the maximum mass of the capsules, Wmax to be dispersed on top of the reinforcing fabric can 
be established as follows: 
 Wmax  =  Nmax × ρMC × VMC 5-3 
Using this equation, for Type-A microcapsules discussed in Chapter 3, the maximum mass of 
the capsules that can be dispersed on top of one-meter square of reinforcing fibre fabric is about 
77 grams, whereas for Type-B (DMC (average) = 65 µm, ρMC = 1.25 g/cm
3) the maximum weight 
is about 42 grams.  
.  
Figure 5-3: Square array. 
For hexagonal packing as shown in Figure 5-4 the packing factor can be defined as follows:  
 φmax  = 
Area of Triangular cell
Area of Microcapusles in cell
 = 
2r sin 
π
6
3∙
πr2
6
 = 0.9 5-4 
where r is the radius of the capsules. From here the maximum number of microcapsules, Nmax 
that can be dispersed on top of reinforcing fabric can be calculated by modifying equation 
(5-2), 
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 Nmax  =  
0.9(ARF)
AMC
 5-5 
The maximum mass of capsules can then be calculated using equation (5-3). Assuming 
hexagonal packing array for one-meter square of reinforcing fabric, the maximum mass of 
Type-A and Type-B capsules that can be distributed to form a mono microcapsules layer is 
about 92 grams and 49 grams respectively. 
 
Figure 5-4: Hexagonal packing array. 
From these two figures (Figure 5-3 and Figure 5-4), it is apparent that microcapsules volume 
fractions (corresponding to interlaminar region) higher than 90% are impossible and that even 
78% would be difficult to achieve, since it is necessary for the microcapsules to be surrounded 
by the matrix for good adhesion between the interlaminar region and the reinforcing fabric. 
However, this approximation is essential to give the upper bound of the mass of capsules that 
can dispersed in the interlaminar region of the high volume fraction composite laminates. 
5.2.2 Materials 
205 gsm unidirectional carbon stitched fabric (fibre volume density = 1.76 g/cm3), made by 
Toray T300 carbon fibre (supply by Nuplex Composites Australia) were used as reinforcing 
fabric in this study. A diglycidyl-ether of bisphenol-A (DGEBA) epoxy resin – Araldite-F 
(supply by Ciba-Geigy) was used as matrix to fabricate CF/EP composite laminates, with 
ARF 
AMC 
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piperidine (Sigma-–Aldrich, Australia) used as a curing agent. Type-A and Type-B 
microcapsules discussed in Chapter 3 were used as the self-healing agent of the composites 
laminates. 
5.2.3 Configuration of the composite laminate 
Figure 5-5 shows the schematic of the configuration of the base CF/EP and self-healing CF/EP 
composites fabricated in this study. 16 layers of carbon fibre fabrics were cut into dimensions 
of 250 mm × 300 mm and stacked together in a basic unidirectional laminate stacking. Three 
types of laminates were produced; one is the base CF/EP without the embedment of self-
healing agents as a reference laminates, and another two contained dual-capsule self-healing 
agents, Type-A and Type-B. 
For self-healing CF/EPs, three of the central layers were embedded with microencapsulated 
self-healing agents. Both epoxy- and mercaptan-loaded microcapsules (0.6 wt. % infused 
DMP-30) with weight ratio 1:1 were mixed prior to being dispersed on top of carbon fabric. 
Microcapsules with a concentration of 75 g/m2 were then dry-dispersed on top of the carbon 
fabric with the aid of a particle sieve shaker. The concentration of 75 g/m2 was chosen for both 
Type-A and Type-B microcapsules to be dispersed based on the estimation done in previous 
section. For Type-B this value is exceeding the estimation. This is because of the shape 
irregularity of the mercaptan-loaded capsules (collapse phenomenon, Figure 3-6b) as well as 
the size of the capsules. For smaller capsules, some of the capsules could fall through the fibre 
bundle gap when sieved on top of the fabric. 
 At one end of the central layer of the laminates, a very thin ethylene tetrafluoroethylene 
(ETFE) film (thickness ≈  25 µm) coated with a release agent was embedded; this is to form a 
starter crack for the Mode I interlaminar fracture toughness test (Figure 5-6). 
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Figure 5-5: (Left) Schematic diagram of base CF/EP (Right) Schematic diagram of self-
healing CF/EP with microcapsules in between CF layer 8-10 . 
 
Figure 5-6: ETFE film as a starter crack. 
Figure 5-7 shows the dispersion of the capsules on top of the carbon fibre fabric. As can be 
seen here, the dispersion of the capsules was very hard to control with dry-disperse technique. 
Some of the capsules can be seen piling up together. Since the dry-dispersing technique is a 
manual process, the result is highly dependent on the accuracy of the operator during the 
sieving process. Therefore, qualitatively for the purpose of this study, the dispersion is 
considered acceptable. 
C/F fabric 
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Figure 5-7: Stereo microscope images showing non-uniform dispersion of microcapsules on 
CF fabric (white line indicating scale equal to 1 mm length). 
5.2.4 Composite laminate fabrication with VARI 
The schematic illustration of the VARI setup is shown in Figure 5-8. In this process, laminate 
stacking configurations as mentioned previously were placed in an open mould prepared with 
peeling ply. Released film and distribution mesh were laid immediately above and beneath the 
dry carbon fabrics stacking. A plastic vacuum bag was placed on the top of the mould and 
sealed. One side of the mould was connected to a resin source and another one to a vacuum 
pump. The liquid resin infused into the laminate stacking with the aid of the vacuum drawn 
through the mould.  
The stoichiometric mixture ratio of DGEBA epoxy and piperidine was 100:5, as suggested by 
manufacturer. Before mixing, DGEBA epoxy was degassed at 60°C in a vacuum oven for 30 
minutes; this is performed in order to remove the air bubbles trapped inside the resin. Mixing 
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with piperidine was done manually at a slow rate to avoid air bubbles entrapment. The resin 
infusion stage began, during which the epoxy resin flowed into the preheated assembly (60°C, 
0.098 MPa vacuum pressure). A temperature of 60°C was maintained in the sealed vacuum 
bag during the VARI process. The vacuum bag with the resin-infiltrated laminate stacking was 
then moved onto a hot press machine at a pressure of 0.4 MPa to achieve a composite laminates 
with target thickness of around 2.8 - 3.0 mm and to ensure the flatness of the cured laminates 
panel. The laminates were cured at 120°C for 16 hours. After that, the assembly was taken out 
from the oven to cool down. Target fibre volume fraction of the laminate is about 65%, which 
can be calculated as follows [190, 191]: 
 Vf = 
NRF
ρ
f
∙
Aw
Tb
 5-6 
where NRF is the number of fabric ply, ρf the fibre volume density, Aw the fabric areal mass, 
and Tb the target laminate thickness. 
 
Figure 5-8: Schematic diagram of VARI process. 
 Mode I interlaminar fracture 
5.3.1 Mode I WTDCB test 
Mode I interlaminar fracture toughness of base CF/EP and self-healing CF/EP laminates with 
and without the encapsulated healant was studied using WTDCB specimens [27] (Figure 5-9). 
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The cured composite panels were cut into the WTDCB specimen geometry using water jet 
cutting. A WTDCB specimen is designed for constant compliance with crack length, so that 
the interlaminar fracture toughness, GIC, is independent of crack length [135]: 
 GIC = 
12PC
2 k2
E1h
3
 5-7 
where Pc is the applied load, E1 is the modulus of elasticity in the longitudinal direction, h is 
the specimen half thickness. The value of k is a constant aspect ratio of WTDCB (k = a/b(a)) 
[27], where b(a) is the width of the specimen at crack length a (Figure 5-9). 
 
Figure 5-9: Geometry of WTDCB specimen for Mode I interlaminar fracture of CF/EP 
laminates. 
Mode I interlaminar fracture toughness testing was conducted on an Instron 5567 universal 
testing machine equipped with a 1 kN load cell at a displacement rate of 5 mm/min. The 
WTDCB specimen was loaded until the crack reached the non-tapered region of the specimen 
(i.e. the crack propagated from a = 60 mm to approximately a = 100 mm) and then unloaded. 
The load and displacement were recorded throughout the test. At least 5 specimens were tested 
for each type of CF/EP laminate.  
For the base CF/EP specimens, after the crack had propagated to about a = 100 mm (the end 
of the tapered region), the specimens were quickly unloaded and injected with a mixture of 
epoxy monomer and mercaptan with DMP-30 as the catalyst, which was the same as that 
released from the capsules. The fractured specimen was then clamped using steel plates and 
placed in an oven at 70°C for 24 hours. After healing, the specimens were cooled to room 
temperature and tested again following the same Mode I interlaminar fracture procedure. 
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Healing of these specimens serves as a benchmark for the strength achieved by this dual-
component (epoxy/mercaptan) healant when full coverage of the healant on fracture surfaces 
was obtained. 
For the self-healing CF/EP specimens, after quick unloading, the specimen was clamped using 
steel plates to bring the two crack surfaces together and then placed in an oven at 70°C for 24 
hours. The healed specimens were tested again following the same procedure. The morphology 
of fracture surfaces was then examined using SEM. 
5.3.2 Quantification of healing efficiency (η) 
As explained in equation (2-12), the critical stress intensity factor, KIC, under the plane stress 
condition for Mode I loading can be defined as: 
 KIC= √GICE 2-12 
where E is the modulus of elasticity. 
Some parameters have been adopted to describe the healing performance of polymers [109]. In 
this study, in line with previous literatures in self-healing of laminated composites materials, 
the healing efficiency, η, was quantified through the critical stress intensity factor, KIC, [27, 66, 
132]. Therefore, healing efficiency could be defined by the ratio of fracture toughness of the 
healed specimen, KIC(healed), to that of the original specimen KIC(original) [27, 109, 132] as 
described in equation (2-13): 
 
η  (%)= 
KIC(healed)
KIC(original)
×100 = √
GIC(healed)
GIC(original)
×100 2-13 
For the interlaminar fracture of each specimen, unstable or “stick-slip” crack propagation was 
observed rather than stable crack propagation, producing multiple peaks of critical load, Pc, for 
onset of crack propagation; this led to multiple values of the interlaminar fracture toughness, 
GIC [27, 192, 193]. For this reason, rather than characterising healing efficiency with only the 
maximum value of fracture toughness, GIC
max
, the average value of fracture toughness, GIC
average
, 
gathered from multiple peaks, Pc, was also taken into consideration. The average healing 
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efficiency, 𝜂average, was defined as the ratio of the average fracture toughness of healed 
specimens (GIC(healed)
average
) to the average fracture toughness of original specimens (GIC(original)
average
): 
 
η
average
(%)=√
GIC(healed)
average
GIC(original)
average ×100 5-8 
The maximum healing efficiency, 𝜂𝑚𝑎𝑥, was defined as the ratio of the maximum fracture 
toughness in healed specimens (GIC(healed)
max
) to the average fracture toughness of original 
specimens (GIC(original)
average
): 
 
η
max
(%)=√
GIC(healed)
max
GIC(original)
average ×100 5-9 
5.3.3 Relationship between healant-covered surface area and healing 
efficiency 
 
Figure 5-10: Healant surface area tracing. 
It was observed that the healant coverage on the fracture surfaces was related to the healing 
efficiency in the CF/EP laminates. A quantitative assessment of the area covered by healant 
was conducted using an ImageJ open-source image analyser [194]. Images of fracture surfaces 
were obtained using SEM (Hitachi 4600). The healant-covered surface area (HSA, highlighted 
in purple in Figure 5-10) was measured with the assumption that the fracture surface of the 
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healant was flatter than that of the CF/EP composites. 20 images covering a total area of 2 cm 
x 2 cm, including 5 images from the crack initiation area, were randomly taken on the fracture 
surface from each Type-A self-healing CF/EP specimen.  The bonded surface area (BSA) was 
then quantified as the ratio of the average HSA to the total scanned area of fracture surface 
(TSA): 
 
BSA (%)=
HSAaverage
TSA
×100 5-10 
 Results and Discussion 
5.4.1 Cross-sectional morphologies and fibre volume fractions of 
CF/EP composites  
Optical microscopy was utilized to identify the morphology of the CF/EP composite laminates. 
The panels were measured for their fibre volume fraction and finished thickness. The average 
thickness of the base and self-healing composite laminated was measured to be around 2.80 
(±0.21) mm as shown in Figure 5-11. The high volume fractions of carbon fibres in the CF/EP 
composites were achieved, being around 65%. 
  
(a) (b) 
Figure 5-11: Cross-sectional image of (a) base CF/EP and (b) self-healing CF/EP laminates. 
Figure 5-12a shows the distribution of microcapsules on three central interlayers of CF/EP 
laminates. As can be seen, a single layer microcapsule dispersion (Figure 5-12b) is possible 
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with VARI process. Single layer microcapsule distribution is important in order to maintain 
the high fibre volume fraction of self-healing composite consistent with the base laminate.  
  
(a) (b) 
Figure 5-12: Distribution of microcapsules on the CF/EP laminates. 
In terms of the quality of the composite laminates, the microcapsules in the interlaminar regions 
apparently induce some imperfection, such as voids between the interlayer as can be seen in 
Figure 5-13a and b. The void formation may be caused by resin viscosity and residual air 
trapped among the microcapsules. Apart from that, additional issues such as microcapsules 
compressed (Figure 5-14a) and microcapsules piling (Figure 5-14a) can also be observed.  
  
(a) (b) 
Figure 5-13: (a-b) Presence of microcapsules have introduced voids on the interlaminar 
region of the laminates. 
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(a) (b) 
Figure 5-14: (a) Microcapsules compressed during VARI process (b) Piling of 
microcapsules. 
5.4.2 Mode I fracture toughness evaluation 
Figure 5-15 shows typical load vs. displacement curves of the interlaminar fracture of CF/EP 
laminates with Type-A or Type-B capsules in comparison to that of the base CF/EP laminate. 
In all cases the load increased linearly until the onset of delamination; then the crack propagated 
in stick-slip mode. The values of averaged fracture toughness were calculated using equation 
(5-7). In Figure 5-16,  GIC
average
 for the base CF/EP laminates were reduced after adding the 
capsules. GIC
average
 of the base CF/EP laminates is 539 J/m2, whereas GIC
average
 of Type-A and 
Type-B CF/EP are 515 J/m2 and 335 J/m2, respectively, reducing the GIC of the base laminate 
by 4.6% and 37.9%, respectively.  As explained earlier, the microcapsules superficially prompt 
some defects in the interlaminar regions, such as voids (Figure 5-13a and b), thus directly 
influencing the interlaminar properties of the composites [195]. The size of microcapsules also 
has a direct influence on the fracture toughness of CF/EP. It can be seen in Figure 5-16 that the 
interlaminar fracture toughness is lowest for the CF/EP laminate with small microcapsules 
(Type-B). Figure 3-6b shows the collapsed Type-B hardener-loaded capsules, which indicates 
that the capsules are flexible and may not retain the spherical shape during contact. This can 
promote agglomeration of capsules with poor adhesion between them. When delamination 
happens, instead of the crack propagating through the capsule, the crack path manoeuvres 
around the capsules (Figure 5-17a). Large clusters of capsules could also leave voids between 
them (Figure 5-17b), contributing to low fracture resistance. 
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Figure 5-15: Typical load-displacement curves of base laminate and laminates with Type-A 
and Type-B capsules. 
 
Figure 5-16: GIC
averagefor the base and laminates with self-healant. 
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(a) (b) 
Figure 5-17: (a) Gouges/ dimples from debonded microcapsules (caused by crack 
manoeuvring around the capsules); highlighted in purple and (b) clustering of smaller 
microcapsules. 
5.4.3 CF/EP injected with healant 
Figure 5-18 shows the typical load-displacement curves for the base CF/EP laminate and that 
healed with the injected healant. The onset of crack propagation occurs at a much higher load 
for the CF/EP laminate healed by injecting healant between the fracture surfaces, and the 
delamination onset load after healing is clearly higher than that for the original fracture. As the 
crack advances, the load increases in a stable manner until it reaches its maximum and drops 
towards the end of the tapered region of the specimen. This process may be associated with 
additional fracture mechanisms, such as fibre bridging and side cracking which were not 
present during the original fracture. However, the result indicates that this dual-mechanism 
(epoxy/mercaptan) healant could potentially heal CF/EP laminates with more than 100% 
recovery of their fracture toughness. 
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Figure 5-18: Typical load-displacement curves of interlaminar fracture of original fracture 
and fracture after healing of base CF/EP laminates with injected healant. 
5.4.4 Self-healing efficiency of CF/EP 
For the typical load-displacement curves of CF/EP laminates with capsules of Type-A or Type-
B in Figure 5-19, both original and healed laminates show stick-slip fracture behaviour, but 
with some clear differences. For the original laminates, after the onset of delamination, the 
loads at “peak” and “valley” seem to remain between the lower and upper bounds as the crack 
propagates. For the laminate with Type-A capsules, the load in all healed laminates increases 
with crack growth (Figure 5-19a). As the main crack advances, microcapsules break, releasing 
healant that can flow towards the narrower space between the upper and lower fracture surfaces 
by virtue of capillary motion, transferring more healant towards the main crack tip [19]. This 
explains the ascending curve of the load with crack growth, as the better healed crack region 
towards the crack tip produces high crack growth resistance, as demonstrated by the enhanced 
fracture resistance in the healed base laminate with the injected healant in Figure 5-18. The 
average healing efficiency, η
avg
, and maximum healing efficiency, η
max
, for the CF/EP 
laminates with Type-A capsules are 69% and 80% respectively. The values of both η
avg
 and 
η
max
 are comparable to those reported previously for a CF/EP laminate (lower fibre volume 
fraction, Vf = 30%) [27]. The fracture of healed CF/EP laminates with Type-B capsules shows 
unstable crack propagation with clearly low values of peak load, Pc (Figure 5-19b). The CF/EP 
laminates with Type-B capsules show values of 54% and 57% respectively for average healing 
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efficiency, η
avg
, and maximum healing efficiency, η
max
, which are much lower than those for 
the laminates with Type-A capsules. Table 5-1 summarises the results of Mode I interlaminar 
fracture tests and the healing efficiency of the CF/EP laminates. As discussed in the previous 
section, small Type-B capsules promoted agglomeration of capsules with poor adhesion 
between them, and the crack path manoeuvred around the capsules without breaking them. The 
large clusters of small capsules mean that smaller areas of fracture surfaces can be covered by 
the healant released from the capsules, leading to poorer healing ability. 
(a) 
 
 
(b) 
 
 
Figure 5-19: Interlaminar fracture of original CF/EP laminates and those after healing (a) 
Type-A CF/EP (b) Type-B CF/EP. 
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Table 5-1: Mode I interlaminar fracture toughness and healing efficiency of base CF/EP and 
CF/EP laminates with Type-A and Type-B capsules. 
Sample 
Type 
GIC (virgin)
average
 
(J/m2) 
GIC(healed)
average
 
(J/m2) 
GIC(healed)
max  
(J/m2) 
η
average
(%) η
max
(%) 
Base 
CF/EP* 
539 (±82) 769 (±274) 934 (±415) 116 126 
Type-A 515 (±99) 253 (±110) 338 (±172) 69 80 
Type-B 335 (±95) 140 (±31) 147 (±35) 54 57 
*For the base CF/EP, the healing was achieved using direct injection of the dual-
component healant in the delaminated area. 
5.4.5 Relationship between bonded surface area and healing efficiency 
Figure 5-20 shows the relationship between the BSA and healing efficiency for the CF/EP 
laminate with Type-A capsules. It can be seen that the healing efficiency is clearly dependent 
upon the surface area bonded by the healing agent. To achieve high healing efficiency, wide 
spreading of the healant on the fracture surface is certainly needed, as demonstrated in the base 
laminate with the injected healant. However, there is a clear difference between healant-rich 
areas from one specimen to another. This is strongly related to the distribution of microcapsules 
in the matrix materials, which in turn is related to the dispersion of microcapsules on top of the 
carbon fabrics before resin infusion. Furthermore, resin transfer during the VARI process might 
also promote non-uniform distribution of microcapsules such as washing and agglomeration. 
 
Figure 5-20: Relationship between bonded surface area (BSA) on fracture surface and 
healing efficiency of CF/EP laminate with Type-A microcapsules. 
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By using 75 g/m2 of microcapsules on the CF fabric, about 64 microcapsules (with average 
diameter 123 m, microcapsule density 1.25 g/cm3) for Type-A and 225 microcapsules for 
Type-B (with average diameter 65 µm) could be distributed in a surface area of 1 mm2. If we 
assume the core volume of the capsules is maintained in the composites, the amount of healant 
fully released from Type-A or Type-B capsules could fully fill in a gap of about 60 m and 30 
µm respectively between the upper and lower surfaces of delamination, and any larger gap 
would certainly leave voids. 
  
(a)  (b) 
 
(c) 
Figure 5-21: Healed delamination gap in Type-A laminate; (a) distant from crack tip (b) 
towards crack tip (c) intra-ply cracking. 
Figure 5-21 shows a gap that was healed with Type-A capsules. The delamination gap varied 
along the crack path, with a larger gap (90 µm) visible distant from the crack tip (Figure 5-21a) 
and a smaller gap (60 µm) seen closer to the crack tip (Figure 5-21b). Furthermore, multi-ply 
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cracking during delamination was also observed (Figure 5-21c) in some specimens, creating 
an even larger gap. This observation explains why 100% HSA could not be achieved during 
the experimental evaluation. 
Figure 5-22 shows SEM fractographs of fracture surfaces of CF/EP laminates with Type-A and 
Type-B capsules. For Type-A, it can be seen that the fracture surface is roughly more than 50% 
covered by the healant. As previously discussed, large microcapsules stored more healant 
within them, subsequently resulting in larger healant-covered areas. However, small Type-B 
capsules tended to form clusters, which directly influenced the healant-covered area. Apart 
from that, smaller microcapsules contained a smaller amount of healant. Given the smaller 
amount of healant, patchy healing occurred on the surface, creating insufficient coverage on 
the fracture surface area. 
  
(a) (b) 
Figure 5-22: SEM fractographs of CF/EP laminates with microencapsulated healant (a) 
Type-A with healant covering fracture surface (b) patchy healing on Type-B fracture surface. 
 Summary 
In this chapter, a procedure was proposed regarding the integration of the dual-capsule healing 
system into laminated composites structure. The estimation of the maximum number and mass 
of microcapsules to be embedded onto the interlaminar region of the composites was 
established.  The fabrication process began with manual dispersion by hand sieving of pre-
calculated amount of capsules onto the reinforcing carbon fabric, followed by the VARI 
process. A two-component healing system consisting of encapsulated DGEBA epoxy and 
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mercaptan as its hardener was developed for producing self-healing CF/EP laminates with a 
high fibre volume fraction of 65%.  
The interlaminar fracture of CF/EP laminates with large and small capsules was characterised 
using WTDCB specimens, and the self-healing efficiency of CF/EP laminates on an 
interlaminar fracture was evaluated, addressing the effect of size of capsules. Based on the 
results, a few useful conclusions can be drawn. 
Firstly, it was observed that the distribution and size of microcapsules have clear effects on the 
inherent interlaminar fracture toughness of CF/EP laminates. Both large and small capsules 
reduce the interlaminar fracture toughness of CF/EP laminate, more notably in laminates with 
smaller microcapsules. Smaller capsules tend to agglomerate, causing poor adhesion between 
the microcapsules and leading to a greater reduction in fracture toughness. 
On the self-healing ability, the incorporation of a dual-microcapsule healant stored in fragile 
microcapsules can indeed provide CF/EP laminates consisting high fibre volume fraction with 
self-healing capability by recovering as much as 80% of the original Mode I fracture toughness. 
The distribution and size of microcapsules also has an effect on the interlaminar fracture 
toughness of CF/EP laminates after healing. Larger capsules provide a higher healing 
efficiency for CF/EP laminates, with more healant stored and released to cover the fracture 
surfaces; small capsules provide a lower healing efficiency for CF/EP laminates, with more 
clustered capsules. The healing efficiency is clearly dependent on the coverage of healant on 
fracture surfaces: broader coverage results in higher healing efficiency. 
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Mode II Interlaminar Fracture of CF/EF 
Composite Containing a Dual-Capsule 
Self-Healing System 
 Introduction 
To this date, fracture toughnesses of self-healing materials have been broadly characterized 
under Mode I loading conditions [19, 20, 22, 27, 48, 54, 66, 113, 114, 132, 196]. In many cases, 
for solid homogenous materials, crack initiation and propagation is caused by normal stresses. 
For these materials, tensile opening mode of failure (Mode I) has the lowest fracture energy; 
consequently the crack will always propagate along the path normal to the direction of the main 
stress, regardless of the orientation of the initial crack [197]. Therefore, more caution and 
studies have been dedicated to Mode I fractures [198]. 
However, in composite laminates, delaminations are restricted to the interlaminar resin-rich 
regions; which are the “low toughness” fracture routes. As a result, propagation is controlled 
by the interlaminar fracture toughness and the crack usually continues to propagates in the 
same plane between the laminate, where unlike homogenous solid, the crack path is not going 
to maintain a pure Mode I conditions at the crack tip [197, 199]. Consequently, in-plane shear 
(Mode II) failures are possible. Currently, only a few studies have considered Mode II 
interlaminar fracture damage in self-healing materials [32, 73, 145]. However, a self-healing 
assessment was not investigated and quantified in either of these studies.  
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In this chapter, the repair of Mode II delamination damage of CF/EP containing the dual-
capsule self-healing system is in focus. Apart from that, the influence of microcapsules 
embedment on the inherent Mode II fracture toughness of CF/EP composite laminates with a 
high fibre volume fraction will also be discussed. Mode II interlaminar fracture toughness of 
CF/EP was evaluated using ENF specimens and the compliance calibration data reduction 
scheme. Test results including toughening mechanisms, self-healing behaviour, and 
fractographic analysis were presented. The outcomes are expected to help increase the 
understanding of crack healing ability of this material for future application. 
 Experimental 
6.2.1 CF/EP laminates with dual-capsule self-healing system 
Type-A DGEBA epoxy- and mercaptan-loaded microcapsules with average diameter 110.6 µm 
and 136.4 µm as discussed in Chapter 3 were used in this study. The fabrication of the CF/EP 
composite laminates was discussed in Chapter 5. Two types of laminates were produced; one 
is the base CF/EP without the embedment of self-healing agents as reference laminates, and 
another one contained an encapsulated dual-mechanism self-healing agent (self-healing 
CF/EP). For self-healing CF/EP, three of the central layers were dispersed with microcapsules. 
Both DGEBA epoxy- and hardener-loaded microcapsules with weight ratio 1:1 were mixed 
prior to being dispersed on top of carbon fabric. Microcapsules with a concentration of 75 g/m2 
were then dry-dispersed on top of the carbon fabric. At one end of the central layer of the 
laminates, a very thin ETFE film (thickness ≈ 25 µm) coated with a release agent was 
embedded; this is to form a starter crack for the Mode II interlaminar fracture toughness test. 
At least 5 specimens were tested for each type of CF/EP laminate. 
6.2.2 Mode II interlaminar fracture specimen and test 
ENF specimens as shown in Figure 6-1a are used in this study. The specimens were cut from 
the composite laminates according to the following dimensions: width, W = 17 ~ 20 mm, 
nominal thickness, t ≈ 2.8 - 3.0 mm, specimen length, Ls = 160 mm. The initial crack length, 
a0, is 25 mm and the half span length, L, is 50 mm. One side of each specimen was painted 
with white paint for better observation of the crack initiation. A mark was made at distance a0 
= 25 mm from the end of ETFE film and six additional marks were made on the specimen at 
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distances of +10 mm, +5 mm, -5 mm, -10 mm, -15 mm and -20 mm from the a0 mark as shown 
in Figure 6-1a. These marks were used as a guide for positioning the specimen during the 
compliance calibration loadings.  
Mode II tests were performed using an Instron 3366 universal testing machine equipped with 
10 kN load cell. Five specimens were tested for both base CF/EP and self-healing CF/EP. The 
method used in this study was based on O’Brien et al. [200] and Zhu et al. [201], using a three 
point bending fixture with a 10 mm diameter loading nose as shown in Figure 6-1b.  
(a) 
 
 
(b) 
 
 
Figure 6-1: (a) ENF specimen (b) Mode II testing assemble. 
For each base CF/EP and original self-healing CF/EP specimen, seven loadings were 
performed at loading rate of 0.5 mm/min. For the first six loadings, the specimen was 
positioned in such a way that the additional markings mentioned earlier were situated above 
one of the lower fixture supports. These were required for compliance calibration of the system 
and were performed at sub-failure loads to prevent crack propagation. The final loading was 
a0 
F2 
b 
t 
L 
F2 
F1 
L 
Guide for positioning 
the specimen for 
compliance calibration 
loadings 
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performed to initiate crack propagation and continued until complete failure (rapid crack); this 
test was done with the specimen positioned such that the a0 = 25 mm mark was situated above 
the lower fixture support. The visual crack initiation point (VIS) was recorded during the 
testing.  
For self-healing CF/EP specimens, after complete failure of the specimens, the fractured 
surfaces were brought back together by clamping them with a steel plate (Figure 6-2) and 
leaving them in the hot-press for 24 hours at 70°C at a lateral pressure of 0.1 MPa. The 
specimens were then cooled at room temperature. Prior to healed specimen fracture testing, 
observation of the healed crack tip was done using optical microscope; this is to ensure the 
position and conditions of crack-tip for healed specimen compliance calibration. The 
specimens were then tested with the same procedure as the original specimens, but only four 
calibration compliance loadings were performed due to the uncertainty of the sub-failure loads 
and the damages that could occur to the healed specimen.  
 
Figure 6-2: Healing process of fractured self-healing CF/EP ENF specimens in hot-press. 
6.2.3 Data reduction – Compliance calibration 
Compliance calibration was first done on all specimens as outlined by O’Brien et al. [200]. 
Seven loadings for base CF/EP and original self-healing CF/EP specimens and four loading for 
healed CF/EP specimens were used to obtain specimens compliance vs. crack length plot. 
Figure 6-3a and b show typical compliance calibration load vs. displacement plots of self-
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healing CF/EP for original specimen and healed specimen respectively. The inverse slope of 
these curves is defined as the specimen compliance at each crack length. As shown in Figure 
6-4, compliances were then plotted against corresponding crack lengths raised to the third 
power and fit a line given by equation (6-1): 
 C = A + m(a3) 6-1 
 
(a) 
 
 
(b) 
 
 
Figure 6-3: Typical compliance calibration load vs. displacement curves of self-healing 
CF/EP (a) original specimen (b) healed specimen. 
0
20
40
60
80
100
120
140
-0.1 0.4 0.9 1.4
L
o
ad
,
P
 (
N
)
Displacement, δ (mm)
35 mm
30 mm
25 mm
20 mm
15 mm
10 mm
5 mm
0
20
40
60
80
100
120
140
0 0.5 1
L
o
ad
,
P
 (
N
)
Displacement, δ (mm)
30 mm
25 mm
20 mm
15 mm
6. Mode II Interlaminar Fracture of CF/EF Composite Containing A Dual-Capsule Self-Healing System 
110 
(a) 
 
 
(b) 
 
 
Figure 6-4: Compliance plot as a function of crack length (a) original specimen (b) healed 
specimen. 
Calibration coefficient m, and A were determined using least-square linear regression analysis 
of compliance calibration plot (Figure 6-4). Rearranging equation (6-1) yields a relationship 
use to calculate the equivalent crack length propagation 𝑎𝑒: 
 ae= (
C - A
m
)
1/3
 6-2 
For a specimen with constant width, W, the Mode II strain energy release rate is given by: 
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 GIIC= 
P2
2W
∂C
∂a
 6-3 
Substituting the compliance relation in equation (6-1) into equation (6-3), results in the 
equation for Mode II strain energy release rate equation as a function of the compliance 
calibration constant, m.  
 GIIC= 
3mP2a2
2W
 6-4 
Mode II interlaminar fracture toughness was determined using this equation, where m is the 
calibration compliance coefficient, P is the load from the fracture test, a, is the crack length, 
and W is the specimen width.  
During crack growth the current compliance, C, is used to estimate an equivalent crack length, 
ae, through equation (6-2). The crack growth resistance curve (R-curve) can now be determined 
without monitoring the crack propagation, which is difficult to perform accurately in this test 
[202].  
6.2.4 Quantification of self-healing efficiency 
The critical stress intensity factor, KIIC, under the plane stress condition for pure Mode II 
loading can be defined as:  
 KIIC= √GIICE 6-5 
where E is the modulus of elasticity. In this study in line with the Mode I study in previous 
chapter (Chapter 5), the healing efficiency, η, was quantified through the Mode II critical stress 
intensity factor, KIIC: 
 
η  (%) = 
KIIC(healed)
KIIC(original)
× 100 = √
GIIC(healed)
GIIC(original)
×100 6-6 
Self-healing efficiency was evaluated at three different points of crack initiation and 
propagation. First is the non-linear (NL) initiation healing efficiency, η
ini
NL. This was evaluated 
in correspondence with crack initiation point as determined from the deviation in linearity of 
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the load vs. displacement curve. Healing efficiency at this point was evaluated based on the 
non-linear crack initiation energy release rate, GIIC(ini)
NL
, of the specimen: 
 
η
ini
NL (%)=√
GIIC(ini, healed)
NL
GIIC (ini, original)
NL
×100 6-7 
Secondly, the healing efficiency was evaluated based on the Mode II interlaminar fracture 
toughness of the specimen at the visual crack initiation point (VIS) that was recorded during 
the testing, η
ini
VIS: 
 
η
ini
VIS (%)=√
GIIC(ini, healed)
VIS
GIIC (ini, original)
VIS
×100 6-8 
To simplify comparisons of the crack propagation results, it is useful to define a single value 
of GIIC(prop) from the propagation region (up to the point before rapid propagation). This value 
is used to quantify the self-healing efficiency for the propagation of crack, η
prop
: 
 
η
prop
 (%)=√
GIIC(prop,healed)
GIIC(prop,original)
×100 6-9 
 Figure 6-5 represent the schematic plot of load vs. displacement curve of Mode II interlaminar 
fracture of CF/EP. The figure shows how the data to calculate GIIC(ini)
NL
, GIIC(ini)
VIS
 and GIIC(prop) 
selected from the curve. 
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Figure 6-5: Schematic plot of load vs. displacement of Mode II interlaminar fracture of 
CF/EP. 
6.2.5 Microstructures 
SEM (Hitachi S4600) is used to evaluate the geometry, size distribution and morphology of 
microcapsules and to observe fracture surfaces of both base CF/EP and self-healing CF/EP. 
Digital microscopes (Leica, DMRXE) are used to observe the crack propagation behaviour of 
the composites, healed interlaminar resin-rich region and conditions of healed crack tip of the 
specimens, through the cross-sectional microstructure imaging.  
6.2.6 Correlation between voids on healed fracture surface and 
healing efficiency 
Figure 6-6a-c shows the schematic of the formations of hackles on the fracture surface of 
CF/EP composite laminates, which are typical for the Mode II interlaminar fracture. For 
composite laminates containing microencapsulated self-healant, it was expected that if the 
healant can cover the cracked interlaminar region and gap in hackles after the original fracture 
forming a dense/solid healed interlaminar region illustrated in Figure 6-6d, full recovery of 
material properties can be achieved. However, based on the observation in Chapter 5, due to 
the limit amount of healant that can be embedded in the interlaminar region in order to maintain 
PROP region 
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the high fibre volume fraction, formation of completely healed interlaminar region without 
voids left by the unfilled hackle and unfilled interlaminar crack is not possible (Figure 6-6e). 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
Figure 6-6: (a-c) Hackles formation under Mode II loading (d) Formation of dense/solid 
healed interlaminar region after original Mode II interlaminar fracture (e) Healed 
interlaminar region with voids due to insufficient healing. 
Here, the correlation between “dry area” in healed fracture surfaces of self-healing CF/EP and 
its healing efficiency was determined with the images of fracture surfaces obtained by SEM. 
A maximum of 20 SEM images of fracture surfaces from each specimen were obtained for this 
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purpose. The 2D “dry area” of the fracture surface were computed from tracings of these 
images. The images were then analysed using a binary image processing technique, which were 
converted to binary images using an open access image processing software, called ImageJ 
[194]. From these binary images, the process selectively represented all the “dry area” by white 
pixels and the healant filled area of the fracture surface by black pixels (Figure 6-7). Following 
conversion, the software automatically calculated area fractions of black and white. Microsoft 
excel was then used to establish the correlation of the “dry area” and healing efficiency. 
  
(a) (b) 
Figure 6-7: Healed fracture surface (a) SEM image (b) converted binary image (black pixels 
indicate healant filled area and white pixels indicate void area). 
 Results and Discussion 
6.3.1 Mode II fracture toughness evaluation 
Load vs. displacement curves for both base CF/EP and self-healing CF/EP show a linear load 
versus displacement behaviour during the initial loading up to the point of crack initiation 
(Figure 6-8). For base CF/EP (Figure 6-8a), with further escalation of displacement, the 
interlaminar crack propagated by a somewhat stable manner up to a certain point. The crack 
then propagated in an irregular drop and increase of load before finally propagating in an 
unstable manner. For self-healing CF/EP (Figure 6-8b) most of the samples failed after the 
maximum value was achieved, and by this time a sudden decrease of the load can obviously be 
seen (rapid propagation).  
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(a) 
 
 
(b) 
 
 
Figure 6-8: Load vs. displacement (a) base CF/EP and (b) self-healing CF/EP. 
Both GIIC,ini (based on non-linear initiation and visual crack initiation observation) and GIIC,prop 
(based on loads before unstable fracture or rapid failure) were determined using equation (6-4) 
and summarised in Figure 6-9a. The GIIC(ini)
NL
, GIIC(ini)
VIS
 and GIIC(prop) were improved by 32%, 
34% and 48% respectively with the presents of microcapsules (Figure 6-9a).  
The results of the Mode II interlaminar fracture toughness observations for all specimens are 
also shown as crack growth resistance curves (R-curves) in Figure 6-9b for base CF/EP and 
Figure 6-9c for self-healing CF/EP (the dotted lines indicate the specimens discussed in Figure 
6-8a and b respectively). A difference in R-curve shape is seen when comparing the base CF/EP 
and self-healing CF/EP. The R-curve for base CF/EP samples initially rises slowly and 
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continues to rise over 40 mm of crack length followed by a slight drop of fracture resistance 
when the test concluded. Conversely, the self-healing CF/EP, reach its peak toughness much 
more quickly (at around 30 mm crack length), followed by a rapid loss in fracture resistance 
with further extension of crack length.  
Both CF/EP composites exhibited a rising R-Curve behaviour following crack initiation. This 
might be due, either wholly or partly, to an increasing extent of matrix plastic deformation 
forming microcracks ahead of the crack tip [203, 204]. As explained by O’Brien [205], Mode 
II loading results in principal tension stress at a 45° angle to the delamination plane responsible 
for creating tension microcracks in the interlaminar region (Figure 6-6a-b). Once these cracks 
appear, the ligaments formed by them are force to bend until they fracture and extent until 
eventually came together with the original delamination. Apart from that, the initial rise in 
Mode II R-curves can also be attributed to friction or mechanical interlocking between the 
delamination surfaces [206-208]. 
From these results, it appears that the incorporation of microcapsules plays a significant role in 
toughening under Mode II. A larger resin-rich interlaminar region can be attributed to this [209, 
210]. The existence of microcapsules between layers of reinforcing fibre fabric subsequently 
increases the thickness of the interlayer and allows plastic deformation to spread out over a 
larger volume. An investigation on fracture surfaces of the base and original fractures of self-
healing CF/EP can be seen in SEM images in Figure 6-10. Unravelled here, a rougher fracture 
surface for self-healing CF/EP (Figure 6-10b) is caused by plastic deformation of matrix as 
compared to base CF/EP (Figure 6-10a). 
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(a) 
 
 
(b) 
 
 
(c) 
 
 
Figure 6-9: (a) Mode II interlaminar fracture toughness of base CF/EP and self-healing 
CF/EP (b) R-curves of base CF/EP and (c) R-curves of self-healing CF/EP. 
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(a) (b) 
Figure 6-10: (a) SEM images showing a fracture surface (a) base CF/EP (b) self-healing 
CF/EP. 
Besides that, it was also speculated that the microcapsules toughened when they act as a barrier 
to prevent direct formation of hackles (particle barrier mechanism).As discussed by Groleau et 
al. [211], in their study involving Nylon-12 particles as a “toughening agent” in composites 
with brittle epoxy matrix, they found that microcracks initiated by the particles in the 
interlaminar region could enhance the delamination resistance of the composites under Mode 
II. Figure 6-11a shows the Mode II crack initiation path in self-healing CF/EP. The formation 
of shear cracks seems to be initiated at the interface region between the matrix and the 
microcapsules (as indicate with arrows in Figure 6-11a), instead of the matrix/fibre interface. 
A higher magnification SEM analysis on fracture surface (original fracture) of self-healing 
CF/EP confirmed some hackles formed around the matrix/microcapsules interfacial region 
(Figure 6-11b). 
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(a)  (b) 
Figure 6-11: (a) An optical micrograph showing initiation of crack at the interface of 
matrix/microcapsules (b) SEM image showing hackles forming around matrix/microcapsules 
interface. 
This finding is in contradiction to the case in Mode I loading discussed in Chapter 5, when the 
presence of microcapsules reduces the original Mode I interlaminar fracture toughness, GIC by 
5%. For Mode I and Mode II loading the delamination is propagated by peel stresses and shear 
stresses as illustrate in Figure 6-12. In Mode I loading the effects of mechanical interlocking 
to prevent crack from propagating is almost non-existence, results in the delamination easier 
to propagate in Mode I [212]. Other than that, by peeling stress (Mode I), it is easier for the 
crack path to manoeuvre around those microcapsules that have poor adhesion with the matrix 
(Figure 5-17a), resulting in even easier delamination propagation. Whereas, in Mode II loading, 
mechanical interlocking will prevent this from happening. 
 
Figure 6-12: Schematic diagram of interlaminar region of CF/EP with microcapsules (a) 
mode I loading and (b) mode II loading conditions. 
 
(a) (b) 
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6.3.2 Self-Healing of CF/EP composites under Mode II fracture 
Figure 6-13 shows the micrograph of a cross section of the central layer of CF/EP composites, 
where the end of ETFE film is located for healed specimen. As can be seen, the crack was close 
to the end of the ETFE film indicating that the dual-capsule healant have successfully closed 
the original fracture, however voids caused by residues from microcapsules shell and unfilled 
hackles spacing have made the resin pocket in front of the film less dense, thus increasing the 
specimen compliance. Figure 6-14a illustrates the typical load vs. displacement curves for 
original and healed fractures of self-healing CF/EP and the R-curves obtained for all self-
healing CF/EP specimens are presented in Figure 6-14b for original fracture and Figure 6-14c 
for healed fracture. For both original and healed fractures, a linear response is observed prior 
to unstable crack propagation. However, for some healed specimens, bending failure of the 
specimen occurred at an early stage; therefore, data points for crack length extensions are lesser 
than original fractures, as can be seen in the R-curves (Figure 6-14c). When a specimen starts 
to go through bending before crack growth, the calculation of toughness will become 
problematic [213].  
 
Figure 6-13: Micrograph of cross section of healed self-healing CF/EP, showing healed 
crack end 
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 (a) 
 
 
(b) 
 
 
(c) 
 
 
Figure 6-14: (a) Typical load vs. displacement of original and healed fracture of self-healing 
CF/EP. R-curve of (b) original and (c) healed fracture of self-healing CF/EP (dotted lines 
represent specimen discussed in Figure 6-14a). 
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For all specimens tested in this study, healing at specified conditions was successfully 
achieved. The summary of healing efficiency was tabulated in Table 6-1. The healing 
mechanism as previously discussed in Chapter 4, section 4.4.4 can be observed by the SEM 
image (Figure 6-15). From this figure, evidence that the healing agent had flowed out of broken 
microcapsules can be seen and a thin layer of cured healing agent covering the original fracture 
surface can also clearly be seen. 
Table 6-1: Summary of self-healing efficiency under Mode II fracture. 
Specimen 
GIIC (Original) (J/m2) GIIC (Healed) (J/m2) 
Healing 
Efficiency (%) 
NL VIS PROP NL VIS PROP ηini
NL η
ini
VIS ηprop 
Base 
CF/EP 
426 
(±92) 
509 
(±81) 
702 
(±82) 
- - - - - - 
Self-
Healing 
563 
(±108) 
682 
(±85) 
1039 
(±148) 
146 
(±10) 
235 
(±46) 
418 
(±84) 
51 
(±7) 
57 
(±4) 
63 
(±4) 
 
 
Figure 6-15: SEM micrograph showing broken microcapsules and thin layer of cured dual-
mechanism healant. 
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For a brittle matrix, such as epoxy, fracture surfaces under Mode II loading exhibit a very rough 
characteristic (hackle characteristic) [205], in contrast to a clean fracture surface in Mode I 
loading; this  can be seen on the original fracture surface of self-healing CF/EP (Figure 6-10b). 
This subsequently increases the fracture surface area that needs to be covered by the healant. 
Figure 6-16a shows a SEM fractograph of the healed surface. Observed here, the released 
healing agents were inadequate to cover the whole fracture surface to form a uniform and 
dense/solid healed interlaminar region as explained in section 6.2.6. An observation of the 
central cross section layer of healed interlaminar also revealed that the residue from the shell 
of the microcapsules and unfilled hackle spacing, have created voids within the interlaminar 
region (Figure 6-16b). As a result of these voids, healed interlaminar regions cannot produce 
the same mechanical properties as the original interlaminar region; therefore 100% healing 
efficiency still cannot be observed at this stage. 
  
(a) (b) 
Figure 6-16: (a) Healant was inadequate to form dense/solid healed interlaminar region (b) 
micrograph of cross section of healed self-healing CF/EP specimen, showing crack closure 
and voids. 
A higher magnification analysis of healed fracture surface is presented with SEM images in 
Figure 6-17. A mixture of cohesive (Figure 6-17a, delamination occurring through the healed 
film) and adhesive (Figure 6-17b, delamination occurring by peeling off the healed film) 
failures of the healant film can be seen. Cracking of the healant film can also be seen, indicating 
its brittleness and its poor interaction with the original fracture surface (Figure 6-17c). This is 
causing the healant layer to be pulled out during Mode II fracture. 
Voids caused by the microcapsules shell 
residue and unfilled hackle spacing 
Healed crack 
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(a) (b) 
  
(c) 
Figure 6-17: SEM micrograph of healed fracture of self-healing CF/EP (a) cohesive and (b) 
adhesive failure of healant layer (c) cracking of healant layer. 
6.3.3 Correlation between voids on healed fracture surface and 
healing efficiency 
In contrast to healing of neat polymer where high healing efficiency (of up to 100%) can be 
observed with the same healing cycle, a high fibre volume fraction composite containing the 
dual-capsule healant still cannot achieve 100% healing efficiency. From the fracture surface 
analysis, it can be concluded that the existence of “dry area” on healed interlaminar region is 
strongly related to the healing efficiency of the composites when subjected to shear loading. 
From the area calculation it was found that the “dry area” for each specimen is about 42% 
(±2%) of the overall traced area, as summarised in Figure 6-18. As can be seen here, specimens 
with higher void content possess a slightly lower healing efficiency. By using 75 g/m2, only 
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about 58% (i.e. 100% minus 42% of the “dry area”) of the fracture surface subjected to Mode 
II loading can be healed to form a dense interlaminar region. This value reflects the calculated 
visual crack initiation healing efficiency (η
ini
VIS) of 57%. 
 
Figure 6-18: Correlation between “dry area” content on fracture surface to healing 
efficiency. 
 Summary 
This chapter investigated the Mode II fracture and healing behaviour of self-healing CF/EP 
laminates with high fibre volume fraction consisting of a dual-capsule self-healing system, 
fabricated with VARI techniques using ENF specimens. The laminates with capsules, imposed 
a higher Mode II fracture toughness as compared to the base CF/EP. The microcapsules 
induced toughness via two mechanisms: i) larger/enhanced plastic deformation due to thicker 
resin-rich area (allowing a larger damage zone), and ii) particle bridging. 
The incorporation of a dual-capsule healant stored in fragile microcapsules can provide CF/EP 
laminates with a self-healing ability when subjected to Mode II fracture, with about 63% 
average healing efficiency. Dual-capsule healants can provide healing ability to structural 
composites by delaying and retarding microcracks from propagating which could cause 
catastrophic failure. But only a single healing event can be achieved.  
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The healing efficiency appears to be related to the concentration of microcapsules distributed 
on top of the carbon fibre fabric as well as the formation of dense resin-rich healed interlaminar 
region. With the amount of healant concentration used in this study, only 58% of the original 
fracture surface could be healed properly, and this seems to vary directly with the 57% healing 
efficiency corresponding to the visual crack initiation healing efficiency (η
ini
VIS).   
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Shear Strength and Mode I Fracture 
Toughness of Epoxy Adhesive Containing 
Dual-Capsule Self-Healing System 
 Introduction 
Two-part epoxy adhesives have been widely used as structural adhesives due to their superior 
mechanical properties, especially in high-performance application such as in automotive and 
aircraft assembly [39, 40]. They are commonly used when a room-temperature cure is preferred 
such as damages in aircraft assembles, where the lower viscosity version of the adhesive can 
be used to impregnate into crack bond line or the delamination of laminated structures [9]. 
However, despite these advantages, as previously discussed epoxy resins are fairly brittle when 
crosslinked, which makes them susceptible to crack initiation and propagation. 
Self-healing materials show a lot of promise in increasing the reliability of structural materials 
but very little has been addressed in its application and performance as a structural adhesive 
that can be used to yield a load-bearing joint [126, 127]. Evidently, the dual-capsule self-
healing system involving DGEBA epoxy/mercaptan healing systems shows a lot of promise in 
providing structural polymeric materials and its composites with self-healing capability and 
modestly increases some of its inherent material properties as discussed in previous chapters. 
Therefore, it is interesting to study the joints involving this material system and further its 
application as a thin film adhesive. 
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This chapter focuses on the self-healing behaviour of commercially available two-part epoxy 
adhesives when incorporated with epoxy/mercaptan microcapsules. The effect of 
microcapsules loading on the shear strength and its recovery after complete fracture were 
studied using a single-lap adhesive joints (SLJs) at room temperature. The Mode I fracture 
behaviour of aluminium/self-healing adhesive joints was also investigated using TDCB 
specimen geometry to evaluate the effectiveness of the dual-capsule self-healing system in 
enhancing the original toughness of the adhesive as well as the effectiveness of this healing 
system to be used in room temperature-cured adhesive. 
 Materials and Methodology 
7.2.1 Preparation of self-healing adhesive 
The adhesive used in this study is a commercially available epoxy adhesive supply by Sulley 
DuluxGroup (Australia). This adhesive cures at a room temperature and consists of two parts 
(A and B) with chemical entity and composition as listed in Table 7-1. Type-A microcapsules 
explained in Chapter 3 section 3.3.1 were employed to prepare self-healing epoxy adhesive. 
DGEBA epoxy- and mercaptan-loaded microcapsules with weight ratio 1:1 and Part-A (epoxy 
part) of the adhesive were mixed in a glass flask. Since the Part-A of the adhesive is quite 
viscous at room temperature, it was heated to ensure better dispersion of the microcapsules. In 
order to uniformly disperse the microcapsules in Part-A, the mixture was sonicated for 13 
minutes in an ultrasonic bath at 35 kHz. After ultra-sonication, the mixture was placed in a 
vacuum chamber to remove bubbles trapped in the mixture. Finally, Part-B of the adhesive 
with mixing ratio 1:1 (corresponding to Part-A) was added to the mixture and stirred 
thoroughly. The curing of the adhesive was done at room temperature for 24 hours as suggested 
by the product datasheet and left for a further 48 hours to ensure that maximum bond strength 
was achieved (suggested complete cure cycle). 
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Table 7-1: Composition of two-part epoxy adhesive (Sulley DuluxGroup (Australia)). 
Part A CAS No. Proportion 
Bisphenol A-Epichlorhydrin reaction product 25068-38-6 >60% 
Bisphenol F epoxy resin 9003-36-5 10-30% 
Ingredients determined to be non-hazardous - Balance 
Part B   
Dimethylaminopropyl-1, 3-propylenediamine 15063-29-8 1-10% 
Triethylenetetramine - 1-10% 
Ingredients determined to be non-hazardous - Balance 
7.2.2 Shear strength assessment with SLJs test 
Aluminium plate 5000 series adherents were cut and used in all joints tested. The adherents’ 
surfaces were manually abraded with emery paper (320 grade), cleaned and degreased with 
acetone. The adherents then underwent alkaline cleaning by immersion in 100 g/l NaOH 
solution, at 60°C for 1 min, and were rinsed in tap water [214]. To study the effect of 
microcapsules loading on shear strength of the adhesive, 3 wt. %, 5 wt. % and 10 wt. % of 
microcapsules were incorporated into the adhesive. Control adhesive specimens were prepared 
using the base epoxy adhesive to obtain its baseline properties.  
 
Figure 7-1: Geometry and dimension of lap shear joints. 
After surface treatment, aluminium adherents were assembled into SLJs according to ASTM 
D 1002 [215], as shown in Figure 7-1, where La, Wa and ba, is the length, width and thickness 
of the adherents respectively. The recommended length of overlap (denoted as O in Figure 7-1) 
was 12.70 ± 0.25 mm (as shown in Figure 7-2a). The applied contact pressure was controlled, 
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which allowed the obtaining of adhesive joints with the same uniform thickness. The thickness 
was measured with the aid of optical microscopy (Leica, DMRXE) as shown in Figure 7-2b. 
The average thickness of the overlap was 172 (±50) µm. 
(a) 
 
 
(b) 
 
 
Figure 7-2: (a) Adherents joint with overlap of 12.70 mm and (b) optical microscopy images 
showing adhesive thickness. 
SLJs tests were performed at room temperature using the universal tensile machine, Instron 
3366 with a 10kN load cell with a crosshead speed of 1.3 mm/min. At least 5 samples were 
tested as a function of the microcapsules’ content in the adhesive. Load and displacement data 
points were recorded and the peak load at failure was recorded, and the apparent shear rupture 
strength, τ, was calculated as follows: 
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 τ =  
PC
Ao
 7-1 
where Pc is the peak load and Ao is the overlapping area. 
For a healing assessment, the broken specimens were reattached using metal clamp and kept at 
room temperature. After 24 hours of healing time, the specimens were retested following the 
same conditions mentioned above for the original specimens. The self-healing efficiency, η, of 
the adhesives in this study was quantified by recovery of specimen shear strength as follows: 
 η(%)= 
τoriginal
τhealed
×100 7-2 
where τoriginal and τhealed is the original shear strength and healed shear strength of the specimen, 
respectively. 
7.2.3 Mode I fracture toughness assessment with TDCB test 
 
Figure 7-3: TDCB specimen. 
Mostovoy et al. [134] were the first to introduce the use of TDCB specimen for the 
measurement of GIC in adhesive joints. In this current study, TDCB substrates shown in Figure 
7-3 were designed based on TDCB specimens used by Brown et al. [22] and Beres et al. [216]. 
The TDCB specimen is designed so that the rate of change of specimen compliance with crack 
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length is constant in a large range of values of crack lengths, a. This is beneficial because it 
eases the measurement of the adhesive fracture energy, GIC, that is independent of the crack 
length, a [217]. To develop a linear change of compliance with crack length, the height, h, of 
the specimen is designed by contouring the substrate beam so that the quantity: 
 3a2
h(a)3
+
1
h
 = mt 7-3 
is constant, where mt is the specimen geometry factor. For TDCB specimen in Figure 7-3, mt 
= 0.5 mm-1 for crack lengths up to 60 mm.  
  
(a) (b) 
Figure 7-4: (a) Assembly of TDCB specimen bonded with self-healing epoxy adhesive (b) 
pre-crack introduced to the bonded joint. 
TDCB aluminum substrates were used in all joints tested. Adherents surfaces were surface 
treated the same way as mentioned for SLJs test specimen. Two types of specimens were 
prepared for Mode I fracture toughness test; i) control adhesive (0% microcapsules) and ii) 
self-healing adhesive (10 wt. % microcapsules). TDCB adhesive specimens were assembled 
for bonding as shown in Figure 7-4a. The two aluminum halves were held together with mild 
steel jigs. The thickness of the adhesive bond was 273 (±66) µm as observed with optical 
microscope. After curing, a precrack was introduced to the specimen with a razor blade. Figure 
7-4b shows the optical images of the pre-crack. All mechanical testing was performed at room 
temperature on an Instron 5567, equipped with 10 kN load cell with a strain rate of 0.05 
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mm/min. For the healing assessment, the broken specimens were reattached using the metal jig 
and kept at room temperature. After 24 hours of healing time, the specimens were retested 
following the same Mode I test. 
Determination of adhesive fracture energy, GIC 
The adhesive fracture energy, GIC, for the TDCB adhesive joint specimen may be determined 
directly using the Irwin-Kies equation as follows: 
 
GIC=
P2
2W
dC
da
 7-4 
where W is the specimen width, P is the applied load, C is the specimen compliance and a is 
the crack length. The value of dC/da is the change in the compliance of the specimen with the 
crack length. For adhesive layers, from simple beam theory dC/da can be calculated as follows 
[217-219]: 
 
dC
da
 =
8
 WES
(
3a2
h3
+
1
h
) 7-5 
where h is the beam height and ES is the modulus of the aluminum substrates. Therefore, if the 
beam was machined to a geometry factor, m, given by equation (7-3), the value of dC/da will 
be constant. Combining equation (7-4) and equation (7-5), the value of GIC can be determined 
as follows:  
 GIC = 
4P2
W2E𝑆
(
3a2
h3
+
1
h
) =
4P2
b
2E𝑆
 ∙ mt 7-6 
Quantification of the healing efficiency of the adhesive was defined as the ratio of stress 
intensity factor of healed specimen to original specimen as explained in equation (2-13). 
7.2.4 DSC analysis 
Calorimetric analysis was carried out by a DSC, TA Instruments (2920 Modulated DSC). The 
adhesive was analysed by scanning the temperature from -50°C to 200°C at a heating rate 
10°C/min. The mass of the sample was around 10 mg put into aluminium pans with a diameter 
of 5 mm. 
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7.2.5 SEM analysis 
The fracture surfaces of specimens were observed using SEM Hitachi S4600 and SEM Zeiss 
EVO/Qemscan to identify the healing mode of the adhesive.  
 Results and Discussion 
7.3.1 Adhesive performance with microcapsules inclusion 
 
Figure 7-5: Cohesive failure of single lap-shear test specimen. 
For SLJs tests, the failed joints all had cohesive failures as shown in Figure 7-5. The typical 
curves of load vs. displacement of the SLJs tests of the control adhesive specimen as well as 
the self-healing adhesives containing 3 wt. %, 5 wt. % and 10 wt. % microcapsules are shown 
in Figure 7-6a. The shear strength of these adhesives with respect to microcapsules content is 
shown in Figure 7-6b, with scattering bars defined by the standard deviation.  
The shear strength of the control adhesive (0% microcapsule) is 11.31 MPa. The addition of 
microcapsules into the adhesive shows an increment of the shear strength. However, it is 
noticeable that the adhesive with 3 wt. % of microcapsules content shows the maximum shear 
strength of about 14.26 MPa, which is about 26% higher than that of the neat adhesive. The 
shear strength of the adhesives containing 5 wt. % and 10 wt. % microcapsules is lower than 
that with 3 wt. % microcapsules. A similar trend was observed for the failure strain values, 
suggesting that further increasing the microcapsules content did not increase the shear strength 
Overlapping surface (top) 
Overlapping surface (bottom) 
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much, though the average shear strength values are still higher than the control adhesive. 
Adhesive bonding takes place during the conversion from adhesive liquid phase to solid phase 
[220]. The liquid properties are needed to fully wet the bonding surface. The inclusion of 
microcapsules with mass fraction higher than 3 wt.% appears to restrict the mobility and 
increase the viscosity of the liquid adhesive, preventing it to be properly spread onto the surface 
of aluminium adherents, consequently this will affect the bonding performance of the adhesive.   
(a) 
 
 
(b) 
 
 
Figure 7-6: (a) Typical stress vs. displacement curves of SLJs tests of control adhesive and 
self-healing adhesive (b) shear strength of control adhesive and self-healing adhesives with 
respect to microcapsules content. 
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Figure 7-7 shows a typical load vs. displacement curve for original fractures of control adhesive 
and self-healing adhesive obtained from Mode I TDCB tests. In the case of control adhesive, 
the adhesive load increases linearly to a critical load of 356 N where unstable crack propagation 
starts to occur. With further escalation of displacement, most samples failed after the maximum 
value was achieved, where the load starts to drop until complete failure. In regards to self-
healing adhesive, the load increases linearly to a higher crack initiation point at about 403N, 
followed by unstable crack propagation. The load continues to increase until the maximum 
value was achieved at about 494 N and then started decreasing in a somewhat stable manner. 
After that, a sudden decrease of load can obviously be seen, which indicates a rapid failure. 
Table 7-2 summarised the Mode I fracture toughness values of specimens tested. The average 
fracture toughness, GIC(initiation) at crack initiation for control adhesive specimen and self-healing 
adhesive are 95 (±4) J/m2 and 141 (±54) J/m2 respectively, indicating around 48% 
improvement in GIC(initiation) by incorporating 10 wt. % of microcapsules into an epoxy adhesive. 
Whereas, the average propagation GIC(propagation) shows an increment of more than 80%.  
 
Figure 7-7: Load vs. displacement of original fracture of both neat epoxy adhesive and self-
healing adhesives. 
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Table 7-2: Mode I fracture toughness of control epoxy adhesive and self-healing adhesive. 
Sample Mode I Fracture Toughness, GIC (J/m2) 
Control         
 Initiation PROP1 PROP2 PROP3 PROP4 PROP5 PROP6 
PROP 
Average 
R01 94.36 94.48 91.66 95.84 96.72 101.09  95.96 
R02 90.38 99.63 95.45 106.68 122.84 129.50 129.32 110.82 
R03 101.16 102.57 78.57 84.73    88.63 
Average 
95.30 
(±4.45) 
      
98.47 
(±9.23) 
Self -Healing 
SH01 64.71 147.37 164.14 173.42 170.13 167.13 166.90 164.85 
SH02 108.23 154.12 203.23 198.41 218.21 245.78  203.95 
SH03 127.46 131.13 172.55 182.50 193.55 164.65  168.88 
SH04 206.32 233.85 222.06 209.84    221.92 
SH05 199.58 128.45      128.45 
Average 
141.26 
(±54.36) 
      
177.61 
(±32.60) 
*PROP indicates crack propagation 
Observation of the fracture surface of both control adhesive and self-healing adhesive is shown 
in Figure 7-8. For the control adhesive, the fracture surface is nearly mirror-like which indicates 
very little plastic deformation.  In contrast the self-healing adhesive fracture reveals a rougher 
fracture surface. The roughness can be attributed to the plastic deformation of the host adhesive 
incorporated with the dual-capsules self-healing system, which gives reason for better shear 
strength and fracture toughness. When loading is applied, the presence of microcapsules seems 
to initiate stress concentration, leading to plastic shear yielding in the host adhesive [221]. 
7. Shear Strength and Mode I Fracture Toughness of Epoxy Adhesive Containing Dual-Capsule Self-Healing 
System 
139 
  
(a) (b) 
Figure 7-8: Fracture surface of original fracture (a) neat epoxy adhesive (b) self-healing 
adhesive. 
Apart from that, crack deflection toughening mechanism was also observed (Figure 7-9a). 
When the crack propagates, it tends to take the path with the lowest resistance, which in this 
case is the interface between the matrix and the microcapsules due to its poor adhesion. As can 
be seen in Figure 7-9b, poor adhesion between the microcapsules and epoxy provides an 
excellent site for crack propagation by manoeuvring around the capsules. As the crack deflects 
out of the plane normal to the applied stress, the stress concentration at the crack-tip reduces, 
reducing the overall crack driving force, and therefore increasing the fracture toughness [222]. 
This will also cause an increase in the total fracture surface area.  
 
 
(a) (b) 
Figure 7-9: (a) Crack deflection toughening mechanism (b) poor adhesion between ductile 
epoxy adhesive with the microcapsules causing debonding of capsules 
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These results demonstrated that the inclusion of microcapsules leads to a significant increase 
of shear strength and fracture toughness of the epoxy adhesive. This tendency was often seen 
on epoxy adhesives with either nano- or microphase soft inclusions, such as rubber particles, 
which increases the ductility of the adhesive [40, 223, 224]. Brittleness in general decreases 
the mechanical properties of materials, including shear strength and fracture toughness. The 
addition of microcapsules produces a ductile adhesive, promoting matrix deformation and 
crack deflection, which is better at absorbing energy than a brittle matrix [126, 223-226]. 
However, these results contradict the results of bulk elevated temperature-cured epoxy 
explained in Chapter 4, where no improvement on fracture toughness was observed. As 
explained in a review by Bahgeri et al. [226], the nature of the matrix as the host for the second 
phase plays a key role in the toughening of epoxies. The elevated temperature piperidine-cured 
neat epoxy used in Chapter 4 is more brittle than the room temperature curing two-part epoxy. 
A more ductile epoxy with low cross-linking density can endure more plastic shear deformation 
and can dissipate more energy compared to brittle epoxy [227, 228].  
7.3.2 Self-healing of epoxy adhesive 
The self-healing ability of the adhesives in this study was quantified by recovery of its shear 
strength (equation (7-2), as well as the recovery of the Mode I fracture toughness. Table 7-3 
shows the summary of the self-healing efficiency of the adhesives based on shear strength 
healing efficiency quantification. With a SJLs test assessment the self-healing adhesive 
containing 10% microcapsules shows the highest healing ability with an average value of 
28.12%. However, with SLJs test specimens, it is very hard to align the fracture surface back 
to its pre-fracture position; therefore, instead of just healing the crack, the healant will also 
need to fill the space created by the misalignment, as illustrates in Figure 7-10. This means that 
the healing efficiency assessment via this method cannot be seen as relevant, as it is not 
conclusive to just crack healing.  
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Table 7-3: Shear strength and healing efficiency of self-healing adhesive. 
Sample No. of 
samples 
Microcapsules 
concentration 
(wt. %) 
Original shear 
strength, 
τoriginal (MPa) 
Healed 
shear 
strength, 
τhealed (MPa) 
Healing 
efficiency, 
η (%) 
Control 5 - 11.32 (±0.91) - - 
Self Healing 
Adhesive I 
7 3 
14.25 (±2.15) 1.63 (±0.88) 12  
Self Healing 
Adhesive II 
7 5 
14.00 (±1.95) 2.82 (±0.69) 20 
Self Healing 
Adhesive III 
5 10 
12.08 (±1.69) 3.35 (±1.12) 28 
 
 
Figure 7-10: Gap issue during single lap-shear test healing process. 
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Figure 7-11 shows the typical Mode I load vs. displacement curves of original fracture and 
healed fracture of self-healing adhesive and Table 7-4 summarised the GIC corresponding to 
crack initiation and propagation for all specimens. The healed fracture curve possesses the 
same unstable crack propagation after crack initiation as the original fracture. However, for a 
healed fracture after maximum critical load was achieved, rapid propagation occurred by a 
sudden drop of load. This behaviour was observed in all specimens that were tested. Healing 
efficiency of the adhesive was defined as the ratio of stress intensity factor of healed specimen 
to original specimen as explained in equation (2-13). The average healing efficiency in relation 
to the crack initiation and propagation fracture toughness is 52% and 74% respectively as 
summarised in Table 7-5. 
 
Figure 7-11: Load vs. displacement of self-healing adhesive before and after healing. 
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Table 7-4: Mode I fracture toughness of original and healed fracture of self-healing adhesive  
Sample Mode I Fracture Toughness, GIC (J/m2) 
Original Fracture 
 Initiation PROP1 PROP2 PROP3 PROP4 PROP5 PROP6 
PROP 
Average 
SH01 64.71 147.37 164.14 173.42 170.13 167.13 166.90 164.85 
SH02 108.23 154.12 203.23 198.41 218.21 245.78  203.95 
SH03 127.46 131.13 172.55 182.50 193.55 164.65  168.88 
SH04 206.32 233.85 222.06 209.84    221.92 
SH05 199.58 128.45      128.45 
Average 
141.26 
(±54.36) 
      
177.61 
(±32.60) 
Healed Fracture 
SH01 37.05 144.59      144.59 
SH02 16.07 80.33 98.74     89.54 
SH03 39.84 61.90 105.52     83.71 
SH04 21.44 45.57      45.57 
SH05 66.71 82.96 144.09     113.53 
Average 
36.22 
(±17.71) 
      
95.39 
(±32.87) 
*PROP indicates crack propagation 
Table 7-5: Healing efficiency of self-healing adhesive. 
Sample  GIC (Original) GIC (Healed) Healing efficiency, η (%) 
  Initiation PROP Initiation PROP Initiation PROP 
SH01 64.71 164.85 37.05 144.59 75.66 93.65 
SH02 108.23 203.95 16.07 89.53 38.53 66.26 
SH03 127.46 168.88 39.84 83.71 55.91 70.40 
SH04 206.32 221.92 21.44 45.57 32.23 45.32 
SH05 199.58 128.45 66.71 113.53 57.82 94.01 
Average 141.26 177.61 36.22 95.39 52.03 73.93 
 (±54.36) (±32.60) (±17.71) (±32.87) (±15.37) (±18.34) 
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However, it was speculated that this healing efficiency was not 100% contributed by the 
healant. Figure 7-12 shows DSC curve of the host epoxy adhesive cured in accordance to 
product specification (curing cycle – room temperature cure for 72 hours). After the suggested 
curing cycle, an exothermic curing peak was observed around 112°C, indicating that more time 
is required for the adhesive to reach its ultimate cure at room temperature. Therefore, during 
the healing of the fracture specimen, it was expected that the curing progression of the adhesive 
was still ongoing. Since the curing of the host adhesive was still ongoing, the unreacted curing 
agent of host adhesive might have reacted with the epoxy monomer release from the capsules, 
resulting in a higher healing efficiency at room temperature in contrast to the results of room 
temperature healing of this dual-capsule system presented in Chapter 4, section 4.4.3. 
 
Figure 7-12: DSC curve of epoxy adhesive after cured for 72 hours at room temperature 
(curing cycle suggested by the product datasheet). 
Figure 7-13 shows SEM images of the fracture surface of the healed specimen. A mixture of 
cohesive and adhesive failure can be observed on the fracture surface. Healant film (resulting 
from reaction between DGEBA epoxy and mercaptan released from the capsules) on the 
interface of the original fracture surface failed adhesively, whereas the bonded surface resulting 
from the post-curing of the epoxy adhesive failed cohesively. 
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Figure 7-13: Healed fracture surface of epoxy adhesive. 
 Summary 
In this work, the SLJs test and TDCB test specimens involving a metal adherent (aluminium) 
were successfully used to investigate the effect of microcapsules incorporated into room 
temperature-cured epoxy adhesive. The results obtained in this study shows that the presence 
of microcapsules in commercially available epoxy adhesive can enhance the inherent 
performance of the adhesive by increasing its baseline shear strength and its baseline fracture 
toughness, with an increment of as high as 80% of its Mode I fracture toughness (GIC) and 
about 26% of its shear strength. The increase in fracture toughness in the epoxy adhesive with 
microcapsules was mainly attributed to the plastic deformation of the host adhesive as well as 
the crack path deflection caused by the poor adhesion between the microcapsules and the epoxy 
adhesive. 
Healing efficiency assessment based on the recovery of the shear strength was deemed as 
unsuitable due to the complexity in achieving the same specimen condition as the original 
specimen. Healing efficiency based on ratio of stress intensity factor of healed specimen to 
original specimen at crack initiation and propagation are 52% and 74%, respectively. However, 
it was found that in using the cure cycle in accordance to the product specification, the host 
epoxy adhesive did not achieve its ultimate cure. Since the curing of the host adhesive was still 
ongoing, the unreacted curing agent of host adhesive might have reacted with the epoxy 
monomer release from the capsules, resulting in a higher healing efficiency at room 
temperature in contrast to the findings of room temperature healing of this dual-capsule system 
100 µm 
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presented in Chapter 4. As a result, the higher room temperature healing efficiency of the epoxy 
adhesive after the original fracture cannot be solely attributed to the microencapsulated 
DGEBA epoxy/mercaptan healant.
147 
 
Conclusions and Future Works 
 Conclusions 
The main objective of the present work consisted of a fabrication of a high fibre volume fraction 
structural composites containing a dual-capsule based self-healing system and the following 
study of its effect on the inherent mechanical properties as well as the healing capability. 
Specifically, a dual-capsule based self-healing system containing DGEBA epoxy and 
mercaptan healing chemistry was developed, since it can provide good healing that is 
independent of the functionality of the matrix and the reinforcement; based on the literature 
studies, this was concluded as an excellent system to be integrated with composite laminate 
consisting high fibre volume fraction. To achieve these objectives, the work took place in the 
following stages: i) microencapsulation of DGEBA epoxy and mercaptan, their 
characterisation, ii) the study on the effect and healing of bulk epoxy integrated with such 
capsules, iii) the integration of microcapsules and fabrication of composite laminate via the 
VARI process, iv) the evaluation on the effect of such integration on the inherent composite 
laminates and adhesive joints properties, and v) assessment of its healing ability. 
By adapting an oil-in-water emulsion in-situ polymerisation microencapsulation technique that 
had been established, microcapsules with two average sizes, 65 µm and 136 µm, were 
successfully fabricated. The average shell wall thickness of the microcapsules was around 1.5 
µm. DGEBA epoxy-loaded microcapsules were chosen as the polymerisable monomer since 
they have better thermal stability compared to other types of epoxy resin; this is essential in 
order to withstand the elevated temperature fabrication process of the composite laminate. Core 
content of the microcapsules was found to be around 90% of its total weight. The reactivity of 
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the capsules validated using DSC analysis showed that fast curing of this healing substance 
began at 70°C.  
Typically, the high performance structural composite involves fabrication processes in which 
the resin is heated and curing is performed at an elevated temperature to obtain good 
mechanical properties and better dimensional stability at various service temperatures. 
Comprehensive experimental investigations have been done on the effect of the incorporation 
of dual-capsule self-healing system on the properties of the elevated temperature-cured epoxy 
resin and its ability to heal. Despite numerous studies in the literature that support the efficacy 
of microcapsules to induce toughening in room temperature-cured epoxy, it was found that in 
elevated temperature-cured epoxy such behaviour cannot be accomplished. KIC and GIC values 
of both neat epoxy and self-healing epoxy were basically identical, measured using TDCB 
specimens. This suggested that microcapsules inducing toughening mechanism could only be 
obtained in a less brittle epoxy such as the room temperature-cured epoxy.  
Furthermore, the influence of temperature and viscosity of the healant on the healing 
performance of the epoxy was also investigated in order to have on overall understanding of 
the healing capacity of DGEBA epoxy-loaded microcapsules. It was found that the healing 
ability of DGEBA epoxy-loaded microcapsules could be optimised with an elevated 
temperature healing cycle, by obtaining a lower viscosity healant to ensure its miscibility and 
subsequently forming better healant film adhesion with the host material. Healing efficiency 
of the epoxy at room temperature, 50°C and 70°C healing conditions are 26%, 70% and 111% 
respectively. 
A procedure was established to estimate the maximum number of capsules that can be 
distributed on the interlaminar region of the composites in order to form a single layer capsule 
distribution. This is important to obtain composite laminates with high fibre volume fraction. 
The integration of microcapsules on top of unidirectional fibre fabric was done using a manual 
dry-dispersed technique and finally the composite laminate with high fibre volume fraction 
(around 65%) and satisfactory quality was successfully achieved via a vacuum-assisted resin 
infusion technique following by hot pressing during curing.  
The results obtained from the Mode I interlaminar fracture toughness test using WTDCB 
specimens for the CF/EP laminates, incorporated with dual-capsule self-healing system, show 
that the baseline Mode I fracture toughness decreases by around 5% with larger size 
8. Conclusions and Future Works 
149 
microcapsules and 38% with the smaller capsules. This is mainly caused by microcapsule-
induced imperfection, such as voids, clustering of the small microcapsules, and debonding of 
the microcapsules/matrix interface caused by the poor adhesion between them. Alternatively, 
the result obtained from Mode II testing using end notch fracture (ENF) specimens shows that 
the incorporation of such microcapsules into structural composites increase its baseline Mode 
II fracture toughness (up to 48%).  It was observed that the microcapsules induced toughening 
via two mechanisms in shear loading: i) enhanced/larger plastic deformation due to thicker 
resin-rich interlaminar region (larger damage zone), and ii) particle bridging. 
The main results of the healing assessment in CF/EP laminates demonstrate that by using the 
larger healant capsules, healing efficiency, up to 80% can be achieved after Mode I interlaminar 
fracture. While for Mode II interlaminar fracture, the healing efficiency with 68% average 
recovery can be achieved. Owing to a low viscosity of epoxy prepolymer of the self-healing 
system at elevated temperature, it is possible to achieve a good healing performance. Since the 
amount of microcapsules that can be embedded are constrained by the interlaminar region, it 
was observed that the recovery of the Mode I interlaminar fracture toughness was directly 
correlated with the amount of healant delivered to the fracture plane, with larger capsules 
providing higher healing efficiency when compared to the small capsules. For the Mode II 
interlaminar fracture, it was also observed that the ability of the healant to form a dense/solid 
resin-rich healed interlaminar region is strongly related to the healing efficiency of the 
composite laminates. 
It is concluded that the dual-capsule consisting of a DGEBA epoxy/mercaptan healing 
chemistry is a suitable candidate to be used as healing agent in laminated composite with high 
fibre volume fraction. Unlike catalyst-capsules and single-capsule self-healing system where 
the healing mechanism is strongly dependent on the functionality of the matrix phase, healing 
in dual-capsule system can occur independently. This is important in composite laminates with 
high fibre volume fraction since the matrix area is limited and damage tends to occur at 
fibre/matrix interface. 
Finally, a preliminary investigation on the use of the dual-capsule system in commercially 
available two-part epoxy adhesive was done. TDCB test specimen using aluminium adherents 
was established to assess the Mode I fracture toughness of adhesive. It was found that the 
incorporation of the microcapsules into the adhesive increased the baseline shear strength and 
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Mode I fracture toughness of the adhesive. The increase in the baseline fracture toughness in 
the adhesive incorporated with microcapsules was mainly attributed to enhanced plastic 
deformation of the ductile adhesive, as well as the crack path deflection caused by the poor 
adhesion between the microcapsules and the adhesive. Initial investigation into the healing of 
the adhesive containing dual-capsule with Mode I TDCB test revealed that the high healing 
efficiency (52% and 74% corresponding to crack initiation and crack initiation respectively) at 
room temperature of the adhesive after the original fracture could not be solely attributed to 
the epoxy/mercaptan healant. By using the cure cycle in accordance to the product 
specification, the base adhesive did not achieve its ultimate cure. Consequently, during the 
healing process of the fractured specimen, post-curing of the base adhesive might be still 
ongoing, and the reactive curing agent of the base adhesive might have reacted with the epoxy 
released from the capsules.  
 Recommendation for future works 
According to the present study, DGEBA epoxy/mercaptan loaded microcapsules have a 
positive potential to be integrated with structural composite consisting high fibre volume 
fraction. However, the fabrication process of these microcapsules appears to be inefficient and 
the mass production cannot be easily industrialised. Furthermore, despite numerous studies on 
the encapsulation technique of the healing agent, the mass production of such microcapsules 
still has not been realised due to the complexity of the process. This opens an opportunity to 
further investigate a more accessible and undemanding way to fabricate these microcapsules 
in large quantity. 
Until now, healing assessments have always been conducted in lab conditions, whereas in 
polymeric material such as epoxy, failure mechanism might be influenced by its surrounding 
environment, such as service temperature, moisture, ultra-violet radiation exposure, chemical 
degradation and environment stress cracking such as crazing. Therefore, any healing 
assessment and mechanisms should also be characterised under these conditions to ensure their 
applicability in the real world.  
Based on the present finding, a small panel of high fibre volume fraction CF/EP with acceptable 
quality and healing ability was successfully fabricated. The effectiveness of the fabrication 
process needs to be validated into a larger panel where a more genuine damage formation and 
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healing mechanism can be assessed. Despite that, other composites structure fabrication 
method such as filament winding and prepreg manufacturing should as well be studied; one 
possible way is to incorporate the microcapsules into the resin bath (Figure 8-1) through which 
the fibres are drawn.  
 
Figure 8-1: Prepreg fabrication process. 
Finally, in addition to the results from the present study, a further investigation needs to be 
carried out to eventually commercialise the capsules of DGEBA epoxy/mercaptan as a healing 
agent in the polymeric adhesive. An experimental analysis on the joints made from different 
adherent materials and with different adhesives’ thickness and their effectiveness to heal at 
different damage modes need to be validated. 
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APPENDIX A 
TDCB SAMPLES (NEAT EPOXY) 
Representative Load vs. Displacement Curve (Figure 4-7); Unmodified TDCB Epoxy - 
Sample 3, Modified TDCB Epoxy - Sample 2. 
 
Table A-A-1: Critical peak loads obtained from original fracture of TDCB samples. 
Sample No. Peak, PC (N) 
Unmodified 1 2 3 4 5 6 7 8 9 10 11 12 
1 48 50 52 59 64 65 48      
2 25 44 52 41 38 34 37 33     
3 65 65 66 61 61        
4 40 67 74 83         
Modified             
1 46 50 52 55 55 44 42      
2 50 52 56 55 58 60 49      
3 26 38 45 48 46 50 47 52 50 53 52 51 
4 51 46 51 51 55 51 58      
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Representative Load displacement curves Figure 4-11: for TDCB sample healed at room 
temperature (Sample No.1). 
 
Table A-A-2: Critical peak loads obtained from original fracture and healed fracture of 
TDCB samples healed at room temperature. 
Sample 
No. 
Peak, PC (N) 
Original 1 2 3 4 5 6 7 8 9 10 11 12 
1 55 47 49 48 47 22       
2 48 28           
3 42 40 29          
4 43 49 48 51 48 47 25      
Healed             
1 8            
2 9 17           
3 24 7           
4 4            
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Representative Load vs. displacement Figure 4 15(a): Thermally activated healing of cured 
TDCB epoxy containing 10 wt. % microcapsules healing at 50°C (Sample 2). 
 
Table A-A-3: Critical peak loads obtained from original fracture and healed fracture of 
TDCB samples healed at 50°C. 
Sample 
No. 
Peak, PC (N) 
Original 1 2 3 4 5 6 7 8 9 10 11 12 
1 51 46 51 51 55 51 38      
2 26 38 45 48 46 50 47 52 50 53 52 51 
3 28 28 56 41 42 43 45      
4 92            
Healed             
1 19 23           
2 28 39 36 40 43        
3 30 61           
4 35 49           
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Representative Load vs. displacement Figure 4 15(a): Thermally activated healing of cured 
epoxy containing 10 wt. % microcapsules healing at 70°C (Sample 2). 
 
Table A-A-4: Critical peak loads obtained from original fracture and healed fracture of 
TDCB samples healed at 70°C. 
Sample 
No. 
Peak, PC (N) 
Original 1 2 3 4 5 6 7 8 9 10 11 12 
1 46 50 51 55 55 44 42      
2 49 51 56 59 60 49 56      
3 38 38 38 39 36        
4 59 54 57          
Healed             
1 69 52           
2 68 65 67 69 49        
3 50 32 41          
4 551 54 59 55         
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APPENDIX B 
Mode I - WTDCB SAMPLES (CF/EP) 
Representative load vs. displacement curves Figure 5-14: Base laminate (sample 1) and 
laminates with Type-A (sample 4) and Type-B capsules (sample 2). 
 
Representative load vs. displacement curves Figure 5-18(a): Type-A CF/EP (Sample 4). 
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Representative load vs. displacement curves Figure 5-18(B): Type-B CF/EP (Sample 4). 
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APPENDIX C 
Mode II - ENF SAMPLES (CF/EP) 
Load vs. displacement curves of original fracture base CF/EP. 
 
Load vs. displacement curves of original fracture self-healing CF/EP. 
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Load vs. displacement curves of original fracture (solid line) and healed fracture (dashed line) 
of self-healing CF/EP. 
Sample 1  
(Representative curves) 
 
 
Sample 2 
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Sample 3 
 
 
Sample 4 
 
 
Sample 5 
 
 185 
APPENDIX D 
Representative load vs. Displacement Curve (Figure 7-7); Unmodified TDCB Epoxy 
Adhesive - Sample 1, Self-Healing TDCB Epoxy Adhesive - Sample 3. 
 
 
Table A-D-1: Critical peak loads obtained from original fracture of TDCB control specimen 
epoxy adhesive and self-healing adhesive 
Sample No. Peak, PC (N) 
Unmodified Initiation 1 2 3 4 5 6 7 8 9 10 11 
1 346 346 341 348 350 358       
2 338 355 348 367 394 405 405      
3 358 360 315 327         
Self-
Healing 
            
1 286 432 456 468 464 460 460      
2 370 442 507 501 525 558       
3 402 407 467 481 495 456       
4 511 544 530 515         
5 503 403           
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Representative load vs. displacement (Figure 7-11) of self-healing adhesive before and after 
healing (Sample No.3). 
 
Table A-D-2: Critical peak loads obtained from original fracture and healed fracture of 
TDCB self-healing adhesive. 
Sample 
No. 
Peak, PC (N) 
Original Initiation 1 2 3 4 5 6 7 8 9 10 11 
1 286 432 456 468 464 460 460      
2 370 442 507 501 525 558       
3 402 407 467 481 495 456       
4 511 544 530 515         
5 503 403           
Healed             
1 217 428           
2 143 319 353          
3 225 280 365          
4 165 240           
5 291 324 427          
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a b s t r a c t
We present an experimental study of the self-healing ability of carbon ﬁbre/epoxy (CF/EP) composite
laminates with microencapsulated epoxy and its hardener (mercaptan) as a healing agent. Epoxy- and
hardener-loaded microcapsules (average size large: 123 lm; small: 65 lm) were prepared by in situ poly-
merisation in an oil-in-water emulsion and were dry-dispersed at the ratio 1:1 on the surface of unidi-
rectional carbon fabric layer. The CF/EP laminates were fabricated using a vacuum-assisted resin
infusion (VARI) process. Width-tapered double cantilever beam (WTDCB) specimens were used to mea-
sure mode-I interlaminar fracture toughness of the CF/EP composites with a pre-crack in the centre plane
where the microcapsules were placed. Incorporation of the dual-component healant stored in the fragile
microcapsules provided the laminates with healing capability on delamination damage by recovering as
much as 80% of its fracture toughness. It was also observed that the recovery of fracture toughness was
directly correlated with the amount of healant covering the fracture plane, with the highest healing efﬁ-
ciency obtained for the laminate with large capsules.
 2015 Elsevier Ltd. All rights reserved.
1. Introduction
The concept of self-healing of materials with encapsulated heal-
ing agents composed of a healing resin and its curing catalyst was
proposed more than a half a century ago. However, it did not
evolve into a viable method because of the very limited ‘‘no-
curing” lifetime, until recently when researchers developed tech-
niques to encapsulate the healing resin and/or encapsulate or graft
the curing catalyst independently. In the early 2000s, researchers
from the University of Illinois at Urbana-Champaign USA devel-
oped a self-healing material system consisting of a microencapsu-
lated healing agent (dicyclopentadiene (DCPD)) and a catalytic
chemical trigger within an epoxy matrix to automatically heal
cracks, and that system has been seen as an engineering approach
to address material failure [1]. The self-healing ability helps mate-
rials to recover their load-bearing capability after damage, with
some approaching 90% recovery [2–6].
Various approaches to self-healing have been developed over
the years. The three approaches receiving most attention are the
capsule-based healing system [1–13], intrinsic healing system
[14–16] and vascular self-healing system [17–20]. Among these
systems, microcapsule-based self-healing can be applied in
polymer composites with the advantage of ease of dispersion into
matrix resins [21,22] with little change to manufacturing
procedures or microstructure of the composites.
Fig. 1 shows the basic concept of a microcapsule-based self-
healing system with a dual-component healing agent. In this sys-
tem, the two components of the healant, namely polymerisable
monomers and hardener, are independently encapsulated in fragile
capsules and incorporated into a matrix material [6]. The capsules
rupture and release the monomer and hardener upon the approach
of a crack, whereupon the mix of monomer and hardener poly-
merise and subsequently heal the crack [22].
Most studies in self-healing have focused on neat resins rather
than structural composites. A dual-component self-healing system,
consisting of microencapsulated epoxy andmercaptan as hardener,
has been reported [6,23], with 104%maximum healing efﬁciency of
neat epoxy. Disturbance of ﬁbre alignment and difﬁculty in uni-
formly dispersing microcapsules to provide consistent healing of
cracks can be a challenge in adopting the microcapsule-based
self-healing technique in structural composites [22]. Kessler et al.
[24] demonstrated a maximum 80% recovery of interlaminar
fracture toughness of CF/EP fabricated using wet hand lay-up and
compression moulding with an epoxy resin mixed with capsules.
http://dx.doi.org/10.1016/j.compositesa.2015.12.012
1359-835X/ 2015 Elsevier Ltd. All rights reserved.
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This healing efﬁciency was achieved by using microencapsulated
DCPD resin and Grubb’s catalyst at the interply region, and had a
ring-opening-metathesis-polymerisation of DCPD at 80 C. Yin
et al. [25] and Tao et al. [26] developed a microencapsulated epoxy
and latent curing agent as a two-component healant in a woven
glass ﬁbre composite with a ﬁbre volume fraction of 27%. They
observed that over 70% recovery of the original interlaminar frac-
ture toughness was achieved with 30 wt% microencapsulated
epoxy and 2 wt% microencapsulated latent hardener in the matrix.
Self-sealing capability in a woven glass ﬁbre composite by the
addition of encapsulated DCPD and Grubb’s catalyst as a healant
in matrix was demonstrated by Moll et al. [27]; self-sealing was
observed in composite laminates with no nitrogen gas ﬂow
through the laminates in the thickness direction after damage by
repeated indentation at prescribed loads. Yuan et al. [28] reported
compressive behaviour after impact damage in glass ﬁbre
reinforced epoxy laminates incorporated with a dual-component
self-healing system consisting of microencapsulated epoxy
and mercaptan as hardener. The study showed that the
dual-component healing system enabled self-repair of glass ﬁbre
reinforced epoxy laminates to a certain degree.
Because of the difﬁculty in applying resins with microcapsules
normally 100 lm in size to reinforcing ﬁbres during the fabrication
process of composites, most studies have adopted a low ﬁbre vol-
ume fraction for ease of processing. However, that approach under-
mines the key advantages of high speciﬁc strength and stiffness of
ﬁbre-reinforced composites. Wet-hand-layup using a brush and a
roller has been widely employed in fabricating composites, but
these normally have clearly lower quality than those fabricated
using advanced techniques. In this study, we developed a dual-
component healing system for fabricating CF/EP composites from
carbon ﬁbre uni-fabrics using vacuum-assisted resin infusion
which led to a high ﬁbre volume fraction. The objective was to fur-
ther understand the self-healing capacity of structural composites
with that healing system, and it is expected that the ﬁndings will
support practical application of such materials.
2. Experimental
2.1. Microencapsulation of a dual-component self-healant
For the dual-component self-healant used in this study, a
diglycidyl-ether of bisphenol-A epoxy resin – Araldite-F
(Ciba-Geigy, Australia) was employed as the polymerisable
component of the healing agent. Pentaerythritol tetrakis
(3-mercaptopropionate) (PETMP) (Sigma Aldrich, Australia) was
used as the hardener for the epoxy and 2,4,6-Tris (dimethy-
laminomethyl) phenol (DMP-30) as the catalyst. This catalyst
was infused into hardener-loaded microcapsules as an accelerator
and to achieve better thermal properties. The epoxy and its hard-
ener were encapsulated independently in melamine–formalde-
hyde according to procedures described elsewhere [6,23].
The shell thickness of the microcapsules was observed using
scanning electron microscopy (SEM). Fig. 2 shows the thickness
of both epoxy- and hardener-loaded microcapsules. The Soxhlet
extraction method was employed to determine the core content
of the microcapsules (weight ratio of core to microcapsule) as out-
lined by Yuan et al. [6]. The core content was about 96.7 wt% for
the epoxy-loaded microcapsules and 93.1 wt% (0.6 wt% DMP-30)
for the hardener-loaded.
To study the effects of microcapsule size and distribution on the
healing ability of CF/EP composites, microcapsules in two different
mean sizes were prepared. For Type A capsules, the average size
was 110.6 lm for epoxy-loaded microcapsules (Fig. 3a) and
136.4 lm for hardener-loaded microcapsules (Fig. 3b), and for
Type B capsules, the average size was about 65.2 lm for epoxy-
loaded microcapsules (Fig. 3c) and 66.1 lm for hardener-loaded
microcapsules (Fig. 3d).
Differential scanning calorimetry was used to investigate the
reactivity of the prepared capsules. A small amount of the mix of
cracked capsules (10–20 mg) at a weight ratio of 1:1 between
epoxy and hardener was heated from 20 C to 200 C at a rate of
10 C/min in an environment with N2 gas. Fig. 4 shows the exother-
mal reaction curve of the mixture. The exothermic reaction peaks
at 102.6 C with the onset temperature at 83.5 C. These data indi-
cate that fast healing in a material with capsules of epoxy and
hardener occurred in a temperature range of 70–100 C when the
epoxy and hardener were released from the capsules.
It is envisaged that the successful spreading of encapsulated
epoxy resin within a crack is an essential step to achieve healing
of the crack; such a process is controlled by capillary ﬂow and
the viscosity of resins. To assess the inﬂuence of the resin viscosity
on the healing performance, the healing of the composite lami-
nates was conducted at both room temperature and an elevated
temperature at 70 C. The room temperature healing was reported
in previous studies using epoxy/mercaptan as a self-healing agent
[6,23,28]; where for example diglycidyl tetrahydro-o-phthalate
(DTHP) [6,23], and a mixture of diglycidyl ether of bisphenol A
(DGEBA) and diglycidyl resorcinol ether (DGRE) [28] were used
as polymerisable monomer. In this study, pure DGEBA was used
as the polymerisable component of the self-healing system, which
Carbon fibre
Matrix
Matrix delamination closure by 
polymerisation of healant
Epoxy-loaded 
microcapsules
Hardener-
loaded 
microcapsules 
Crack tip
Fig. 1. Schematic of self-healing mechanism for crack/delamination closure in ﬁbre composites. (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)
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(a)
(b)
3 μm30 μm
2 μm40 μm 
1.48 μm 
1.53 μm 
Fig. 2. SEM images showing the thickness of (a) epoxy-loaded microcapsules (b) hardener-loaded microcapsules. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
(a) (b) 
(c) (d) 
150 μm
Fig. 3. SEMmicrograph of microcapsules: (a) Type A epoxy-loaded capsules, (b) Type A hardener-loaded capsules, (c) Type B epoxy-loaded capsules, and (d) typical collapsed
shell of Type B hardener-loaded capsule.
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matches that of the matrix of the composite laminates. In addition,
replacing DTHP by DGEBA also greatly improves thermal resistance
of the healing agent [29,30].
2.2. CF/EP laminates with self-healant
T300 unidirectional carbon ﬁbre fabric (FGI Fibre Glass Interna-
tional, Australia) and a DGEBA epoxy resin (Araldite-F, Ciba-Geigy,
Australia) were used to fabricate CF/EP composites, with piperidine
(Sigma–Aldrich, Australia) as a curing agent. Composite panels
were manufactured using a VARI process. Sixteen plies of
300 mm  250 mm sheets were cut from T300 unidirectional car-
bon fabric and stacked together. At one end of the laminate, a very
thin polyimide ﬁlm was embedded at the central plane, coated
with a release agent, to form a starter crack for mode-I
interlaminar fracture toughness testing. For the CF/EP laminates
with encapsulated healant, microcapsules of the epoxy and
hardener, Type A or Type B, were ﬁrst mixed at a weight ratio of
1:1 and then dry-dispersed using a particle sifter onto the top sur-
face of the carbon ﬁbre fabric, modulated by the mass of capsules
per unit area (75 g/m2). Only three interlayer regions (the central
region and immediately above and below the central region) of
laminates were incorporated with these microcapsules (Fig. 5).
The total mass fraction of the microcapsules is 5.3% in the three
interlayers corresponding to the total mass of the laminate.
The temperature of in the sealed vacuum bag was maintained at
60 C during VARI. The vacuum bag with the resin-inﬁltrated
carbon ﬁbre fabric stack was then moved onto a hot press at a pres-
sure of 0.4 MPa to achieve a composite laminate with a high ﬁbre
volume fraction of about 65% and to ensure ﬂatness of the cured
laminate panel.
Three types of laminates were fabricated. The base CF/EP lami-
nate was fabricated to serve as the benchmark without microcap-
sules. Type A CF/EP laminates were fabricated with Type A capsules
and Type B CF/EP laminates with Type B capsules. The laminates
were cured in the hot press at 120 C for 16 h. The cured composite
panels were then cut into the specimens using water jet cutting.
Mode-I interlaminar fracture toughness of CF/EP laminates with
and without the encapsulated healant was studied using width-
tapered double cantilever beam (WTDCB) specimens [24] (Fig. 6).
A WTDCB specimen is designed for constant compliance with crack
length, so that the interlaminar fracture toughness, GIC, is indepen-
dent of crack length [31].
GIC ¼ 12P
2
c K
2
E1h
3 ð1Þ
where Pc is the critical load, E1 is the modulus of elasticity in the
longitudinal direction, h is the specimen half thickness. K is a con-
stant aspect ratio of WTDCB (K = a/b(a)) [24], where b(a) is the
width of the specimen at crack length a (Fig. 6).
2.3. Mode-I interlaminar fracture
Mode-I interlaminar fracture toughness testing was conducted
on an Instron 5567 universal testing machine equipped with a
1 kN load cell at a displacement rate of 5 mm/min. The WTDCB
specimen was loaded until the crack reached the non-tapered
region of the specimen (i.e. the crack propagated from a = 60 mm
to approximately a = 100 mm) and then unloaded. The load and
displacement were recorded throughout the test. At least 5 speci-
mens were tested for each type of CF/EP laminate.
For the base CF/EP specimens, after the crack had propagated to
about a = 100 mm (the end of the tapered region), the specimens
were quickly unloaded and injected with a mixture of epoxy
monomer and mercaptan with DMP-30 as catalyst, which was
the same as that released from the capsules. The fractured speci-
men was then clamped using steel plates and placed in an oven
at 70 C for 24 h. After healing, the specimens were cooled to room
temperature and tested again following the same mode-I interlam-
inar fracture procedure. Healing of these specimens serves as a
benchmark for the strength achieved by this dual-component
(epoxy/mercaptan) healant when full coverage of the healant on
fracture surfaces was obtained.
For the self-healing CF/EP specimens, after quick unloading, the
specimen was clamped using steel plates to bring the two crack
surfaces together and then placed in an oven at 70 C for 24 h.
The healed specimens were tested again following the same
procedure. The morphology of fracture surfaces was then exam-
ined using SEM.
Fig. 4. Exothermal reaction curve of a mixture of epoxy and hardener.
1 mm
Fig. 5. Distribution of epoxy- and hardener-loaded microcapsules on top of carbon
ﬁbre fabric. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
Fig. 6. Geometry of WTDCB specimen for mode-I interlaminar fracture of CF/EP
laminates.
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2.4. Quantiﬁcation of healing efﬁciency (g)
The critical stress intensity factor, KIC, under the plane stress
condition for mode-I loading can be deﬁned as,
K IC ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
GICE
p
ð2Þ
Some parameters have been adopted to describe the healing per-
formance of polymers [32]. In this study, in line with previous liter-
atures in self-healingof laminated compositesmaterials, thehealing
efﬁciency,g, was quantify through the critical stress intensity factor,
KIC, [24–26]. Therefore, healing efﬁciency could be deﬁned by the
ratio of critical stress intensity factor of the healed specimen,
K ICðhealedÞ, to that of the original specimen K ICðoriginalÞ [24,26,32],
gð%Þ ¼ K ICðhealedÞ
K ICðoriginalÞ
 100 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
GICðhealedÞ
GICðoriginalÞ
s
 100 ð3Þ
For the interlaminar fracture of each specimen, rather than stable
crack propagation, unstable or ‘‘stick–slip” crack propagation was
observed, producing multiple peaks of critical load, Pc, for onset of
crackpropagation, leading tomultiplevaluesof the interlaminar frac-
ture toughness, GIC [24,33,34]. For this reason, rather than character-
ising healing efﬁciency with only the maximum value of fracture
toughness, GmaxIC , the average value of fracture toughness, G
average
IC ,
gathered from multiple peaks, Pc, was also taken into consideration.
The average healing efﬁciency, gaverage , was deﬁned as the ratio of
the average fracture toughness of healed specimens (GaverageICðhealedÞ) to
the average fracture toughness of original specimens (GaverageICðoriginalÞ),
gaverageð%Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
GaverageICðhealedÞ
GaverageICðoriginalÞ
vuut  100 ð4Þ
The maximum healing efﬁciency, gmax, was deﬁned as the ratio
of the maximum fracture toughness in healed specimens (GmaxICðhealedÞ)
to the average fracture toughness of original specimens (GaverageICðoriginalÞ),
gmaxð%Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
GmaxICðhealedÞ
GaverageICðoriginalÞ
vuut  100 ð5Þ
2.5. Relationship between healant-covered surface area and healing
efﬁciency
It was observed that the healant coverage on the fracture sur-
faces was related to the healing efﬁciency in the CF/EP laminates.
A quantitative assessment of the area covered by healant was con-
ducted using an ImageJ open-source image analyser. Images of frac-
ture surfaces were obtained using SEM. The healant-covered
surface area (HSA) was measured with the assumption that the
fracture surface of the healant was ﬂatter than that of the CF/EP
composites. 20 images covering total area of 2 cm  2 cm, including
5 images from the crack initiation area, were randomly taken on the
fracture surface from each Type A self-healing CF/EP specimen. The
bonded surface area (BSA) was then quantiﬁed as the ratio of the
average HSA to the total scanned area of fracture surface (TSA),
BSA ð%Þ ¼ HSAaverage
TSA
 100 ð6Þ
3. Results and discussion
3.1. Mode-I fracture toughness evaluation
Fig. 7a shows typical load–displacement curves of the interlam-
inar fracture of CF/EP laminates with Type A and Type B capsules in
comparison to that of the base CF/EP laminate. In all cases the load
increased linearly until the onset of delamination; then the crack
propagated in stick–slip mode. The values of averaged fracture
toughness were calculated using Eq. (1). In Fig. 7b, GaverageIC for the
base CF/EP laminates was reduced after adding the capsules. The
GaverageIC of the base CF/EP laminates is 539 J/m
2, whereas the
GaverageIC of Type A and Type B CF/EP is 515 J/m
2 and 335 J/m2,
respectively, reducing the GIC of the base laminate by 4.6% and
37.9%, respectively. The microcapsules in the interlaminar regions
apparently induced some imperfections, such as voids between
them (Fig. 8a), thus directly inﬂuencing the interlaminar properties
of the composites [35]. Microcapsule size also had a direct inﬂu-
ence on the fracture toughness of the CF/EP. It can be seen in
Fig. 7b that the interlaminar fracture toughness was lowest for
the CF/EP laminate with small microcapsules (Type B). Fig. 3d
shows a collapsed Type B hardener-loaded capsules, indicating that
the capsules were ﬂexible and might not retain a spherical shape
during contact. This feature could promote agglomeration of
capsules with poor adhesion between them. When delamination
occured, instead of the crack propagating through the capsule,
the crack path manoeuvred around the capsules (Fig. 8b). Large
clusters of capsules could also leave voids between them,
(Fig. 8c), contributing to low fracture resistance.
3.2. CF/EP injected with healant
For the composite laminates with healing at both room temper-
ature and elevated temperature at 70 C, the healing performance
achieved at the room temperature was much lower than that
achieved at the elevated temperature. Therefore, only the results
achieved at the elevated temperature are presented here, and the
inﬂuence of temperature on healing mechanisms is discussed.
Fig. 9 shows the typical load–displacement curves for the base
CF/EP laminate and that healed with the injected healant. The
onset of crack propagation onset occurs at a much higher load
for the CF/EP laminate healed by injecting healant between the
fracture surfaces, and the delamination onset load after healing is
clearly higher than that for the original fracture. As the crack
advances, the load increases in a stable manner until it reaches
its maximum and drops towards the end of the tapered region of
the specimen. This process may be associated with additional frac-
ture mechanisms such as ﬁbre bridging and side cracking which
were not present during the original fracture. However, the result
indicates that this dual-mechanism (epoxy/mercaptan) healant
could potentially heal CF/EP laminates with more than 100% recov-
ery of their fracture toughness.
3.3. Self-healing efﬁciency of CF/EP
For the typical load–displacement curves of CF/EP laminates
with capsules of Type A or Type B in Fig. 10, both original and healed
laminates show stick–slip fracture behaviour, but with some clear
differences. For the original laminates, after the onset of delamina-
tion, the loads at ‘‘peak” and ‘‘valley” seem to remain between the
lower and upper bounds as the crack propagates. For the laminate
with Type A capsules, the load in all healed laminates increases
with crack growth (Fig. 10a). As themain crack advances, microcap-
sules break, releasing healant that can ﬂow towards the narrower
space between the upper and lower fracture surfaces by virtue of
capillary motion, transferring more healant towards the main crack
tip [1]. This explains the ascending curve of the load with crack
growth, as the better healed crack region towards the crack tip pro-
duces high crack growth resistance, as demonstrated by the
enhanced fracture resistance in the healed base laminate with the
injected healant in Fig. 9. The average healing efﬁciency, gavg, and
maximum healing efﬁciency, gmax, for the CF/EP laminates with
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Type A capsules are 69% and 80% respectively. The values of both
gavg and gmax are comparable to those reported previously for a
CF/EP laminate [24]. The fracture of healed CF/EP laminates with
Type B capsules shows unstable crack propagation with clearly
low values of peak load, Pc (Fig. 10b). The CF/EP laminates with Type
B capsules show values of 54% and 57% respectively for average
healing efﬁciency, gavg, and maximum healing efﬁciency, gmax,
which are much lower than those for the laminates with Type A
capsules. Table 1 summarises the results of mode-I interlaminar
fracture tests and healing efﬁciency of the CF/EP laminates. As
discussed in the previous section, small Type B capsules promoted
agglomeration of capsules with poor adhesion between them, and
the crack path manoeuvred around the capsules without breaking
them. The large clusters of small capsules mean that smaller areas
of fracture surfaces can be covered by the healant released from the
capsules, leading to poorer healing ability.
The viscosity of the DGEBA epoxy used as healant in this study
was measured using a parallel-plate type rheometer (Anton Paar –
MCR 300 rheometer) as shown in Fig. 11, the viscosity of the epoxy
dropped dramatically by two orders to about 0.1 Pa s when the
temperature increases to 70 C.
The SEM images, Fig. 12, on the healing of bulk epoxy contain-
ing these microcapsules at room temperature, show that the epoxy
healant remains inside the capsule instead of spreading, resulting
from the high viscosity of the DGEBA epoxy. In the studies by Yuan
et al. [6,23], diglycidyl tetrahydro-o-phthalate (DTHP) (with viscos-
ity 0.36–0.53 Pa s) and a mixture of diglycidyl ether of bisphenol A
(DGEBA) and diglycidyl resorcinol ether (DGRE) [28], were used as
the healing agent, where DGRE has a viscosity 0.3–0.5 Pa s. A high
ﬂowrate epoxy prepolymer of a self-healing system with its viscos-
ity less than 0.5 Pa s is a prerequisite for achieving good healing
performance.
3.4. Relationship between bonded surface area and healing efﬁciency
Fig. 13 shows the relationship between the BSA and healing efﬁ-
ciency for the CF/EP laminate with Type A capsules. It can be seen
that healing efﬁciency is clearly dependent upon the surface area
Fig. 7. Interlaminar fracture of base laminate and laminates with Type A and Type B capsules; (a) typical load–displacement curves and (b) GaverageIC for the base and laminates
with self-healant.
Fig. 8. CF/EP laminates with microcapsules; (a) void caused by microcapsules, (b) dimples from debonded microcapsules (caused by crack manoeuvring around the capsules)
and (c) clustering of smaller microcapsules. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 9. Typical load–displacement curves of interlaminar fracture of original
fracture and fracture after healing of base CF/EP laminates with injected healant.
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bonded by the healing agent. To achieve high healing efﬁciency,
wide spreading of the healant on the fracture surface is certainly
needed, as demonstrated in the base laminate with the injected
healant. However, there is a clear difference between healant-
rich areas from one specimen to another. This is strongly related
to the distribution of microcapsules in the matrix materials, which
in turn is related to the dispersion of microcapsules on top of the
carbon fabrics before resin infusion. Furthermore, resin transfer
during the VARI process might also promote non-uniform distribu-
tion of microcapsules such as washing and agglomeration.
Previous studies on the effect of microcapsules weight fraction
and microcapsule/carrier diameter (size) by Rule et al. [36] and He
Table 1
Mode-I interlaminar fracture toughness and healing efﬁciency of base CF/EP and
CF/EP laminates with Type A and Type B capsules.
Sample
type
GaverageICðvirginÞ
(J/m2)
GaverageICðhealedÞ
(J/m2)
GmaxICðhealedÞ
(J/m2)
gaverage
ð%Þ
gmax
ð%Þ
Base CF/EPa 539 (±82) 769 (±274) 934 (±415) 116 126
Type A 515 (±99) 253 (±110) 338 (±172) 69 80
Type B 335 (±95) 140 (±31) 147 (±35) 54 57
a For the base CF/EP, the healing was achieved using direct injection of the dual-
component healant in the delaminated area.
Fig. 11. Viscosity of DGEBA epoxy at room temperature (d) and 70 C ( ).
Fig. 12. DGEBA monomer retained inside microcapsules due to its higher viscosity when healed at room temperature.
Fig. 13. Relationship between bonded surface area (BSA) on fracture surface and
healing efﬁciency of CF/EP laminate with Type A microcapsules. (For interpretation
of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
(a) Type A (b) Type B
Fig. 10. Interlaminar fracture of original CF/EP laminates and those after healing.
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and Jinglei [37] on bulk epoxy have also reported similar outcome.
As discussed in these studies, the healing efﬁciency can be maxi-
mized when the amount of healing agent delivered to a crack is
enough to seal the ‘‘crack” volume. As discussed by Rule et al.
[36] for a bulk epoxy system, the amount of liquid that microcap-
sules deliver to a crack face varies linearly with microcapsule
diameter for a given weight fraction of capsules. Huang and Yang
[38], have investigated the self-healing anticorrosive property of
the hexamethylene diisocyanate (HDI) microcapsule-based coat-
ings with various coating thickness (200–400 lm). They observed
that corrosion protection performance is directly related to the
microcapsules diameter, microcapsules weight fraction and coat-
ing thickness and a simpliﬁed model was established to explain
the inﬂuences of these parameters.
However, in composites of a high ﬁbre volume fraction, the
weight fraction of microcapsules that can be embedded is con-
strained by the interlaminar region. By using 75 g/m2 of microcap-
sules on the CF fabric, about 64 microcapsules (with average
diameter 123 lm, microcapsule density 1.25 g/cm3) for Type A
and 225 microcapsules for Type B (with average diameter 65 lm)
could be distributed in a surface area of 1 mm2. If we assume the
core volume of the capsules is maintained in the composites, the
amount of healant fully released from Type A or Type B capsules
could fully ﬁll in a gap of about 60 lm and 30 lm respectively
between the upper and lower surfaces of delamination, and any
larger gap would certainly leave voids.
Fig. 14 shows a gap that was healed with Type A capsules. The
delamination gap varied along the crack path, with a larger gap
(90 lm) visible distant from the crack tip (Fig. 14a) and a smaller
gap (60 lm) seen closer to the crack tip (Fig. 14b). Furthermore,
multi-ply cracking during delamination was also observed
(Fig. 14c) in some specimens, creating an even larger gap. This
observation explains why 100% HSA could not be achieved during
the experimental evaluation.
Fig. 15 shows SEM fractographs of fracture surfaces of CF/EP
laminates with Type A and Type B capsules. For Type A, it can be
seen that the fracture surface is roughly 50% covered by the hea-
lant. As previously discussed, large microcapsules stored more hea-
lant within them, subsequently resulting in larger healant-covered
areas. However, small Type B capsules tended to form clusters,
which directly inﬂuenced the healant-covered area. Apart from
that, smaller microcapsules contained a smaller amount of healant.
Given the smaller amount of healant, patchy healing occurred on
the surface, creating insufﬁcient coverage on the fracture surface
area.
4. Conclusions
A two-component healing system consisting of encapsulated
epoxy and mercaptan as its hardener was developed for producing
self-healing CF/EP laminates with a high ﬁbre volume fraction of
65%, fabricated using a VARI process. The interlaminar fracture of
CF/EP laminates with large and small capsules was characterised
using WTDCB specimens, and the self-healing efﬁciency of CF/EP
laminates on interlaminar fracture was evaluated addressing the
effect of size of capsules. Based on the results, a few useful conclu-
sions can be drawn:
1. The incorporation of a dual-component healant stored in fragile
microcapsules can provide CF/EP laminates with self-healing
capability by recovering as much as 80% of the original fracture
toughness.
(a) (b) (c)
Fig. 14. Healed delamination gap in Type A laminate; (a) distant from crack tip (b) towards crack tip (c) intra-ply cracking.
(a) Type A (b) Type B
Fig. 15. SEM fractographs of CF/EP laminates with microencapsulated healant (a) Type A with healant covering fracture surface (HSA highlighted in purple) (b) patchy healing
on Type B fracture surface. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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2. The distribution and size of microcapsules have clear effects on
the original interlaminar fracture toughness of CF/EP laminates.
Both large and small capsules reduce the interlaminar fracture
toughness of CF/EP laminate, more notably in laminates with
smaller microcapsules. Smaller capsules tend to agglomerate,
causing poor adhesion between the microcapsules and leading
to greater reduction in fracture toughness.
3. The distribution and size of microcapsules also has an effect on
the interlaminar fracture toughness of CF/EP laminates after
healing. Larger capsules provide higher healing efﬁciency for
CF/EP laminates, with more healant stored and released to
cover the fracture surfaces; small capsules provide lower heal-
ing efﬁciency for CF/EP laminates, with more clustered cap-
sules. Healing efﬁciency is clearly dependent on the coverage
of healant on fracture surfaces: broader coverage results in
higher healing efﬁciency.
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KHDOLQJRIWKHDGKHVLYHFDQUHVWRUHPRUHWKDQDKDOIRILWVIUDFWXUHWRXJKQHVV
6LQJOHODSVKHDUMRLQW6/6-LVYHU\VLPSOHWRSUHSDUHFRVWHIIHFWLYHDQGSUDFWLFDODQG LW LVFRPPRQO\XVHGLQ
DXWRPRWLYHDQGDHURVSDFHLQGXVWU\>@'HVSLWHWKHIDFWWKDWVHOIKHDOLQJKDVEHHQVXFFHVVIXOO\REWDLQHGIRUEXON
SRO\PHUVYHU\OLWWOHZRUNGDWDKDVEHHQSXEOLVKHGRQVHOIKHDOLQJRISRO\PHULFDGKHVLYH7KHUHIRUHLWLVLQWHUHVWLQJ
WRVWXG\WKHMRLQWVLQYROYLQJWKHVHPDWHULDOVWRIXUWKHULWVDSSOLFDWLRQDVDGKHVLYH
,Q WKH SUHVHQW ZRUN ZH GHPRQVWUDWHG VHOIKHDOLQJ LQ WKLQ OD\HU HSR[\ DGKHVLYH ZKHQ LQFRUSRUDWHG ZLWK
HSR[\PHUFDSWDQPLFURFDSVXOHV7KHHIIHFWRIPLFURFDSVXOHVORDGLQJRQWKHODSVKHDUVWUHQJWKDQGWKHUHFRYHU\RI
WKHODSVKHDUVWUHQJWKRIWKHDGKHVLYHZDVVWXGLHGDWURRPWHPSHUDWXUHDIWHUFRPSOHWHIUDFWXUH
Proceedings of PPS-31
AIP Conf. Proc. 1713, 140004-1–140004-5; doi: 10.1063/1.4942339
© 2016 AIP Publishing LLC 978-0-7354-1360-3/$30.00
140004-1
 Reuse of AIP Publishing content is subject to the terms at: https://publishing.aip.org/authors/rights-and-permissions IP:  124.168.146.76 On: Mon, 27 Jun 2016 05:04:07
(;3(5,0(17$/
0LFURHQFDSVXODWLRQRIWZRFRPSRQHQWVHOIKHDOLQJV\VWHP
)RUDWZRFRPSRQHQWVHOIKHDOLQJV\VWHPXVHGLQWKLVVWXG\DGLJO\FLG\OHWKHURI%LVSKHQRO$$UDOGLWH)&LED
*HLJ\$XVWUDOLDHSR[\ UHVLQZDVHPSOR\HGDV DSRO\PHUL]DEOHFRPSRQHQWRI WKHKHDOLQJDJHQW3HQWDHU\WKULWRO
WHWUDNLVPHUFDSWRSURSLRQDWH REWDLQHG IURP6LJPD$OGULFKZDV XVHG DV D KDUGHQHU IRU WKH HSR[\ IRU FXULQJ DW
URRP WHPSHUDWXUH %RWK HSR[\ DQG LWV KDUGHQHU ZHUH HQFDSVXODWHG LQGHSHQGHQWO\ LQ PHODPLQHIRUPDOGHK\GH
DFFRUGLQJWRDPHWKRGGHVFULEHHOVHZKHUH>@7KHDYHUDJHGLDPHWHULVPIRUHSR[\ORDGHGPLFURFDSVXOHV
ZKLOVW  P IRU PHUFDSWDQORDGHG PLFURFDSVXOHV *HRPHWU\ DQG VXUIDFH IHDWXUH RI WKH VKHOO IRU ERWK
PLFURFDSVXOHVDUHVKRZQLQ)LJXUH




),*85(*HRPHWU\DQGVL]HRIPLFURFDSVXOHVDHSR[\ORDGHGPLFURFDSVXOHVEKDUGHQHUORDGHGPLFURFDSVXOHV

3UHSDUDWLRQRI6HOI+HDOLQJ$GKHVLYH

7KH DGKHVLYH XVHG LQ WKLV VWXG\ LV D FRPPHUFLDOO\ DYDLODEOH HSR[\ DGKHVLYH VXSSO\ E\ 6XOOH\ 'XOX[*URXS
$XVWUDOLD7KLVDGKHVLYHFXUHVDWDURRPWHPSHUDWXUHDQGFRQVLVWVRIWZRSDUWV$DQG%ZLWKFKHPLFDOHQWLW\DQG
FRPSRVLWLRQ OLVWHG LQ 7DEOH   (SR[\0HUFDSWDQ PLFURFDSVXOHV DQG 3DUW $ HSR[\ UHVLQ RI WKH DGKHVLYH ZHUH
PL[HGLQDJODVVIODVN6LQFH WKHHSR[\UHVLQLVYHU\YLVFRXVDWURRPWHPSHUDWXUHLWZDVKHDWHGWR°&WRHQVXUH
EHWWHUPLVFLELOLW\ZLWK WKHPLFURFDSVXOHV ,Q RUGHU WR GLVSHUVHPLFURFDSVXOHV LQ WKH HSR[\ UHVLQ WKHPL[WXUHZDV
VRQLFDWHG IRU PLQ DW °& LQ DQ XOWUDVRQLF EDWK DW  N+]$IWHU XOWUDVRQLFDWLRQ WKHPL[WXUHZDV SODFHG LQ D
YDFXXPFKDPEHUWRUHPRYHEXEEOHVWUDSSHGLQWKHPL[WXUH)LQDOO\SDUW%RIWKHDGKHVLYHZLWKPL[LQJUDWLRZDV
DGGHG WR WKH PL[WXUH ZLWK VWLUULQJ WR HQVXUH KRPRJHQHLW\ $IWHU FXULQJ WKH DGKHVLYH ZDV PDLQWDLQHG DW URRP
WHPSHUDWXUHIRUDWOHDVWKEHIRUHWHVWLQJ6FDQQLQJHOHFWURQPLFURVFRS\ZDVXVHGWRDQDO\]HWKHIUDFWXUHVXUIDFH
RIWKHDGKHVLYH

/DS6KHDU6WUHQJWK7HVW

$OXPLQXPSODWHVHULHVDGKHUHQWVZHUHFXWDQGXVHGLQDOOMRLQWVWHVWHG$GKHUHQWs’ surfaceZHUHPDQXDOO\
DEUDGHGZLWK HPHU\ SDSHU  JUDGH FOHDQHG DQG GHJUHDVHG ZLWK DFHWRQH 7KH DGKHUHQWV ZLOO WKHQ XQGHUJRHV
DONDOLQHFOHDQLQJE\LPPHUVLRQLQJO1D2+VROXWLRQDW&IRUPLQDQGULQVHGLQWDSZDWHU>@
$IWHU VXUIDFH WUHDWPHQW DOXPLQXP SLHFHV ZHUH DVVHPEOHG LQWR VLQJOHODS VKHDU MRLQWV DFFRUGLQJ WR $670'
DVVKRZQLQ)LJXUHDZLWKWKHUHFRPPHQGHGOHQJWKRIRYHUODSRIPPDVVKRZQLQ)LJXUH
E7KH DSSOLHG FRQWDFW SUHVVXUHZDV FRQWUROOHGZKLFK DOORZV REWDLQLQJ DGKHVLYH MRLQWVZLWK WKH VDPH XQLIRUP
DGKHVLYHWKLFNQHVV7KHWKLFNQHVVZDVPHDVXUHGZLWKKHOSRIRSWLFDOPLFURVFRS\DVVKRZQLQ)LJXUHF6LQJOHODS
VKHDUWHVWVZHUHSHUIRUPHGDWURRPWHPSHUDWXUHXVLQJWKHXQLYHUVDOWHQVLOHPDFKLQH,QVWURQZLWKDN1ORDG
FHOO7KHFURVVKHDGVSHHGZDVPPPLQ$WOHDVWVDPSOHVZHUHWHVWHGDVDIXQFWLRQRIPLFURFDSVXOHVFRQWHQWLQ
WKHDGKHVLYH/RDGDQGGLVSODFHPHQWGDWDZHUHUHFRUGHGDQGWKHSHDNORDGDWIDLOXUHZDVUHFRUGHGDQGWKHDSSDUHQW
VKHDUUXSWXUHVWUHQJWKZDVFDOFXODWHGE\GLYLGLQJWKHSHDNORDGE\WKHRYHODSSLQJDUHD7KHIUDFWXUHVXUIDFHVZHUH
DQDO\VHG YLVXDOO\ WR GHWHUPLQH WKH SHUFHQWDJH RI FRKHVLYH IDLOXUH )RU VHOIKHDOLQJ WKH EURNHQ VSHFLPHQV ZHUH
UHDWWDFKHGXVLQJPHWDO FODPSDQG NHSW DW URRP WHPSHUDWXUH$IWHU KRXUV RI KHDOLQJ WLPH WKH VSHFLPHQVZHUH
UHWHVWHGIROORZLQJWRWKHVDPHFRQGLWLRQVPHQWLRQHGDERYHIRUWKHRULJLQDOVSHFLPHQV
D E
140004-2
 Reuse of AIP Publishing content is subject to the terms at: https://publishing.aip.org/authors/rights-and-permissions IP:  124.168.146.76 On: Mon, 27 Jun 2016 05:04:07


),*85(D*HRPHWU\DQGGLPHQVLRQRIODSVKHDUMRLQWVEDGKHUHQWVZLWKRYHUODSRIPPDQGFRSWLFDOPLFURVFRS\
LPDJHVVKRZLQJDGKHVLYHWKLFNQHVV

7$%/(&RPSRVLWLRQRIWZRSDUWHSR[\DGKHVLYH
3DUW$ 3URSRUWLRQ
%LVSKHQRO$(SLFKORUK\GULQUHDFWLRQSURGXFW !
%LVSKHQRO)HSR[\UHVLQ 
,QJUHGLHQWGHWHUPLQHGWREHQRQKD]DUGRXV %DODQFH
3DUW% 
'LPHWK\ODPLQRSURS\OSURS\OHQHGLDPLQH 
7ULHWK\OHQHWHWUDPLQH 
,QJUHGLHQWGHWHUPLQHGWREHQRQKD]DUGRXV %DODQFH

5(68/76$1'',6&866,21
2ULJLQDO/DS6KHDU6WUHQJWKRI6HOI+HDOLQJ$GKHVLYH

7KH W\SLFDO FXUYHV RI ORDG YV GLVSODFHPHQW RI WKH WHQVLOH ODS VKHDU WHVWV RI WKH DGKHVLYH MRLQWV ZLWK WKH QHDW
DGKHVLYH DVZHOODV WKHDGKHVLYHVFRQWDLQLQJZW ZW DQGZWRI VHOIKHDOLQJPLFURFDSVXOHVDUH
VKRZQLQ)LJD7KHWHQVLOHODSVKHDUVWUHQJWKRIWKHVHDGKHVLYHVZLWKUHVSHFWWRPLFURFDSVXOHVFRQWHQWLVVKRZQ
LQ)LJEZLWKVFDWWHULQJEDUVGHILQHGE\WKHVWDQGDUGGHYLDWLRQ7KHODSVKHDUVWUHQJWKRIWKHQHDWHSR[\DGKHVLYH
LV03D$GGLWLRQRIPLFURFDSVXOHVLQWRWKHDGKHVLYHVKRZVDQLQFUHPHQWRIWKHODSVKHDUVWUHQJWK+RZHYHULW
LVQRWLFHDEOHWKDWWKHDGKHVLYHZLWKZWRIPLFURFDSVXOHVFRQWHQWVKRZVWKHPD[LPXPODSVKHDUVWUHQJWKRIDERXW
03DZKLFKLVDERXWKLJKHUWKDQWKDWRIWKHQHDWDGKHVLYH7KHVKHDUVWUHQJWKRIWKHDGKHVLYHVFRQWDLQLQJ
DQGPLFURFDSVXOHVLVORZHUWKDQWKDWZLWKPLFURFDSVXOHV7KHVLPLODUWUHQGLVREVHUYHGIRUWKHIDLOXUH
VWUDLQYDOXHV VXJJHVWLQJ WKDW WKH IXUWKHU LQFUHDVHRIPLFURFDSVXOHVFRQWHQW GLGQRW LQFUHDVH WKH ODSVKHDU VWUHQJWK
PXFKWKRXJKWKHDYHUDJHVWUHQJWKYDOXHVDUHVWLOOKLJKHUWKDQWKHQHDWDGKHVLYH
7KLV UHVXOW VKRZHG WKDW WKH ODSVKHDU VWUHQJWK GHSHQGHG RQ WKH FRQWHQW RI PLFURFDSVXOHV LQ DGKHVLYH 7KLV
WHQGHQF\ZDVRIWHQVHHQRQHSR[\DGKHVLYHVZLWKHLWKHUQDQRRUPLFURSKDVHVRIWLQFOXVLRQVVXFKDVUXEEHUSDUWLFOHV
WKDW LQFUHDVH WKH GXFWLOLW\ RI WKH DGKHVLYH > @ %ULWWOHQHVV LQ JHQHUDO GHFUHDVHV PHFKDQLFDO SURSHUWLHV RI
E
/
2
)
)
/ OHQJWKRIDGKHUHQWV
: ZLGWKRIDGKHUHQWV
E WKLFNQHVV
2 RYHUODSDUHD
) DSSOLHGIRUFH
D E
F
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PDWHULDOVLQFOXGLQJODSVKHDUVWUHQJWK7KHDGGLWLRQRIPLFURFDSVXOHVSURGXFHVDGXFWLOHDGKHVLYHSURPRWLQJPDWUL[
GHIRUPDWLRQZKLFKLVEHWWHULQDEVRUELQJHQHUJ\WKDQDEULWWOHPDWUL[>@ )LJXUHVKRZVWKHIUDFWXUHVXUIDFHRI
WKH VHOIKHDOLQJ DGKHVLYH DIWHU WKH ODS VKHDU VWUHQJWK WHVW ,Q FRQWUDVW WR VPRRWK FOHDQ IUDFWXUH RI QHDW HSR[\
DGKHVLYHWKHVHOIKHDOLQJDGKHVLYHIUDFWXUHUHYHDOVVLGHFUDFNV LQFUHDVLQJWKHUHVLVWDQFHWRPDLQFUDFNSURSDJDWLRQ
ZKLFKJLYHVWKHUHDVRQIRUEHWWHUVKHDUVWUHQJWK
),*85( D7\SLFDOVWUHVVYVGLVSODFHPHQWFXUYHVRIVLQJOHODSVKHDUMRLQWRIQHDWHSR[\DQGHSR[\DGKHVLYHFRQWDLQLQJVHOI
KHDOLQJPLFURFDSVXOHVE/DSVKHDUVWUHQJWKRIVHOIKHDOLQJDGKHVLYHVZLWKUHVSHFWWRPLFURFDSVXOHVFRQWHQW
),*85( )UDFWXUHSODQHRIDGKHVLYHFRQWDLQLQJPLFURFDSVXOHV
7$%/(+HDOLQJDELOLW\RIDGKHVLYH
6DPSOH7\SH 1R2I
6SHFLPHQ
0LFURFDSVXOHV
ZW IUDFWLRQ
$YHUDJH
RULJLQDO
6KHDU
6WUHQJWK
03D
$YHUDJH
+HDOHG6KHDU
6WUHQJWK
3HUFHQW6KHDU
6WUHQJWK
5HFRYHUHG

+HDOLQJ
&RQGLWLRQ
&RQWURO     
KRXUVDW
URRP
WHPSHUDWXUH
6HOI+HDOLQJ
,
    
6HOI+HDOLQJ
,,
    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6HOI+HDOLQJ&DSDELOLW\RI(SR[\$GKHVLYH

6HOIKHDOLQJFDSDELOLW\RI WKHDGKHVLYHV LQ WKLV VWXG\ZDVTXDQWLILHGE\ UHFRYHU\RI LWV VKHDU VWUHQJWK7DEOH
VKRZVWKHVXPPDU\RIWKHVHOIKHDOLQJDELOLW\RIWKHDGKHVLYHVZLWKGLIIHUHQWDPRXQWRIKHDOLQJFDSVXOHV7KHVHOI
KHDOLQJDGKHVLYHFRQWDLQLQJPLFURFDSVXOHVVKRZVWKHKLJKHVWKHDOLQJDELOLW\ZLWKDQDYHUDJHYDOXHRI
ZKLFKLVGLUHFWO\UHODWHGWRWKHDPRXQWRIKHDODQWFRQWDLQHGLQWKHDGKHVLYH)URPWKHUHVXOWVLWFDQEHFRQFOXGHGWKDW
WKHKHDOLQJDELOLW\RIWKHDGKHVLYHLVVWURQJO\LQIOXHQFHE\WKHDPRXQWRIKHDODQWHPEHGGHGLQWRWKHDGKHVLYHZLWK
WKHORZHVWKHDOLQJDELOLW\REWDLQHGIRUWKHDGKHVLYHFRQWDLQLQJWKHVPDOOHVWDPRXQWRIPLFURFDSVXOHV

&21&/86,216
7KHVHOIKHDOLQJDGKHVLYHFRQWDLQLQJWZRFRPSRQHQWKHDOLQJFDSVXOHVZLWKHSR[\DQGPHUFDSWDQDVLWVKDUGHQHU
KDVEHHQGHYHORSHG7KHHIIHFWRIPLFURFDSVXOHFRQWHQWRQWKHODSVKHDUVWUHQJWKDQGKHDOLQJDELOLW\KDVEHHQ
VWXGLHG6HYHUDOFRQFOXVLRQVFDQEHGUDZQIURPWKHILQGLQJ

 ,QFRUSRUDWLRQRIPLFURFDSVXOHV LQWR WKHHSR[\DGKHVLYHKDV LQFUHDVHG LWV RULJLQDO ODS VKHDU VWUHQJWKZLWK
PLFURFDSVXOHVFRQWHQWVKRZLQJ WKHRSWLPXPUHVXOWZLWK DQ LQFUHPHQWRIDVFRPSDUHG WR WKDWRI
QHDWHSR[\DGKHVLYH
 ,QFRUSRUDWLRQRIHSR[\PHUFDSWDQPLFURFDSVXOHVLQWRWKHHSR[\DGKHVLYHVKRZVDUHFRYHU\DVKLJKDV
RILWVRULJLQDOODSVKHDUVWUHQJWKDIWHUFRPSOHWHIUDFWXUH

$&.12:/('*0(176
7KH DXWKRUV ZLVK WR H[SUHVV WKHLU VLQFHUH DSSUHFLDWLRQ WR WKH &HQWHU IRU $GYDQFHG 0DWHULDOV 7HFKQRORJ\
&$07RIWKH8QLYHUVLW\RI6\GQH\DQG0LQLVWU\RI+LJKHU(GXFDWLRQ0DOD\VLDIRUWKHLUVXSSRUWLQWKLVSURMHFW

5()(5(1&(6
 65:KLWHet.al1DWXUH
 (1%URZQet. al([SHULPHQWDO0HFKDQLFV
 /<DRet.al3RO\PHU
 ;/XRet.al$&6$SSOLHG0DWHULDOV	,QWHUIDFHV
 567UDVNet.al-RXUQDORI7KH5R\DO6RFLHW\,QWHUIDFH
 7<LQet.al&RPSRVLWHV6FLHQFHDQG7HFKQRORJ\
 +-LQet.al,QWHUQDWLRQDO-RXUQDORI$GKHVLRQDQG$GKHVLYHV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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ABSTRACT 
This paper presents an experimental study on self-healing ability of carbon fibre/epoxy (CF/EP) composite 
laminates with microencapsulated epoxy and its hardener (mercaptan) as healing agent. Both epoxy- and 
hardener-loaded microcapsules (large with average size of 120 μm and small with 65 μm) prepared by in 
situ polymerization in an oil-in-water emulsion and they were dry-dispersed with ratio 1:1 on the surface 
of unidirectional carbon fabric layer. The laminates were fabricated using vacuum assisted resin infusion 
(VARI) process. Width tapered double cantilever beam (WTDCB) specimens were used to measure 
mode-I interlaminar fracture toughness of CF/EP composites with a pre-crack at the centre plane where 
the microcapsules were placed. It was found that the incorporation of dual component healant stored in 
fragile microcapsules can provide the laminates with delamination damage on healing capability by 
recovering as high as 80% or its original fracture toughness. It was also found that, the recovery of 
fracture toughness is directly influenced by the amount of healant covering the fracture plane, with the 
highest healing efficiency obtained for the laminate with large capsules. 
1 INTRODUCTION 
The concept of self-healing of materials with encapsulated healing agents composed of both 
healing resin and curing catalyst was proposed more than half a century ago. However, it did not evolve 
into a viable method because of a very limited “no-curing” lifetime, until recently when researchers 
developed techniques to encapsulate or graft the healing resin and curing catalyst independently. In the 
early 2000s researchers from University of Illinois at Urbana-Champaign USA developed a self-healing 
material system consisting microencapsulated healing agent (dicyclopentadiane (DCPD)) and a catalytic 
chemical trigger within an epoxy matrix to automatically heal cracks, which can be seen as an engineering 
solution to address materials failure [1]. This self-healing ability helps the materials to recover their load 
bearing ability after damage happen, with some approaching 90% [2-6]. 
Various approaches of self-healing mechanism have been established over the years. The three 
approaches receiving most attention are the capsule based healing system [1-7], intrinsic healing system 
[8-10] and hollow fibre embedment [11]. Among these systems, microcapsules based self-healing has 
advantages to be applied in polymer composites compared to the other two systems; this includes the ease 
of dispersion into matrix resins [12]. 
Figure 1 shows the basic concept of a microcapsule-based self-healing system with dual 
component healing agent. In this system, two-component healant consists of polymerizable monomers and 
its hardener were encapsulated separately in fragile capsules and incorporated into a matrix material [6]. 
Habibah Ghazali, Lin Ye and Ming Q. Zhang 
These capsules rupture and release the monomer and hardener upon approaching of a crack, the mix of 
monomer and hardener polymerizes and subsequently heals the crack [13]. 
 
 
Figure 1: Schematic of crack/delamination closure of fibre composites self-healing mechanism 
Most of studies in self-healing materials were focused on neat resins systems instead of structural 
composites. Disturbance on fibre orientation by microcapsules and difficulty to uniformly disperse the 
microcapsules to provide consistent healing throughout the structure can be a challenge in adapting the 
microcapsule-based self-healing technique to structural composites [13]. Kessler et al., [14] have 
successfully demonstrated maximum 80% recovery of interlaminar fracture toughness of CF/EP fabricated 
using wet hand lay-up and compression moulding using an epoxy resin mixed with capsules. This healing 
efficiency was achieved by using the microencapsulated DCPD resin and Grubb’s catalyst at the interply 
region to initiates a ring-opening-metathesis-polymerization (ROMP) of DCPD while healing at 80°C. A 
study by Yin et al., [15, 16] implemented microencapsulated epoxy and latent curing agent as two-
component healant in a woven glass fibre composite with a fibre volume fraction of 27%. It was observed 
that over 70% recovery of original interlaminar fracture toughness can be achieved with 30 wt% 
microencapsulated epoxy and 2 wt% microencapsulated latent hardener in the matrix.   
Self-sealing functionality of a woven glass fibre composite by addition of encapsulated DCPD and 
Grubb’s catalyst as healant in matrix was demonstrated by Moll et al. [17]. It was found that after being 
damaged by repeated indentation at prescribed loads, self- sealing was observed in composites laminates 
with no nitrogen flow through the thickness direction of the composite.  
A dual-component self-healing system consisting microencapsulated epoxy and mercaptan as hardener, 
has been reported [6, 18], with 104% maximum healing efficiency of neat epoxy. Lee et al., [19], and 
Yuan et al., [20] have reported compressive behaviour after impact damage in glass fibre reinforced epoxy 
laminates incorporated with this healing system. Both studies show the dual-component healing system 
enables self-repair of glass fibre reinforced epoxy laminates at a certain degree. 
In this study, we developed a dual-component healing system for fabricating CF/EP composites from 
carbon fibre uni-fabrics with vacuum assisted resin-infusion. The objective is to further understand the 
self-healing capacity of structural composites with such a healing system, and it is expected that the 
findings will help practical applications of such materials. 
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2 EXPERIMENTAL 
2.1. Microencapsulation of a dual-component self-healant 
For the dual-component self-healant used in this study, a diglycidyl-ether of bisphenol-A epoxy resin – 
Araldite-F (Ciba-Geigy, Australia) was employed as the polymerizable component of the healing agent. 
Pentaerythritol tetrakis (3-mercaptopropionate) (PETMP) (Sigma Aldrich, Australia) was used as a 
hardener for the epoxy and 2,4,6-Tris (dimethylaminomethyl) phenol (DMP-30). This catalyst was infused 
into hardener loaded microcapsules as an accelerator and for better thermal properties. Both epoxy and its 
hardener were encapsulated independently in melamine-formaldehyde according to the procedures 
described elsewhere [6, 18]. 
To study the effect of microcapsule size and distribution on healing ability of CF/EP composites, 
microcapsules with different mean sizes were prepared. The shell thickness of the microcapsules is about 
1.50 ± 0.30 micron as observed with SEM (scanning electron microscopy). The core content of the epoxy-
loaded microcapsules (weight ratio of core to microcapsule shell) is about 96.70 wt % and 93.10 wt% for 
hardener-loaded ones as determined by the Soxhlet extraction method. For Type A capsules the average 
size is 110.6 μm for epoxy-loaded microcapsules (Figure 2a) and 136.4 μm for hardener-loaded 
microcapsules (Figure 2b), meanwhile for Type B capsules, the average size is about 65.2 μm for epoxy-
loaded microcapsules (Figure 2c) and 66.1 μm for hardener-loaded microcapsules (Figure 2d). 
(a) 
 
(b) 
(c) 
 
(d) 
Figure 2: SEM micrograph of microcapsules (a) Type A epoxy-loaded microcapsules (b) rough surface of 
Type A hardener-loaded microcapsules (c) Type B epoxy-loaded microcapsules (d) collapse phenomenon 
of Type B hardener loaded microcapsules 
Differential scanning calorimetry (DSC) was used to investigate the reactivity of the prepared capsules. 
Small amounts of cracked capsules (10-20 mg) at a weight ratio of 1:1 between the epoxy and hardener 
were heated from 20 to 200°C at a rate of 10°C/min in an environment with N2.  Figure 3 shows the 
exothermal reaction curve of the mixture. The exothermic reaction peaks at 102.62°C with the onset 
temperature at 83.49°C is the curing temperatures of the mixture. These results indicate healing in a 
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material with the capsules of epoxy and hardener will occur in a temperature range of 70 to 100°C when 
the epoxy and hardener are released from the capsules. 
 
Figure 3: Exothermal reaction curve of epoxy and hardener mixture 
2.2. CF/EP laminates with self-healant 
T300 unidirectional carbon fibre fabric (FGI Fibre Glass International, Australia) and a diglycidyl ether 
of bisphenol A (DGEBA) epoxy resin (Araldite-F, Ciba-Geigy, Australia), were used to fabricate CF/EP 
composites in this study, with Piperidine (Sigma-–Aldrich, Australia) as curing agent. Composite panels 
were manufactured using a vacuum-assisted resin infusion (VARI) process. Sixteen pieces of 300 mm × 
250 mm sheets were cut from T300 unidirectional carbon fabric and stacked together. At one end of the 
laminate, a very thin polyimide film was embedded at the central plane, coated with a release agent, to 
form a starter crack for mode-I interlaminar fracture toughness test. For the CF/EP laminates with 
encapsulated healant, microcapsules of the epoxy and hardener, Type A or Type B, were mixed at a 
weight ratio of 1:1 loaded and then were dry-dispersed using a particle sifter onto the top surface of 
carbon fibre fabric, modulated by the mass of capsules per unit area. Only three interlayer regions (the 
central, immediately above and below the central) of laminates were incorporated with these 
microcapsules (Figure 4). 
 
Figure 4: Distribution of epoxy and hardener loaded microcapsules on top of carbon fibre fabric 
A temperature of 60 °C in the sealed vacuum bag was maintained during VARI. The vacuum bag with 
the resin-infiltrated carbon fibre fabric stack was then moved onto a hot press at a pressure of 0.4 MPa to 
achieve a composite laminate with a high fibre volume fraction of about 65% and to ensure the flatness of 
the cured laminate panel. 
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Three types of laminates were fabricated, as listed in Table 1. Base CF/EP laminate was fabricated to 
serve as the benchmark without microcapsules. Type A CF/EP laminates were fabricated with Type A 
microcapsules (75 g/m2) while Type B CF/EP laminates were fabricated with Type B microcapsules (75 
g/m2). The laminates were cured in the hot press at 120 °C for 16 h. The cured composite panels were then 
cut into specimens using water jet cutting. 
Specimen 
type 
No of 
WTDCB 
test 
Details Healant concentration 
(g/m2) 
Healing 
Conditions 
Epoxy 
loaded 
Hardener 
loaded 
Base CF/EP 5 Epoxy matrix with CF (Fracture 
surfaces reattached with 
mercaptan hardened epoxy 
adhesive) 
37.5 37.5 70°C, 24 hrs. 
Type A 
CF/EP 
5 Epoxy matrix with 
epoxy/hardener microcapsules 
embedded on the surface of CF 
37.5 37.5 70°C, 24 hrs. 
Type B 
CF/EP 
5 Epoxy matrix with 
epoxy/hardener microcapsules 
embedded on the surface of CF 
37.5 37.5 70°C, 24 hrs. 
Table 1: Summary and details of the various laminates 
Mode-I interlaminar fracture toughness of CF/EP laminates with and without the encapsulated 
healant were studied by adapting a width tapered double cantilever beam (WTDCB) specimens [14] 
(Figure 5). A WTDCB specimen is designed for constant compliance with crack length, so that the 
interlaminar fracture toughness, GIC is independent of crack length [21]. 
 
GIC=
12PC2K2
E1h
3  
(1) 
where Pc is the applied load, E1is the modulus of elasticity in the longitudinal direction, h is the specimen 
half thickness. K is a constant aspect ratio of on WTDCB (K = a/b(a)) [14], where b(a) is the width of 
specimen at crack length a, Figure 5. 
 
  
Figure 5: Geometry of WTDCB specimen for mode-I interlaminar fracture of CF/EP laminates 
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2.3. Mode-I interlaminar fracture 
Mode-I interlaminar fracture toughness test was conducted on an Instron 5567 universal testing 
machine equipped with 1 kN load cell at a displacement rate of 5 mm/min. The WTDCB specimen was 
loaded until the crack reaches the non-tapered region of the specimen (i.e. crack propagated from a = 60 
mm to approximately a = 100 mm) and then unloaded. The load and displacement were recorded 
throughout the test. At least 5 specimens were tested for each type of CF/EP laminates. 
For the base CF/EP specimens, after the crack propagated to about a=100 mm (the end of tapered 
region), the specimens were quickly unloaded and injected with the epoxy monomer mixed with 
mercaptan and DMP-30 as catalyst (i.e. mercaptan hardened epoxy adhesive), which is the same as that 
released from the capsules. The fractured specimen was than clamped using steel plates and then placed in 
an oven at 70°C for 24 hours. After healing, the specimens were cooled down to room temperature and 
tested again following the same mode-I interlaminar fracture procedure. Healing of these specimens 
serves as a benchmark on how strong this dual-component (epoxy/mercaptan) healant can get when the 
full coverage of healant on fracture surfaces is achieved. 
For self-healing CF/EP specimens, after quickly unloaded, the specimen was clamped using steel 
plates to bring the two crack surfaces together and then placed in an oven at 70°C for 24 hours. The healed 
specimens were tested again following the same procedure. The morphology of fracture surfaces was then 
examined using Scanning Electron Microscopy (SEM). 
2.4. Quantification of healing efficiency (η) 
Some parameters have been adopted to describe the healing performance of polymers [22]. Healing of 
CF/EP in this study was quantified by the recovery of its fracture toughness [14, 16]. Therefore, healing 
efficiency can be defined by the ratio of fracture toughness of the healed specimen, GICሺhealedሻ, and that of 
original specimen GIC(original) [22], 
 
η (%)=ඨGIC(healed)GIC(original) ×100 
(2) 
Instead of stable crack propagation, unstable or “stick-slip” crack propagation was observed for 
interlaminar fracture of the CF/EP laminates, which produces multiple peaks of critical load, Pc, for onset 
of crack propagation, leading to multiple values of the interlaminar fracture toughness, GIC  [14, 23, 24]. 
Due to this, instead of characterizing the healing efficiency with only the maximum value of fracture 
toughness, GICmax, the average value of fracture toughness, GIC
average, gathered from multiple peaks, Pc, was 
also taken into consideration. Average healing efficiency,Ʉaverage is defined as a ratio of the average 
fracture toughness in healed specimens (GIC(healed)
average ) to the average fracture toughness in original specimens 
(GIC(original)
average ), 
 
ηaverageሺ%ሻ=ඨ
GICሺhealedሻ
average
GICሺoriginalሻ
average ×100 (3) 
The maximum healing efficiency,ߟ௠௔௫, is defined as the ratio of the maximum fracture toughness in 
healed specimens (GIC(healed)max ) to the average fracture toughness in original specimens (GIC(original)
average ), 
 
ηmax(%)=ඨ
GIC(healed)max
GIC(original)
average ×100 (4) 
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2.5. Relationship between healant covered surface area and healing efficiency 
It was observed that the healant coverage on the fracture surfaces is related to the healing efficiency in 
CF/EP laminates. Quantitative assessment of the area covered by healant was conducted using ImageJ 
open-source image analyser. Images of fracture surfaces were obtained using SEM. The healant surface 
area was measured with the assumption that the fracture surface of healant is flatter than that of CF/EP 
composites. 20 images were randomly taken on the fracture surface from each Type A self-healing CF/EP 
specimens, with 5 images from the crack initiation area.  Bonded surface area (BSA) is then quantified as 
the ratio of the average healant covered surface area (HSA) to the total scanned area of fracture surface 
(TSA), 
 
Bonded Surface Area(%)=
HSAaverage
TSA
×100 (5) 
3 RESULTS AND DISCUSSION 
3.1. Mode-I fracture toughness evaluation 
Figure 8a shows typical load-displacement curves of interlaminar fracture of CF/EP laminates with 
Type A or Type B capsules in comparison to that of the base CF/EP laminate. In all cases the load 
increased linearly until the onset of delamination; then the crack propagated in stick-slip mode. The values 
of averaged fracture toughness were calculated using Equation (1). In Figure 8b, GICaverage for the base 
CF/EP laminates were reduced after adding the capsules. GIC
average of the base CF/EP laminates is 539.4 
J/m2, whereas GIC
average of Type A and Type B CF/EP are 514.4 J/m2 and 335.2 J/m2 , respectively. The 
microcapsules in the interlaminar regions apparently act as imperfection - voids (Figure 8a), thus directly 
influencing GIC of composites [25]. The size of microcapsules also has a direct influence on the fracture 
toughness of CF/EP. It can be seen in Figure 8b that the interlaminar fracture toughness is lowest for the 
CF/EP laminate with small microcapsules (Type B). Figure 2d shows the collapsed Type B hardener-
loaded microcapsules, which indicates that the capsules are flexible and may not retain the spherical shape 
during contact. This can promote agglomeration of capsules with poor adhesion between them. When 
delamination happens, instead of crack propagating through the capsule, the crack path manoeuvres 
around the capsules (Figure 8b). Large clusters of capsules may also leave voids between them, Figure 8c, 
which contributes to low fracture resistance. 
 
(a) (b) 
Figure 7: Interlaminar fracture of base laminate and laminates with Type A and Type B microcapsules; (a) 
typical load-displacement curves and (b) GIC
averagefor the base and self-healing laminates 
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(a) (b) (c) 
Figure 8: Fracture surfaces of CF/EP laminates; (a) voids, (b) dimples from debonded microcapsules and 
(c) clustering of smaller size microcapsules 
3.2. CF/EP injected with healant 
Figure 9 show the typical load-displacement curves for the base CF/EP laminate and that healed with 
the injected healant. The crack propagation onset occurs at a much higher load for CF/EP laminate healed 
by injecting healant between the fracture surfaces, and the delamination onset load after healing is clearly 
higher than that for the original fracture. As the crack advances, the load increased in a stable manner until 
it reached its maximum load and dropped towards the end of tapered region of the specimen. This may be 
associated with additional fracture mechanisms, such as fibre bridging and side cracking, which were not 
present during the original fracture. However, the result indicates that this dual-mechanism 
(epoxy/mercaptan) healant can potentially heal CF/EP laminates with more than 100% recovery of its 
fracture toughness. 
 
Figure 9: Typical load-displacement curves of interlaminar fracture of original fracture and fracture after 
healing of base CF/EP laminates with injected healant 
3.3. Self-healing efficiency of CF/EP 
For the typical load-displacement curves of CF/EP laminates with capsules in Figure 10, both original 
and healed laminates show stick-slip fracture behaviour, but with some clear differences. For fracture of 
the original laminates, after onset of delamination, the loads at “peak” and “valley” seem to remain 
between the lower and upper bounds as the crack propagated. For the laminate with Type A capsules, the 
load in all healed laminates increase with the crack growth, Figure 10a. As the main crack advances, 
microcapsules breaks releasing healant that has the ability to flow towards the narrower space between the 
upper and lower fracture surfaces through capillary motion, transferring more healant towards the main 
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crack tip [1]. This explains the ascending curve of the load with crack growth, as the better healed crack 
region developed in the region towards the crack tip produces high crack growth resistance, as 
demonstrated by the enhanced fracture resistance in the healed base laminate with injected healant in 
Figure 9. The average healing efficiency, ηavg, and maximum healing efficiency, ηmax, for CF/EP 
laminates with Type A capsules are 69% and 80% respectively. The values of both ηavg and ηmax are 
comparable to those reported before for a CF/EP laminate [14]. The fracture of healed CF/EP laminates 
with Type B capsules shows unstable crack propagation with clearly low values of peak load, Pc , The 
CF/EP laminates with Type B capsules showed the values of 54% and 57% for the average healing 
efficiency, ηavg, and the maximum healing efficiency, ηmax, which are much lower than those for the 
laminates with Type A capsules. Table 2 summarizes the results of mode-I interlaminar fracture tests and 
healing efficiency of the CF/EP laminates. As discussed in the previous section, small Type B capsules 
promote agglomeration of capsules with poor adhesion between them, and the crack path manoeuvres 
around the capsules without breaking them. The large clusters of small capsules means smaller areas of 
fracture surfaces can be covered by the healant released from the capsules, leading to poor healing ability. 
 
(a) Type A (b) Type B 
Figure 10: Interlaminar fracture of original CF/EP laminates and those after healing 
Sample Type GIC (virgin)
average  
(J/m2) 
GIC(healed)
average  
(J/m2) 
GIC(healed)max  
(J/m2) 
ηaverage(%) ηmax(%) 
Base CF/EP* 539.38 769.28 934.33 116 126 
Type-A 514.55 253.47 337.65 69 80 
Type-B 335.06 139.58 146.67 54 56 
*For the base CF/EP, the healing was achieved using direct injection of dual-component healant in the 
delaminated area. 
Table 2: Mode-I interlaminar fracture toughness and healing efficiency of base CF/EP and CF/EP 
laminates with Type A and Type B capsules 
3.4. Relationship between healant covered surface area and healing efficiency 
Figure 11 shows the relationship between the healant rich area on fracture surface and the healing 
efficiency for the CF/EP laminate with Type A capsules. It can be seen that the healing efficiency is 
clearly dependent upon the bonded surface area by healing agent. To achieve a high value of healing 
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efficiency, wide-spreading of healant on fracture surface is certainly needed, as demonstrated in the base 
laminate with the injected healant. However, there is a clear difference between the healant rich areas 
from one specimen to another. This is strongly related to distribution of microcapsules in matrix materials, 
which is related to dispersion of microcapsules on top of carbon fabrics before resin infusion. In addition, 
resin transfer during the VARI process may also promote non-uniform distribution of microcapsules, such 
as washing and agglomeration.  
 
Figure 11: Relationship between healant-area on fracture surface and healing efficiency of CF/EP laminate 
with Type A microcapsules 
3.5. Fractographic Analysis 
Figure 12 shows SEM fractographs of fracture surface of CF/EP laminates with Type A and Type B 
capsules. For Type A, it can be seen that fracture surface was roughly 50% covered by the healant. As 
previously discussed, large size microcapsules store more healant in them, subsequently resulting bigger 
healant rich areas. However, small capsules of Type B intend to form clusters. This directly influences the 
healant rich area; apart from that, smaller microcapsules contain a small amount of healant. With the 
smaller amount of healant, patchy healing happens on the surface causing insufficient coverage on the 
fracture surface area. 
 
(a) Type A (b) Type B 
Figure 12: SEM fractographs of CF/EP laminates with microencapsulated healant (a) Type A with healant 
covering fracture surface (b) patchy healing on Type-B fracture surface 
4 CONCLUSIONS 
A two-component healing system consisting of encapsulated epoxy and mercaptan as its hardener was 
developed for producing self-healing CF/EP laminates with a high fibre volume fraction of 65%, 
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fabricated using a VARI process. The interlaminar fracture of CF/EP laminates with large and small 
capsules was characterised using WTDCB specimens, and the self-healing efficiency of CF/EP laminates 
on interlaminar fracture was evaluated addressing the effect of size of capsules. Base on the results, a few 
useful points can be drawn: 
1. Incorporation of dual-component healant stored in fragile microcapsules can provide CF/EP laminates 
with self-healing capability by recovering as high as 80% of its original fracture toughness. 
2. Distribution and size of microcapsules have effects on the original interlaminar fracture toughness of 
CF/EP laminates. Both large and small capsules reduce the original interlaminar fracture toughness. 
Smaller capsules intend to agglomerate, causing poor adhesion between the microcapsules and leading 
more reduction in the fracture toughness. 
3. Distribution and size of microcapsules also has an effect on the interlaminar fracture toughness of 
CF/EP laminates after healing.  Larger capsules provide high healing efficiency for CF/EP laminates, 
with more healant stored and released to cover the fracture surfaces; small capsules provide low 
healing efficiency for CF/EP laminates with more clustered capsules. The healing efficiency is clearly 
dependent on the coverage of healant on fracture surfaces; wider coverage results in higher healing 
efficiency. 
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